Section 1 PE Tables – Results from the 2020 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

210604

Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	138,027	138,543	57,203	59,277	35,803	37,309
Marijuana	127,139	126,504	48,242	49,634	31,606	32,784
Cocaine	41,445	39,261	5,468	5,172	1,998	1,831
Crack	9,375	9,356	778	657	378	335
Heroin	5,696	6,252	745	902	431	513
Hallucinogens	44,087	43,949	6,010	7,133	1,915	1,761
LSD	27,528	28,123	2,470	2,637	580	649
PCP	5,516	6,141	73	95	*	24
Ecstasy	20,097	20,478	2,539	2,622	663	681
Inhalants	25,090	26,749	2,142	2,390	807	904
Methamphetamine	16,013	15,397	1,999	2,550	1,173	1,722
Misuse of Prescription Psychotherapeutics	nr	nr	16,304	16,073	5,337	5,278
Pain Relievers	nr	nr	9,724	9,254	2,819	2,536
Stimulants	nr	nr	4,929	5,092	1,566	1,493
Tranquilizers or Sedatives	nr	nr	5,895	6,205	1,958	2,196
Tranquilizers	nr	nr	5,220	5,460	1,781	1,891
Sedatives	nr	nr	1,098	1,240	304	481
Benzodiazepines	--	--	4,841	4,779	--	--
Opioids	nr	nr	10,065	9,490	3,101	2,885
Central Nervous System Stimulants	nr	nr	10,136	10,306	4,264	4,483
Illicit Drugs Other Than Marijuana²	nr	nr	23,588	23,962	9,333	9,305
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	50.2	50.0	20.8	21.4	13.0	13.5
Marijuana	46.2	45.7	17.5	17.9	11.5	11.8
Cocaine	15.1	14.2	2.0	1.9	0.7	0.7
Crack	3.4	3.4	0.3	0.2	0.1	0.1
Heroin	2.1	2.3	0.3	0.3	0.2	0.2
Hallucinogens	16.0	15.9	2.2	2.6	0.7	0.6
LSD	10.0	10.2	0.9	1.0	0.2	0.2
PCP	2.0	2.2	0.0	0.0	*	0.0
Ecstasy	7.3	7.4	0.9	0.9	0.2	0.2
Inhalants	9.1	9.7	0.8	0.9	0.3	0.3
Methamphetamine	5.8	5.6	0.7	0.9	0.4	0.6
Misuse of Prescription Psychotherapeutics	nr	nr	5.9	5.8	1.9	1.9
Pain Relievers	nr	nr	3.5	3.3	1.0	0.9
Stimulants	nr	nr	1.8	1.8	0.6	0.5
Tranquilizers or Sedatives	nr	nr	2.1	2.2	0.7	0.8
Tranquilizers	nr	nr	1.9	2.0	0.6	0.7
Sedatives	nr	nr	0.4	0.4	0.1	0.2
Benzodiazepines	--	--	1.8	1.7	--	--
Opioids	nr	nr	3.7	3.4	1.1	1.0
Central Nervous System Stimulants	nr	nr	3.7	3.7	1.5	1.6
Illicit Drugs Other Than Marijuana²	nr	nr	8.6	8.7	3.4	3.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	6,090	5,229	4,279	3,436	2,167	1,679
Marijuana	3,947	3,103	3,284	2,531	1,837	1,472
Cocaine	154	105	97	84	34	11
Crack	20	3	11	2	5	2
Heroin	21	*	*	*	*	*
Hallucinogens	615	563	440	370	152	80
LSD	392	317	279	219	68	27
PCP	41	7	21	*	*	*
Ecstasy	225	183	144	86	40	23
Inhalants	2,202	2,327	743	683	216	106
Methamphetamine	75	48	41	21	11	7
Misuse of Prescription Psychotherapeutics	nr	nr	1,062	688	329	169
Pain Relievers	nr	nr	567	396	165	96
Stimulants	nr	nr	430	288	123	72
Tranquilizers or Sedatives	nr	nr	436	226	121	26
Tranquilizers	nr	nr	392	196	112	25
Sedatives	nr	nr	82	35	29	1
Benzodiazepines	--	--	381	157	--	--
Opioids	nr	nr	567	396	165	96
Central Nervous System Stimulants	nr	nr	499	346	160	87
Illicit Drugs Other Than Marijuana²	nr	nr	1,862	1,507	598	305
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	24.5	20.9	17.2	13.8	8.7	6.7
Marijuana	15.8	12.4	13.2	10.1	7.4	5.9
Cocaine	0.6	0.4	0.4	0.3	0.1	0.0
Crack	0.1	0.0	0.0	0.0	0.0	0.0
Heroin	0.1	*	*	*	*	*
Hallucinogens	2.5	2.3	1.8	1.5	0.6	0.3
LSD	1.6	1.3	1.1	0.9	0.3	0.1
PCP	0.2	0.0	0.1	*	*	*
Ecstasy	0.9	0.7	0.6	0.3	0.2	0.1
Inhalants	8.8	9.3	3.0	2.7	0.9	0.4
Methamphetamine	0.3	0.2	0.2	0.1	0.0	0.0
Misuse of Prescription Psychotherapeutics	nr	nr	4.3	2.8	1.3	0.7
Pain Relievers	nr	nr	2.3	1.6	0.7	0.4
Stimulants	nr	nr	1.7	1.2	0.5	0.3
Tranquilizers or Sedatives	nr	nr	1.8	0.9	0.5	0.1
Tranquilizers	nr	nr	1.6	0.8	0.5	0.1
Sedatives	nr	nr	0.3	0.1	0.1	0.0
Benzodiazepines	--	--	1.5	0.6	--	--
Opioids	nr	nr	2.3	1.6	0.7	0.4
Central Nervous System Stimulants	nr	nr	2.0	1.4	0.6	0.3
Illicit Drugs Other Than Marijuana²	nr	nr	7.5	6.0	2.4	1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	131,937	133,314	52,924	55,841	33,636	35,630
Marijuana	123,192	123,401	44,958	47,103	29,769	31,312
Cocaine	41,291	39,155	5,371	5,088	1,965	1,821
Crack	9,355	9,354	766	655	372	333
Heroin	5,675	6,251	745	902	431	513
Hallucinogens	43,472	43,386	5,571	6,763	1,763	1,681
LSD	27,137	27,806	2,191	2,418	512	622
PCP	5,475	6,134	52	95	*	24
Ecstasy	19,872	20,295	2,395	2,537	623	659
Inhalants	22,889	24,422	1,399	1,707	591	797
Methamphetamine	15,939	15,349	1,958	2,528	1,161	1,715
Misuse of Prescription Psychotherapeutics	nr	nr	15,242	15,385	5,008	5,108
Pain Relievers	nr	nr	9,158	8,858	2,654	2,440
Stimulants	nr	nr	4,499	4,804	1,443	1,421
Tranquilizers or Sedatives	nr	nr	5,459	5,979	1,837	2,170
Tranquilizers	nr	nr	4,829	5,264	1,669	1,866
Sedatives	nr	nr	1,016	1,205	275	480
Benzodiazepines	--	--	4,460	4,622	--	--
Opioids	nr	nr	9,499	9,094	2,936	2,789
Central Nervous System Stimulants	nr	nr	9,638	9,960	4,103	4,396
Illicit Drugs Other Than Marijuana²	nr	nr	21,727	22,455	8,735	9,000
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	52.7	52.9	21.1	22.2	13.4	14.1
Marijuana	49.2	49.0	18.0	18.7	11.9	12.4
Cocaine	16.5	15.5	2.1	2.0	0.8	0.7
Crack	3.7	3.7	0.3	0.3	0.1	0.1
Heroin	2.3	2.5	0.3	0.4	0.2	0.2
Hallucinogens	17.4	17.2	2.2	2.7	0.7	0.7
LSD	10.8	11.0	0.9	1.0	0.2	0.2
PCP	2.2	2.4	0.0	0.0	*	0.0
Ecstasy	7.9	8.1	1.0	1.0	0.2	0.3
Inhalants	9.1	9.7	0.6	0.7	0.2	0.3
Methamphetamine	6.4	6.1	0.8	1.0	0.5	0.7
Misuse of Prescription Psychotherapeutics	nr	nr	6.1	6.1	2.0	2.0
Pain Relievers	nr	nr	3.7	3.5	1.1	1.0
Stimulants	nr	nr	1.8	1.9	0.6	0.6
Tranquilizers or Sedatives	nr	nr	2.2	2.4	0.7	0.9
Tranquilizers	nr	nr	1.9	2.1	0.7	0.7
Sedatives	nr	nr	0.4	0.5	0.1	0.2
Benzodiazepines	--	--	1.8	1.8	--	--
Opioids	nr	nr	3.8	3.6	1.2	1.1
Central Nervous System Stimulants	nr	nr	3.9	4.0	1.6	1.7
Illicit Drugs Other Than Marijuana²	nr	nr	8.7	8.9	3.5	3.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	18,832	17,879	13,193	12,398	8,406	8,016
Marijuana	17,450	16,604	11,952	11,566	7,749	7,727
Cocaine	3,809	3,065	1,789	1,441	540	424
Crack	339	247	61	49	18	35
Heroin	389	226	87	62	38	26
Hallucinogens	5,597	5,269	2,425	2,446	625	645
LSD	3,368	3,284	1,202	1,254	260	273
PCP	249	167	30	63	8	*
Ecstasy	3,500	2,946	1,089	845	214	187
Inhalants	3,099	2,929	577	507	157	160
Methamphetamine	904	538	275	171	110	74
Misuse of Prescription Psychotherapeutics	nr	nr	3,868	3,193	1,145	764
Pain Relievers	nr	nr	1,754	1,361	420	288
Stimulants	nr	nr	1,951	1,616	587	267
Tranquilizers or Sedatives	nr	nr	1,409	1,237	365	371
Tranquilizers	nr	nr	1,313	1,108	337	357
Sedatives	nr	nr	175	251	44	78
Benzodiazepines	--	--	1,266	1,097	--	--
Opioids	nr	nr	1,776	1,376	439	296
Central Nervous System Stimulants	nr	nr	3,205	2,567	1,127	682
Illicit Drugs Other Than Marijuana²	nr	nr	5,791	5,169	2,059	1,600
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	55.8	53.4	39.1	37.0	24.9	23.9
Marijuana	51.7	49.6	35.4	34.5	23.0	23.1
Cocaine	11.3	9.1	5.3	4.3	1.6	1.3
Crack	1.0	0.7	0.2	0.1	0.1	0.1
Heroin	1.2	0.7	0.3	0.2	0.1	0.1
Hallucinogens	16.6	15.7	7.2	7.3	1.9	1.9
LSD	10.0	9.8	3.6	3.7	0.8	0.8
PCP	0.7	0.5	0.1	0.2	0.0	*
Ecstasy	10.4	8.8	3.2	2.5	0.6	0.6
Inhalants	9.2	8.7	1.7	1.5	0.5	0.5
Methamphetamine	2.7	1.6	0.8	0.5	0.3	0.2
Misuse of Prescription Psychotherapeutics	nr	nr	11.5	9.5	3.4	2.3
Pain Relievers	nr	nr	5.2	4.1	1.2	0.9
Stimulants	nr	nr	5.8	4.8	1.7	0.8
Tranquilizers or Sedatives	nr	nr	4.2	3.7	1.1	1.1
Tranquilizers	nr	nr	3.9	3.3	1.0	1.1
Sedatives	nr	nr	0.5	0.7	0.1	0.2
Benzodiazepines	--	--	3.8	3.3	--	--
Opioids	nr	nr	5.3	4.1	1.3	0.9
Central Nervous System Stimulants	nr	nr	9.5	7.7	3.3	2.0
Illicit Drugs Other Than Marijuana²	nr	nr	17.2	15.4	6.1	4.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	113,104	115,435	39,731	43,443	25,231	27,614
Marijuana	105,742	106,797	33,007	35,537	22,020	23,585
Cocaine	37,483	36,091	3,582	3,646	1,425	1,396
Crack	9,016	9,107	706	606	355	298
Heroin	5,287	6,024	658	840	392	488
Hallucinogens	37,876	38,117	3,146	4,317	1,138	1,036
LSD	23,769	24,521	989	1,164	252	349
PCP	5,226	5,967	22	31	*	24
Ecstasy	16,372	17,348	1,306	1,692	409	472
Inhalants	19,790	21,493	822	1,200	434	637
Methamphetamine	15,034	14,811	1,682	2,358	1,051	1,641
Misuse of Prescription Psychotherapeutics	nr	nr	11,374	12,192	3,863	4,344
Pain Relievers	nr	nr	7,404	7,498	2,234	2,152
Stimulants	nr	nr	2,548	3,188	856	1,154
Tranquilizers or Sedatives	nr	nr	4,050	4,742	1,472	1,799
Tranquilizers	nr	nr	3,516	4,156	1,332	1,509
Sedatives	nr	nr	841	954	231	402
Benzodiazepines	--	--	3,194	3,526	--	--
Opioids	nr	nr	7,723	7,717	2,497	2,493
Central Nervous System Stimulants	nr	nr	6,433	7,393	2,976	3,714
Illicit Drugs Other Than Marijuana²	nr	nr	15,936	17,286	6,676	7,400
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2019 and 2020
Drug	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
ILLICIT DRUGS¹	52.2	52.8	18.3	19.9	11.6	12.6
Marijuana	48.8	48.9	15.2	16.3	10.2	10.8
Cocaine	17.3	16.5	1.7	1.7	0.7	0.6
Crack	4.2	4.2	0.3	0.3	0.2	0.1
Heroin	2.4	2.8	0.3	0.4	0.2	0.2
Hallucinogens	17.5	17.5	1.5	2.0	0.5	0.5
LSD	11.0	11.2	0.5	0.5	0.1	0.2
PCP	2.4	2.7	0.0	0.0	*	0.0
Ecstasy	7.6	7.9	0.6	0.8	0.2	0.2
Inhalants	9.1	9.8	0.4	0.5	0.2	0.3
Methamphetamine	6.9	6.8	0.8	1.1	0.5	0.8
Misuse of Prescription Psychotherapeutics	nr	nr	5.3	5.6	1.8	2.0
Pain Relievers	nr	nr	3.4	3.4	1.0	1.0
Stimulants	nr	nr	1.2	1.5	0.4	0.5
Tranquilizers or Sedatives	nr	nr	1.9	2.2	0.7	0.8
Tranquilizers	nr	nr	1.6	1.9	0.6	0.7
Sedatives	nr	nr	0.4	0.4	0.1	0.2
Benzodiazepines	--	--	1.5	1.6	--	--
Opioids	nr	nr	3.6	3.5	1.2	1.1
Central Nervous System Stimulants	nr	nr	3.0	3.4	1.4	1.7
Illicit Drugs Other Than Marijuana²	nr	nr	7.4	7.9	3.1	3.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	138,027	138,543	57,203	59,277	35,803	37,309
12-20	12,323	10,691	9,116	7,486	5,137	4,208
21 or Older	125,704	127,852	48,087	51,791	30,666	33,101
12-17	6,090	5,229	4,279	3,436	2,167	1,679
12-13	1,041	941	582	442	214	76
14-15	1,970	1,780	1,313	1,209	622	599
16-17	3,080	2,507	2,384	1,785	1,331	1,004
18 or Older	131,937	133,314	52,924	55,841	33,636	35,630
18-25	18,832	17,879	13,193	12,398	8,406	8,016
18-20	6,233	5,463	4,837	4,051	2,970	2,529
21-25	12,599	12,416	8,356	8,347	5,436	5,487
26 or Older	113,104	115,435	39,731	43,443	25,231	27,614
26-49	59,083	58,674	26,092	27,784	16,479	18,165
26-29	11,523	10,746	6,690	6,234	4,419	4,177
30-34	13,677	13,638	6,520	6,967	4,056	4,508
35-39	12,847	13,127	5,338	6,053	3,337	3,914
40-44	10,694	10,448	3,887	4,323	2,337	2,926
45-49	10,342	10,714	3,657	4,207	2,330	2,641
50 or Older	54,021	56,762	13,639	15,660	8,752	9,449
50-54	11,391	11,192	3,108	3,624	2,024	2,302
55-59	12,209	12,248	3,498	3,797	2,203	2,187
60-64	12,176	12,056	3,303	3,955	2,281	2,419
65 or Older	18,245	21,266	3,730	4,284	2,243	2,541
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	50.2	50.0	20.8	21.4	13.0	13.5
12-20	32.4	28.6	23.9	20.0	13.5	11.2
21 or Older	53.0	53.4	20.3	21.6	12.9	13.8
12-17	24.5	20.9	17.2	13.8	8.7	6.7
12-13	12.7	11.1	7.1	5.2	2.6	0.9
14-15	23.2	20.6	15.5	14.0	7.3	6.9
16-17	37.3	31.8	28.9	22.6	16.1	12.7
18 or Older	52.7	52.9	21.1	22.2	13.4	14.1
18-25	55.8	53.4	39.1	37.0	24.9	23.9
18-20	47.3	43.9	36.7	32.6	22.6	20.3
21-25	61.3	59.0	40.6	39.6	26.4	26.1
26 or Older	52.2	52.8	18.3	19.9	11.6	12.6
26-49	58.3	57.8	25.8	27.4	16.3	17.9
26-29	63.8	60.3	37.1	35.0	24.5	23.5
30-34	61.4	60.0	29.3	30.7	18.2	19.8
35-39	60.0	58.8	24.9	27.1	15.6	17.5
40-44	55.5	53.9	20.2	22.3	12.1	15.1
45-49	51.1	55.5	18.1	21.8	11.5	13.7
50 or Older	46.9	48.6	11.8	13.4	7.6	8.1
50-54	55.3	56.2	15.1	18.2	9.8	11.6
55-59	57.4	56.9	16.4	17.6	10.4	10.2
60-64	59.2	57.7	16.1	18.9	11.1	11.6
65 or Older	34.5	39.0	7.1	7.9	4.2	4.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	127,139	126,504	48,242	49,634	31,606	32,784
12-20	9,580	8,003	7,696	6,325	4,626	3,952
21 or Older	117,559	118,501	40,546	43,310	26,981	28,832
12-17	3,947	3,103	3,284	2,531	1,837	1,472
12-13	253	158	201	111	84	32
14-15	1,165	1,031	992	897	527	517
16-17	2,528	1,914	2,091	1,523	1,227	923
18 or Older	123,192	123,401	44,958	47,103	29,769	31,312
18-25	17,450	16,604	11,952	11,566	7,749	7,727
18-20	5,633	4,900	4,412	3,794	2,788	2,480
21-25	11,817	11,704	7,539	7,773	4,961	5,247
26 or Older	105,742	106,797	33,007	35,537	22,020	23,585
26-49	55,315	54,599	22,016	23,445	14,559	15,950
26-29	10,906	10,105	5,958	5,420	4,026	3,787
30-34	12,842	12,750	5,562	5,924	3,627	4,028
35-39	12,077	12,385	4,451	5,214	2,932	3,561
40-44	9,922	9,864	3,134	3,611	2,023	2,478
45-49	9,568	9,496	2,911	3,276	1,951	2,097
50 or Older	50,427	52,198	10,990	12,091	7,461	7,635
50-54	10,707	9,961	2,562	2,789	1,695	1,995
55-59	11,394	11,409	2,867	2,870	1,906	1,580
60-64	11,664	11,474	2,891	3,140	2,024	2,024
65 or Older	16,662	19,354	2,670	3,292	1,836	2,035
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	46.2	45.7	17.5	17.9	11.5	11.8
12-20	25.2	21.4	20.2	16.9	12.1	10.6
21 or Older	49.6	49.5	17.1	18.1	11.4	12.0
12-17	15.8	12.4	13.2	10.1	7.4	5.9
12-13	3.1	1.9	2.5	1.3	1.0	0.4
14-15	13.7	11.9	11.7	10.4	6.2	6.0
16-17	30.6	24.3	25.3	19.3	14.9	11.7
18 or Older	49.2	49.0	18.0	18.7	11.9	12.4
18-25	51.7	49.6	35.4	34.5	23.0	23.1
18-20	42.8	39.4	33.5	30.5	21.2	19.9
21-25	57.5	55.6	36.7	36.9	24.1	24.9
26 or Older	48.8	48.9	15.2	16.3	10.2	10.8
26-49	54.6	53.8	21.7	23.1	14.4	15.7
26-29	60.4	56.7	33.0	30.4	22.3	21.3
30-34	57.7	56.1	25.0	26.1	16.3	17.7
35-39	56.4	55.5	20.8	23.4	13.7	16.0
40-44	51.5	50.9	16.3	18.6	10.5	12.8
45-49	47.2	49.2	14.4	17.0	9.6	10.9
50 or Older	43.7	44.7	9.5	10.3	6.5	6.5
50-54	51.9	50.0	12.4	14.0	8.2	10.0
55-59	53.6	53.0	13.5	13.3	9.0	7.3
60-64	56.7	54.9	14.0	15.0	9.8	9.7
65 or Older	31.5	35.5	5.1	6.0	3.5	3.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	41,445	39,261	5,468	5,172	1,998	1,831
12-20	925	558	529	357	161	95
21 or Older	40,520	38,703	4,939	4,815	1,838	1,736
12-17	154	105	97	84	34	11
12-13	12	8	12	4	*	*
14-15	30	21	20	19	11	1
16-17	112	76	65	62	23	10
18 or Older	41,291	39,155	5,371	5,088	1,965	1,821
18-25	3,809	3,065	1,789	1,441	540	424
18-20	771	452	432	273	127	84
21-25	3,038	2,612	1,357	1,168	413	340
26 or Older	37,483	36,091	3,582	3,646	1,425	1,396
26-49	17,622	17,641	2,863	3,002	1,051	1,156
26-29	3,298	2,744	957	924	296	286
30-34	4,173	4,021	811	535	309	175
35-39	3,870	4,272	565	676	200	287
40-44	3,346	3,122	284	437	149	226
45-49	2,936	3,482	246	431	98	183
50 or Older	19,861	18,450	720	644	374	240
50-54	4,307	3,548	181	218	118	127
55-59	5,339	4,611	219	150	96	70
60-64	5,323	5,172	220	120	129	16
65 or Older	4,892	5,118	100	157	32	27
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	15.1	14.2	2.0	1.9	0.7	0.7
12-20	2.4	1.5	1.4	1.0	0.4	0.3
21 or Older	17.1	16.2	2.1	2.0	0.8	0.7
12-17	0.6	0.4	0.4	0.3	0.1	0.0
12-13	0.1	0.1	0.1	0.0	*	*
14-15	0.4	0.2	0.2	0.2	0.1	0.0
16-17	1.4	1.0	0.8	0.8	0.3	0.1
18 or Older	16.5	15.5	2.1	2.0	0.8	0.7
18-25	11.3	9.1	5.3	4.3	1.6	1.3
18-20	5.9	3.6	3.3	2.2	1.0	0.7
21-25	14.8	12.4	6.6	5.5	2.0	1.6
26 or Older	17.3	16.5	1.7	1.7	0.7	0.6
26-49	17.4	17.4	2.8	3.0	1.0	1.1
26-29	18.3	15.4	5.3	5.2	1.6	1.6
30-34	18.7	17.7	3.6	2.4	1.4	0.8
35-39	18.1	19.1	2.6	3.0	0.9	1.3
40-44	17.4	16.1	1.5	2.3	0.8	1.2
45-49	14.5	18.0	1.2	2.2	0.5	0.9
50 or Older	17.2	15.8	0.6	0.6	0.3	0.2
50-54	20.9	17.8	0.9	1.1	0.6	0.6
55-59	25.1	21.4	1.0	0.7	0.5	0.3
60-64	25.9	24.7	1.1	0.6	0.6	0.1
65 or Older	9.3	9.4	0.2	0.3	0.1	0.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	9,375	9,356	778	657	378	335
12-20	71	46	27	25	10	25
21 or Older	9,304	9,311	751	632	368	310
12-17	20	3	11	2	5	2
12-13	*	*	*	*	*	*
14-15	3	*	*	*	*	*
16-17	16	3	11	2	5	2
18 or Older	9,355	9,354	766	655	372	333
18-25	339	247	61	49	18	35
18-20	51	43	15	23	4	23
21-25	287	204	46	26	13	12
26 or Older	9,016	9,107	706	606	355	298
26-49	4,334	4,463	343	371	168	244
26-29	469	389	38	40	22	19
30-34	949	854	69	52	31	17
35-39	945	1,259	110	118	49	81
40-44	1,024	829	63	83	32	78
45-49	947	1,132	63	79	34	50
50 or Older	4,682	4,644	363	234	187	53
50-54	1,275	1,116	94	138	67	29
55-59	1,266	1,523	96	14	28	6
60-64	1,376	852	99	*	75	*
65 or Older	765	1,153	75	82	18	19
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	3.4	3.4	0.3	0.2	0.1	0.1
12-20	0.2	0.1	0.1	0.1	0.0	0.1
21 or Older	3.9	3.9	0.3	0.3	0.2	0.1
12-17	0.1	0.0	0.0	0.0	0.0	0.0
12-13	*	*	*	*	*	*
14-15	0.0	*	*	*	*	*
16-17	0.2	0.0	0.1	0.0	0.1	0.0
18 or Older	3.7	3.7	0.3	0.3	0.1	0.1
18-25	1.0	0.7	0.2	0.1	0.1	0.1
18-20	0.4	0.3	0.1	0.2	0.0	0.2
21-25	1.4	1.0	0.2	0.1	0.1	0.1
26 or Older	4.2	4.2	0.3	0.3	0.2	0.1
26-49	4.3	4.4	0.3	0.4	0.2	0.2
26-29	2.6	2.2	0.2	0.2	0.1	0.1
30-34	4.3	3.8	0.3	0.2	0.1	0.1
35-39	4.4	5.6	0.5	0.5	0.2	0.4
40-44	5.3	4.3	0.3	0.4	0.2	0.4
45-49	4.7	5.9	0.3	0.4	0.2	0.3
50 or Older	4.1	4.0	0.3	0.2	0.2	0.0
50-54	6.2	5.6	0.5	0.7	0.3	0.1
55-59	6.0	7.1	0.5	0.1	0.1	0.0
60-64	6.7	4.1	0.5	*	0.4	*
65 or Older	1.4	2.1	0.1	0.2	0.0	0.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	44,087	43,949	6,010	7,133	1,915	1,761
12-20	1,999	1,823	1,271	1,202	360	358
21 or Older	42,088	42,126	4,739	5,931	1,554	1,404
12-17	615	563	440	370	152	80
12-13	50	24	29	14	17	6
14-15	175	161	125	130	50	19
16-17	390	378	285	227	85	55
18 or Older	43,472	43,386	5,571	6,763	1,763	1,681
18-25	5,597	5,269	2,425	2,446	625	645
18-20	1,385	1,260	831	831	208	278
21-25	4,212	4,010	1,593	1,614	416	368
26 or Older	37,876	38,117	3,146	4,317	1,138	1,036
26-49	21,719	21,938	2,742	3,757	1,002	979
26-29	4,398	3,815	1,023	1,142	358	308
30-34	5,101	5,020	878	988	326	159
35-39	4,857	4,825	396	770	157	298
40-44	4,086	3,957	268	460	89	124
45-49	3,277	4,321	178	397	71	90
50 or Older	16,157	16,178	404	560	136	57
50-54	3,312	3,274	114	303	29	11
55-59	3,927	3,353	129	17	51	17
60-64	4,240	4,545	52	81	6	*
65 or Older	4,678	5,006	109	160	51	29
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	16.0	15.9	2.2	2.6	0.7	0.6
12-20	5.3	4.9	3.3	3.2	0.9	1.0
21 or Older	17.7	17.6	2.0	2.5	0.7	0.6
12-17	2.5	2.3	1.8	1.5	0.6	0.3
12-13	0.6	0.3	0.4	0.2	0.2	0.1
14-15	2.1	1.9	1.5	1.5	0.6	0.2
16-17	4.7	4.8	3.4	2.9	1.0	0.7
18 or Older	17.4	17.2	2.2	2.7	0.7	0.7
18-25	16.6	15.7	7.2	7.3	1.9	1.9
18-20	10.5	10.1	6.3	6.7	1.6	2.2
21-25	20.5	19.0	7.7	7.7	2.0	1.7
26 or Older	17.5	17.5	1.5	2.0	0.5	0.5
26-49	21.4	21.6	2.7	3.7	1.0	1.0
26-29	24.4	21.4	5.7	6.4	2.0	1.7
30-34	22.9	22.1	3.9	4.4	1.5	0.7
35-39	22.7	21.6	1.8	3.4	0.7	1.3
40-44	21.2	20.4	1.4	2.4	0.5	0.6
45-49	16.2	22.4	0.9	2.1	0.3	0.5
50 or Older	14.0	13.8	0.3	0.5	0.1	0.0
50-54	16.1	16.4	0.6	1.5	0.1	0.1
55-59	18.5	15.6	0.6	0.1	0.2	0.1
60-64	20.6	21.7	0.3	0.4	0.0	*
65 or Older	8.9	9.2	0.2	0.3	0.1	0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	25,090	26,749	2,142	2,390	807	904
12-20	3,124	3,254	967	848	259	158
21 or Older	21,966	23,495	1,175	1,541	548	746
12-17	2,202	2,327	743	683	216	106
12-13	675	760	285	247	85	24
14-15	827	874	266	232	69	51
16-17	699	693	192	204	63	31
18 or Older	22,889	24,422	1,399	1,707	591	797
18-25	3,099	2,929	577	507	157	160
18-20	922	927	224	165	43	51
21-25	2,176	2,002	353	341	114	109
26 or Older	19,790	21,493	822	1,200	434	637
26-49	11,893	12,957	623	1,062	332	563
26-29	1,957	2,059	184	325	73	164
30-34	2,671	2,802	167	179	101	71
35-39	2,574	2,723	133	268	56	143
40-44	2,440	2,639	81	97	47	34
45-49	2,252	2,733	59	192	54	151
50 or Older	7,897	8,536	199	139	102	75
50-54	2,035	2,057	63	15	15	1
55-59	2,059	2,052	47	41	37	27
60-64	1,963	2,338	*	52	*	16
65 or Older	1,839	2,089	89	30	50	30
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	9.1	9.7	0.8	0.9	0.3	0.3
12-20	8.2	8.7	2.5	2.3	0.7	0.4
21 or Older	9.3	9.8	0.5	0.6	0.2	0.3
12-17	8.8	9.3	3.0	2.7	0.9	0.4
12-13	8.3	9.0	3.5	2.9	1.0	0.3
14-15	9.8	10.1	3.1	2.7	0.8	0.6
16-17	8.5	8.8	2.3	2.6	0.8	0.4
18 or Older	9.1	9.7	0.6	0.7	0.2	0.3
18-25	9.2	8.7	1.7	1.5	0.5	0.5
18-20	7.0	7.4	1.7	1.3	0.3	0.4
21-25	10.6	9.5	1.7	1.6	0.6	0.5
26 or Older	9.1	9.8	0.4	0.5	0.2	0.3
26-49	11.7	12.8	0.6	1.0	0.3	0.6
26-29	10.8	11.6	1.0	1.8	0.4	0.9
30-34	12.0	12.3	0.7	0.8	0.5	0.3
35-39	12.0	12.2	0.6	1.2	0.3	0.6
40-44	12.7	13.6	0.4	0.5	0.2	0.2
45-49	11.1	14.1	0.3	1.0	0.3	0.8
50 or Older	6.8	7.3	0.2	0.1	0.1	0.1
50-54	9.9	10.3	0.3	0.1	0.1	0.0
55-59	9.7	9.5	0.2	0.2	0.2	0.1
60-64	9.5	11.2	*	0.2	*	0.1
65 or Older	3.5	3.8	0.2	0.1	0.1	0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	16,013	15,397	1,999	2,550	1,173	1,722
12-20	242	125	115	60	34	34
21 or Older	15,771	15,273	1,884	2,490	1,139	1,688
12-17	75	48	41	21	11	7
12-13	12	1	9	1	3	1
14-15	16	6	9	4	5	4
16-17	47	40	24	16	3	2
18 or Older	15,939	15,349	1,958	2,528	1,161	1,715
18-25	904	538	275	171	110	74
18-20	167	77	74	38	23	27
21-25	737	462	202	133	88	47
26 or Older	15,034	14,811	1,682	2,358	1,051	1,641
26-49	7,727	8,215	1,262	1,549	800	1,107
26-29	1,001	1,002	238	260	139	151
30-34	1,619	1,679	312	233	164	179
35-39	1,779	2,102	318	512	211	334
40-44	1,800	1,588	228	273	162	238
45-49	1,528	1,844	165	270	124	204
50 or Older	7,307	6,597	420	809	251	534
50-54	1,549	1,175	159	202	81	134
55-59	1,687	1,577	102	227	83	90
60-64	1,934	1,966	99	102	73	79
65 or Older	2,137	1,879	60	278	14	231
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	5.8	5.6	0.7	0.9	0.4	0.6
12-20	0.6	0.3	0.3	0.2	0.1	0.1
21 or Older	6.7	6.4	0.8	1.0	0.5	0.7
12-17	0.3	0.2	0.2	0.1	0.0	0.0
12-13	0.1	0.0	0.1	0.0	0.0	0.0
14-15	0.2	0.1	0.1	0.1	0.1	0.1
16-17	0.6	0.5	0.3	0.2	0.0	0.0
18 or Older	6.4	6.1	0.8	1.0	0.5	0.7
18-25	2.7	1.6	0.8	0.5	0.3	0.2
18-20	1.3	0.6	0.6	0.3	0.2	0.2
21-25	3.6	2.2	1.0	0.6	0.4	0.2
26 or Older	6.9	6.8	0.8	1.1	0.5	0.8
26-49	7.6	8.1	1.2	1.5	0.8	1.1
26-29	5.5	5.6	1.3	1.5	0.8	0.8
30-34	7.3	7.4	1.4	1.0	0.7	0.8
35-39	8.3	9.4	1.5	2.3	1.0	1.5
40-44	9.3	8.2	1.2	1.4	0.8	1.2
45-49	7.5	9.5	0.8	1.4	0.6	1.1
50 or Older	6.3	5.6	0.4	0.7	0.2	0.5
50-54	7.5	5.9	0.8	1.0	0.4	0.7
55-59	7.9	7.3	0.5	1.1	0.4	0.4
60-64	9.4	9.4	0.5	0.5	0.4	0.4
65 or Older	4.0	3.4	0.1	0.5	0.0	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.13A – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	82,559	75,198	9,724	9,254	2,819	2,536
12-20	7,054	5,543	1,143	781	301	162
21 or Older	75,505	69,655	8,582	8,474	2,518	2,374
12-17	3,980	3,079	567	396	165	96
12-13	950	710	112	84	36	16
14-15	1,400	1,166	176	130	51	42
16-17	1,630	1,203	278	183	77	38
18 or Older	78,579	72,118	9,158	8,858	2,654	2,440
18-25	8,357	6,858	1,754	1,361	420	288
18-20	3,074	2,463	576	385	136	66
21-25	5,284	4,395	1,178	976	284	222
26 or Older	70,222	65,261	7,404	7,498	2,234	2,152
26-49	30,585	26,783	4,797	4,535	1,370	1,264
26-29	5,089	3,898	1,023	795	322	231
30-34	6,752	5,650	1,205	943	325	191
35-39	6,459	5,927	1,074	946	277	236
40-44	5,992	4,880	802	727	205	218
45-49	6,292	6,429	693	1,125	241	388
50 or Older	39,637	38,477	2,607	2,962	864	888
50-54	6,674	6,084	646	567	227	138
55-59	7,169	7,373	638	682	208	194
60-64	7,325	7,285	422	682	197	266
65 or Older	18,470	17,735	900	1,032	232	289
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.13B – Any Use of Prescription Pain Relievers in Past Year and Misuse of Prescription Pain Relievers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	30.0	27.2	3.5	3.3	1.0	0.9
12-20	18.5	14.8	3.0	2.1	0.8	0.4
21 or Older	31.8	29.1	3.6	3.5	1.1	1.0
12-17	16.0	12.3	2.3	1.6	0.7	0.4
12-13	11.6	8.4	1.4	1.0	0.4	0.2
14-15	16.5	13.5	2.1	1.5	0.6	0.5
16-17	19.7	15.3	3.4	2.3	0.9	0.5
18 or Older	31.4	28.6	3.7	3.5	1.1	1.0
18-25	24.8	20.5	5.2	4.1	1.2	0.9
18-20	23.3	19.8	4.4	3.1	1.0	0.5
21-25	25.7	20.9	5.7	4.6	1.4	1.1
26 or Older	32.4	29.9	3.4	3.4	1.0	1.0
26-49	30.2	26.4	4.7	4.5	1.4	1.2
26-29	28.2	21.9	5.7	4.5	1.8	1.3
30-34	30.3	24.9	5.4	4.2	1.5	0.8
35-39	30.1	26.6	5.0	4.2	1.3	1.1
40-44	31.1	25.2	4.2	3.8	1.1	1.1
45-49	31.1	33.3	3.4	5.8	1.2	2.0
50 or Older	34.4	32.9	2.3	2.5	0.7	0.8
50-54	32.4	30.6	3.1	2.8	1.1	0.7
55-59	33.7	34.2	3.0	3.2	1.0	0.9
60-64	35.6	34.8	2.1	3.3	1.0	1.3
65 or Older	35.0	32.5	1.7	1.9	0.4	0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	18,290	18,332	4,929	5,092	1,566	1,493
12-20	3,339	2,793	1,093	769	301	131
21 or Older	14,950	15,539	3,835	4,323	1,265	1,363
12-17	1,837	1,593	430	288	123	72
12-13	378	389	24	29	3	3
14-15	619	526	119	103	38	19
16-17	841	678	287	157	82	51
18 or Older	16,453	16,739	4,499	4,804	1,443	1,421
18-25	4,320	3,773	1,951	1,616	587	267
18-20	1,502	1,199	664	481	178	58
21-25	2,818	2,574	1,287	1,135	409	209
26 or Older	12,133	12,966	2,548	3,188	856	1,154
26-49	8,105	8,086	2,247	2,640	754	1,072
26-29	1,998	1,841	695	718	198	193
30-34	2,134	2,195	748	835	253	327
35-39	1,588	1,634	410	529	147	260
40-44	1,230	1,159	263	332	114	141
45-49	1,156	1,257	130	226	43	152
50 or Older	4,028	4,880	301	548	102	82
50-54	865	1,464	72	295	5	65
55-59	1,096	962	128	117	38	5
60-64	727	754	66	78	59	13
65 or Older	1,340	1,700	34	58	*	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	6.6	6.6	1.8	1.8	0.6	0.5
12-20	8.8	7.5	2.9	2.1	0.8	0.3
21 or Older	6.3	6.5	1.6	1.8	0.5	0.6
12-17	7.4	6.4	1.7	1.2	0.5	0.3
12-13	4.6	4.6	0.3	0.3	0.0	0.0
14-15	7.3	6.1	1.4	1.2	0.5	0.2
16-17	10.2	8.6	3.5	2.0	1.0	0.6
18 or Older	6.6	6.6	1.8	1.9	0.6	0.6
18-25	12.8	11.3	5.8	4.8	1.7	0.8
18-20	11.4	9.6	5.0	3.9	1.3	0.5
21-25	13.7	12.2	6.3	5.4	2.0	1.0
26 or Older	5.6	5.9	1.2	1.5	0.4	0.5
26-49	8.0	8.0	2.2	2.6	0.7	1.1
26-29	11.1	10.3	3.9	4.0	1.1	1.1
30-34	9.6	9.7	3.4	3.7	1.1	1.4
35-39	7.4	7.3	1.9	2.4	0.7	1.2
40-44	6.4	6.0	1.4	1.7	0.6	0.7
45-49	5.7	6.5	0.6	1.2	0.2	0.8
50 or Older	3.5	4.2	0.3	0.5	0.1	0.1
50-54	4.2	7.4	0.3	1.5	0.0	0.3
55-59	5.2	4.5	0.6	0.5	0.2	0.0
60-64	3.5	3.6	0.3	0.4	0.3	0.1
65 or Older	2.5	3.1	0.1	0.1	*	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	44,051	43,001	5,895	6,205	1,958	2,196
12-20	2,564	2,102	909	641	231	109
21 or Older	41,488	40,899	4,986	5,564	1,727	2,088
12-17	1,370	936	436	226	121	26
12-13	276	234	24	33	10	2
14-15	435	340	124	70	34	12
16-17	659	362	287	122	78	13
18 or Older	42,682	42,065	5,459	5,979	1,837	2,170
18-25	3,995	3,805	1,409	1,237	365	371
18-20	1,194	1,166	473	415	110	82
21-25	2,801	2,638	936	822	254	289
26 or Older	38,687	38,261	4,050	4,742	1,472	1,799
26-49	16,129	16,192	2,582	3,175	1,006	1,053
26-29	2,519	2,301	600	662	230	171
30-34	3,428	2,957	743	648	318	177
35-39	3,305	3,509	514	721	180	294
40-44	3,363	3,603	413	552	181	233
45-49	3,514	3,823	312	593	97	179
50 or Older	22,558	22,068	1,468	1,567	467	746
50-54	3,575	3,642	358	325	106	114
55-59	4,234	3,911	408	479	151	250
60-64	4,133	4,209	378	350	103	119
65 or Older	10,615	10,306	325	412	106	262
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	16.0	15.5	2.1	2.2	0.7	0.8
12-20	6.7	5.6	2.4	1.7	0.6	0.3
21 or Older	17.5	17.1	2.1	2.3	0.7	0.9
12-17	5.5	3.7	1.8	0.9	0.5	0.1
12-13	3.4	2.8	0.3	0.4	0.1	0.0
14-15	5.1	3.9	1.5	0.8	0.4	0.1
16-17	8.0	4.6	3.5	1.6	0.9	0.2
18 or Older	17.1	16.7	2.2	2.4	0.7	0.9
18-25	11.8	11.4	4.2	3.7	1.1	1.1
18-20	9.1	9.4	3.6	3.3	0.8	0.7
21-25	13.6	12.5	4.6	3.9	1.2	1.4
26 or Older	17.9	17.5	1.9	2.2	0.7	0.8
26-49	15.9	15.9	2.5	3.1	1.0	1.0
26-29	14.0	12.9	3.3	3.7	1.3	1.0
30-34	15.4	13.0	3.3	2.9	1.4	0.8
35-39	15.4	15.7	2.4	3.2	0.8	1.3
40-44	17.4	18.6	2.1	2.8	0.9	1.2
45-49	17.3	19.8	1.5	3.1	0.5	0.9
50 or Older	19.6	18.9	1.3	1.3	0.4	0.6
50-54	17.3	18.3	1.7	1.6	0.5	0.6
55-59	19.9	18.2	1.9	2.2	0.7	1.2
60-64	20.1	20.1	1.8	1.7	0.5	0.6
65 or Older	20.1	18.9	0.6	0.8	0.2	0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	35,601	35,018	5,220	5,460	1,781	1,891
12-20	1,995	1,552	840	547	216	106
21 or Older	33,606	33,466	4,381	4,912	1,565	1,785
12-17	1,010	588	392	196	112	25
12-13	140	125	16	32	5	2
14-15	308	216	105	59	32	12
16-17	562	246	271	105	75	12
18 or Older	34,591	34,430	4,829	5,264	1,669	1,866
18-25	3,419	3,338	1,313	1,108	337	357
18-20	985	965	448	352	104	81
21-25	2,434	2,374	865	756	233	276
26 or Older	31,172	31,092	3,516	4,156	1,332	1,509
26-49	13,668	13,962	2,342	2,901	952	924
26-29	2,183	1,981	570	598	227	154
30-34	2,986	2,624	711	624	312	169
35-39	2,835	3,029	448	648	161	261
40-44	2,886	3,136	373	516	169	199
45-49	2,778	3,192	240	515	83	141
50 or Older	17,504	17,130	1,174	1,255	380	585
50-54	2,905	2,930	300	264	94	100
55-59	3,335	3,136	300	402	124	231
60-64	3,234	3,453	336	333	97	119
65 or Older	8,030	7,611	238	256	65	135
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	12.9	12.6	1.9	2.0	0.6	0.7
12-20	5.2	4.1	2.2	1.5	0.6	0.3
21 or Older	14.2	14.0	1.8	2.1	0.7	0.7
12-17	4.1	2.4	1.6	0.8	0.5	0.1
12-13	1.7	1.5	0.2	0.4	0.1	0.0
14-15	3.6	2.5	1.2	0.7	0.4	0.1
16-17	6.8	3.1	3.3	1.3	0.9	0.1
18 or Older	13.8	13.7	1.9	2.1	0.7	0.7
18-25	10.1	10.0	3.9	3.3	1.0	1.1
18-20	7.5	7.8	3.4	2.8	0.8	0.7
21-25	11.8	11.3	4.2	3.6	1.1	1.3
26 or Older	14.4	14.2	1.6	1.9	0.6	0.7
26-49	13.5	13.8	2.3	2.9	0.9	0.9
26-29	12.1	11.1	3.2	3.4	1.3	0.9
30-34	13.4	11.6	3.2	2.7	1.4	0.7
35-39	13.2	13.6	2.1	2.9	0.8	1.2
40-44	15.0	16.2	1.9	2.7	0.9	1.0
45-49	13.7	16.5	1.2	2.7	0.4	0.7
50 or Older	15.2	14.7	1.0	1.1	0.3	0.5
50-54	14.1	14.7	1.5	1.3	0.5	0.5
55-59	15.7	14.6	1.4	1.9	0.6	1.1
60-64	15.7	16.5	1.6	1.6	0.5	0.6
65 or Older	15.2	14.0	0.5	0.5	0.1	0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	15,636	15,364	1,098	1,240	304	481
12-20	883	799	138	139	43	23
21 or Older	14,752	14,565	960	1,101	261	458
12-17	545	429	82	35	29	1
12-13	166	131	10	2	5	*
14-15	187	160	35	15	14	*
16-17	192	139	37	18	10	1
18 or Older	15,091	14,935	1,016	1,205	275	480
18-25	1,051	1,066	175	251	44	78
18-20	339	370	56	104	15	21
21-25	712	695	119	147	30	56
26 or Older	14,040	13,869	841	954	231	402
26-49	4,862	4,751	423	483	112	179
26-29	615	626	71	90	11	23
30-34	967	759	85	41	43	9
35-39	978	1,040	104	127	31	54
40-44	1,008	940	72	125	12	55
45-49	1,293	1,385	91	99	14	38
50 or Older	9,178	9,119	417	472	119	223
50-54	1,320	1,574	93	96	35	49
55-59	1,752	1,525	145	171	38	43
60-64	1,701	1,509	72	47	6	4
65 or Older	4,405	4,510	107	158	41	127
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	5.7	5.5	0.4	0.4	0.1	0.2
12-20	2.3	2.1	0.4	0.4	0.1	0.1
21 or Older	6.2	6.1	0.4	0.5	0.1	0.2
12-17	2.2	1.7	0.3	0.1	0.1	0.0
12-13	2.0	1.6	0.1	0.0	0.1	*
14-15	2.2	1.8	0.4	0.2	0.2	*
16-17	2.3	1.8	0.4	0.2	0.1	0.0
18 or Older	6.0	5.9	0.4	0.5	0.1	0.2
18-25	3.1	3.2	0.5	0.7	0.1	0.2
18-20	2.6	3.0	0.4	0.8	0.1	0.2
21-25	3.5	3.3	0.6	0.7	0.1	0.3
26 or Older	6.5	6.3	0.4	0.4	0.1	0.2
26-49	4.8	4.7	0.4	0.5	0.1	0.2
26-29	3.4	3.5	0.4	0.5	0.1	0.1
30-34	4.3	3.3	0.4	0.2	0.2	0.0
35-39	4.6	4.7	0.5	0.6	0.1	0.2
40-44	5.2	4.9	0.4	0.6	0.1	0.3
45-49	6.4	7.2	0.5	0.5	0.1	0.2
50 or Older	8.0	7.8	0.4	0.4	0.1	0.2
50-54	6.4	7.9	0.4	0.5	0.2	0.2
55-59	8.2	7.1	0.7	0.8	0.2	0.2
60-64	8.3	7.2	0.4	0.2	0.0	0.0
65 or Older	8.3	8.3	0.2	0.3	0.1	0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)
TOTAL	29,408	27,026	4,841	4,779
12-20	1,619	1,259	817	504
21 or Older	27,789	25,766	4,024	4,275
12-17	749	418	381	157
12-13	78	52	14	10
14-15	215	163	107	59
16-17	455	203	259	88
18 or Older	28,659	26,607	4,460	4,622
18-25	2,983	2,861	1,266	1,097
18-20	870	841	436	347
21-25	2,113	2,019	830	749
26 or Older	25,676	23,747	3,194	3,526
26-49	11,285	10,816	2,169	2,608
26-29	1,850	1,628	550	542
30-34	2,617	2,160	683	538
35-39	2,268	2,339	399	573
40-44	2,343	2,407	312	496
45-49	2,207	2,282	225	457
50 or Older	14,391	12,931	1,026	918
50-54	2,384	2,003	251	199
55-59	2,705	2,428	269	290
60-64	2,629	2,654	268	255
65 or Older	6,673	5,846	238	174
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year (2019)	Misuse in Past Year (2020)
TOTAL	10.7	9.8	1.8	1.7
12-20	4.3	3.4	2.1	1.3
21 or Older	11.7	10.8	1.7	1.8
12-17	3.0	1.7	1.5	0.6
12-13	1.0	0.6	0.2	0.1
14-15	2.5	1.9	1.3	0.7
16-17	5.5	2.6	3.1	1.1
18 or Older	11.4	10.6	1.8	1.8
18-25	8.8	8.5	3.8	3.3
18-20	6.6	6.8	3.3	2.8
21-25	10.3	9.6	4.0	3.6
26 or Older	11.9	10.9	1.5	1.6
26-49	11.1	10.7	2.1	2.6
26-29	10.2	9.1	3.0	3.0
30-34	11.7	9.5	3.1	2.4
35-39	10.6	10.5	1.9	2.6
40-44	12.2	12.4	1.6	2.6
45-49	10.9	11.8	1.1	2.4
50 or Older	12.5	11.1	0.9	0.8
50-54	11.6	10.1	1.2	1.0
55-59	12.7	11.3	1.3	1.3
60-64	12.8	12.7	1.3	1.2
65 or Older	12.6	10.7	0.5	0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.19A – Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	10,065	9,490	3,101	2,885
12-20	1,145	781	305	162
21 or Older	8,920	8,709	2,796	2,723
12-17	567	396	165	96
12-13	112	84	36	16
14-15	176	130	51	42
16-17	278	183	77	38
18 or Older	9,499	9,094	2,936	2,789
18-25	1,776	1,376	439	296
18-20	578	385	140	66
21-25	1,197	992	300	229
26 or Older	7,723	7,717	2,497	2,493
26-49	4,971	4,704	1,514	1,419
26-29	1,041	841	351	294
30-34	1,271	984	351	221
35-39	1,126	982	328	263
40-44	821	740	222	245
45-49	712	1,157	262	397
50 or Older	2,752	3,013	983	1,075
50-54	657	568	237	188
55-59	680	695	248	295
60-64	436	682	209	276
65 or Older	979	1,068	290	316
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.19B – Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	3.7	3.4	1.1	1.0
12-20	3.0	2.1	0.8	0.4
21 or Older	3.8	3.6	1.2	1.1
12-17	2.3	1.6	0.7	0.4
12-13	1.4	1.0	0.4	0.2
14-15	2.1	1.5	0.6	0.5
16-17	3.4	2.3	0.9	0.5
18 or Older	3.8	3.6	1.2	1.1
18-25	5.3	4.1	1.3	0.9
18-20	4.4	3.1	1.1	0.5
21-25	5.8	4.7	1.5	1.1
26 or Older	3.6	3.5	1.2	1.1
26-49	4.9	4.6	1.5	1.4
26-29	5.8	4.7	1.9	1.7
30-34	5.7	4.3	1.6	1.0
35-39	5.3	4.4	1.5	1.2
40-44	4.3	3.8	1.2	1.3
45-49	3.5	6.0	1.3	2.1
50 or Older	2.4	2.6	0.9	0.9
50-54	3.2	2.9	1.2	0.9
55-59	3.2	3.2	1.2	1.4
60-64	2.1	3.3	1.0	1.3
65 or Older	1.9	2.0	0.5	0.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.20A – Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	10,136	10,306	4,264	4,483
12-20	1,444	1,021	465	237
21 or Older	8,693	9,285	3,799	4,246
12-17	499	346	160	87
12-13	39	34	7	4
14-15	144	123	54	24
16-17	316	189	100	59
18 or Older	9,638	9,960	4,103	4,396
18-25	3,205	2,567	1,127	682
18-20	945	675	305	150
21-25	2,260	1,892	823	532
26 or Older	6,433	7,393	2,976	3,714
26-49	5,196	5,742	2,311	2,889
26-29	1,591	1,531	570	593
30-34	1,467	1,305	637	584
35-39	1,039	1,334	489	797
40-44	617	884	370	538
45-49	483	688	245	376
50 or Older	1,236	1,651	665	825
50-54	367	644	202	326
55-59	379	468	208	164
60-64	316	221	223	95
65 or Older	174	318	33	239
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.20B – Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Misuse in Past Year (2019)	Misuse in Past Year (2020)	Misuse in Past Month (2019)	Misuse in Past Month (2020)
TOTAL	3.7	3.7	1.5	1.6
12-20	3.8	2.7	1.2	0.6
21 or Older	3.7	3.9	1.6	1.8
12-17	2.0	1.4	0.6	0.3
12-13	0.5	0.4	0.1	0.0
14-15	1.7	1.4	0.6	0.3
16-17	3.8	2.4	1.2	0.7
18 or Older	3.9	4.0	1.6	1.7
18-25	9.5	7.7	3.3	2.0
18-20	7.2	5.4	2.3	1.2
21-25	11.0	9.0	4.0	2.5
26 or Older	3.0	3.4	1.4	1.7
26-49	5.1	5.7	2.3	2.8
26-29	8.8	8.6	3.2	3.3
30-34	6.6	5.7	2.9	2.6
35-39	4.9	6.0	2.3	3.6
40-44	3.2	4.6	1.9	2.8
45-49	2.4	3.6	1.2	1.9
50 or Older	1.1	1.4	0.6	0.7
50-54	1.8	3.2	1.0	1.6
55-59	1.8	2.2	1.0	0.8
60-64	1.5	1.1	1.1	0.5
65 or Older	0.3	0.6	0.1	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2019 and 2020
Age Category	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	23,588	23,962	9,333	9,305
12-20	3,788	3,077	1,224	799
21 or Older	19,800	20,885	8,110	8,506
12-17	1,862	1,507	598	305
12-13	425	359	141	48
14-15	590	513	165	113
16-17	848	635	292	144
18 or Older	21,727	22,455	8,735	9,000
18-25	5,791	5,169	2,059	1,600
18-20	1,926	1,570	626	494
21-25	3,865	3,598	1,433	1,106
26 or Older	15,936	17,286	6,676	7,400
26-49	11,025	11,693	4,650	5,034
26-29	2,888	2,743	1,132	1,144
30-34	2,966	2,861	1,266	965
35-39	2,169	2,419	926	1,138
40-44	1,625	1,628	685	847
45-49	1,377	2,042	641	940
50 or Older	4,911	5,593	2,026	2,366
50-54	1,257	1,468	504	597
55-59	1,224	1,434	512	689
60-64	996	1,133	518	416
65 or Older	1,433	1,557	493	665
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2019 and 2020
Age Category	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	8.6	8.7	3.4	3.4
12-20	9.9	8.2	3.2	2.1
21 or Older	8.3	8.7	3.4	3.6
12-17	7.5	6.0	2.4	1.2
12-13	5.2	4.3	1.7	0.6
14-15	6.9	5.9	1.9	1.3
16-17	10.3	8.1	3.5	1.8
18 or Older	8.7	8.9	3.5	3.6
18-25	17.2	15.4	6.1	4.8
18-20	14.6	12.6	4.8	4.0
21-25	18.8	17.1	7.0	5.3
26 or Older	7.4	7.9	3.1	3.4
26-49	10.9	11.5	4.6	5.0
26-29	16.0	15.4	6.3	6.4
30-34	13.3	12.6	5.7	4.2
35-39	10.1	10.8	4.3	5.1
40-44	8.4	8.4	3.6	4.4
45-49	6.8	10.6	3.2	4.9
50 or Older	4.3	4.8	1.8	2.0
50-54	6.1	7.4	2.4	3.0
55-59	5.8	6.7	2.4	3.2
60-64	4.8	5.4	2.5	2.0
65 or Older	2.7	2.9	0.9	1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2019 and 2020
Prescription Drug/Age Group	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users (2019)	Misuse in Past Year among Past Year Any Users (2020)
PSYCHOTHERAPEUTICS	108,037	101,602	16,304	16,073	16,304	16,073
12-17	5,612	4,723	1,062	688	1,062	688
18 or Older	102,425	96,879	15,242	15,385	15,242	15,385
18-25	12,187	10,529	3,868	3,193	3,868	3,193
26 or Older	90,238	86,350	11,374	12,192	11,374	12,192
PAIN RELIEVERS	82,559	75,198	9,724	9,254	9,724	9,254
12-17	3,980	3,079	567	396	567	396
18 or Older	78,579	72,118	9,158	8,858	9,158	8,858
18-25	8,357	6,858	1,754	1,361	1,754	1,361
26 or Older	70,222	65,261	7,404	7,498	7,404	7,498
STIMULANTS	18,290	18,332	4,929	5,092	4,929	5,092
12-17	1,837	1,593	430	288	430	288
18 or Older	16,453	16,739	4,499	4,804	4,499	4,804
18-25	4,320	3,773	1,951	1,616	1,951	1,616
26 or Older	12,133	12,966	2,548	3,188	2,548	3,188
TRANQUILIZERS OR SEDATIVES	44,051	43,001	5,895	6,205	5,895	6,205
12-17	1,370	936	436	226	436	226
18 or Older	42,682	42,065	5,459	5,979	5,459	5,979
18-25	3,995	3,805	1,409	1,237	1,409	1,237
26 or Older	38,687	38,261	4,050	4,742	4,050	4,742
TRANQUILIZERS	35,601	35,018	5,220	5,460	5,220	5,460
12-17	1,010	588	392	196	392	196
18 or Older	34,591	34,430	4,829	5,264	4,829	5,264
18-25	3,419	3,338	1,313	1,108	1,313	1,108
26 or Older	31,172	31,092	3,516	4,156	3,516	4,156
SEDATIVES	15,636	15,364	1,098	1,240	1,098	1,240
12-17	545	429	82	35	82	35
18 or Older	15,091	14,935	1,016	1,205	1,016	1,205
18-25	1,051	1,066	175	251	175	251
26 or Older	14,040	13,869	841	954	841	954
BENZODIAZEPINES	29,408	27,026	4,841	4,779	4,841	4,779
12-17	749	418	381	157	381	*
18 or Older	28,659	26,607	4,460	4,622	4,460	4,622
18-25	2,983	2,861	1,266	1,097	1,266	1,097
26 or Older	25,676	23,747	3,194	3,526	3,194	3,526
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2019 and 2020
Prescription Drug/Age Group	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users (2019)	Misuse in Past Year among Past Year Any Users (2020)
PSYCHOTHERAPEUTICS	39.3	36.7	5.9	5.8	15.1	15.8
12-17	22.5	18.9	4.3	2.8	18.9	14.6
18 or Older	40.9	38.5	6.1	6.1	14.9	15.9
18-25	36.1	31.4	11.5	9.5	31.7	30.3
26 or Older	41.7	39.5	5.3	5.6	12.6	14.1
PAIN RELIEVERS	30.0	27.2	3.5	3.3	11.8	12.3
12-17	16.0	12.3	2.3	1.6	14.2	12.9
18 or Older	31.4	28.6	3.7	3.5	11.7	12.3
18-25	24.8	20.5	5.2	4.1	21.0	19.8
26 or Older	32.4	29.9	3.4	3.4	10.5	11.5
STIMULANTS	6.6	6.6	1.8	1.8	26.9	27.8
12-17	7.4	6.4	1.7	1.2	23.4	18.1
18 or Older	6.6	6.6	1.8	1.9	27.3	28.7
18-25	12.8	11.3	5.8	4.8	45.2	42.8
26 or Older	5.6	5.9	1.2	1.5	21.0	24.6
TRANQUILIZERS OR SEDATIVES	16.0	15.5	2.1	2.2	13.4	14.4
12-17	5.5	3.7	1.8	0.9	31.8	24.1
18 or Older	17.1	16.7	2.2	2.4	12.8	14.2
18-25	11.8	11.4	4.2	3.7	35.3	32.5
26 or Older	17.9	17.5	1.9	2.2	10.5	12.4
TRANQUILIZERS	12.9	12.6	1.9	2.0	14.7	15.6
12-17	4.1	2.4	1.6	0.8	38.8	33.3
18 or Older	13.8	13.7	1.9	2.1	14.0	15.3
18-25	10.1	10.0	3.9	3.3	38.4	33.2
26 or Older	14.4	14.2	1.6	1.9	11.3	13.4
SEDATIVES	5.7	5.5	0.4	0.4	7.0	8.1
12-17	2.2	1.7	0.3	0.1	15.1	8.1
18 or Older	6.0	5.9	0.4	0.5	6.7	8.1
18-25	3.1	3.2	0.5	0.7	16.6	23.5
26 or Older	6.5	6.3	0.4	0.4	6.0	6.9
BENZODIAZEPINES	10.7	9.8	1.8	1.7	16.5	17.7
12-17	3.0	1.7	1.5	0.6	50.9	*
18 or Older	11.4	10.6	1.8	1.8	15.6	17.4
18-25	8.8	8.5	3.8	3.3	42.4	38.3
26 or Older	11.9	10.9	1.5	1.6	12.4	14.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	138,027	138,543	6,090	5,229	131,937	133,314	18,832	17,879	113,104	115,435
GENDER
Male	72,406	70,362	3,015	2,406	69,390	67,957	9,451	8,624	59,939	59,332
Female	65,621	68,181	3,075	2,823	62,546	65,358	9,381	9,255	53,165	56,103
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	118,981	119,274	4,505	3,877	114,476	115,397	14,881	14,325	99,595	101,072
White	94,912	95,781	3,122	2,752	91,790	93,029	10,891	10,566	80,899	82,463
Black or African American	15,581	15,491	856	627	14,725	14,863	2,449	2,267	12,276	12,596
AIAN	871	1,056	65	*	806	936	139	*	667	*
NHOPI	481	*	*	*	449	*	*	*	386	*
Asian	3,805	3,404	169	235	3,636	3,169	737	672	2,899	2,497
Two or More Races	3,331	3,218	261	131	3,070	3,087	601	669	2,469	2,418
Hispanic or Latino	19,046	19,269	1,585	1,352	17,461	17,917	3,952	3,554	13,509	14,363
EDUCATION LEVEL
< High School	da	da	da	da	12,295	11,139	2,341	1,524	9,953	9,615
High School Graduate	da	da	da	da	29,913	35,032	5,528	5,203	24,384	29,828
Some College/Associate’s Degree	da	da	da	da	45,346	44,402	7,868	7,943	37,478	36,460
College Graduate	da	da	da	da	44,383	42,741	3,094	3,209	41,289	39,532
EMPLOYMENT STATUS
Full-Time	da	da	da	da	72,662	68,078	9,025	7,574	63,637	60,504
Part-Time	da	da	da	da	18,201	17,264	4,539	4,729	13,663	12,534
Unemployed	da	da	da	da	5,717	7,094	1,750	1,822	3,967	5,272
Other¹	da	da	da	da	35,357	40,879	3,519	3,754	31,838	37,125
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	50.2	50.0	24.5	20.9	52.7	52.9	55.8	53.4	52.2	52.8
GENDER
Male	54.2	52.4	23.8	18.9	57.4	55.9	55.9	51.4	57.7	56.6
Female	46.3	47.8	25.2	23.0	48.3	50.2	55.7	55.3	47.2	49.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	52.2	52.2	24.1	20.8	54.8	55.0	57.1	55.6	54.4	54.9
White	55.6	56.1	24.3	21.5	58.2	58.9	60.4	59.0	57.9	58.9
Black or African American	46.9	46.1	25.5	20.1	49.3	48.7	52.8	49.3	48.6	48.6
AIAN	55.7	63.7	37.5	*	58.0	65.0	64.0	*	56.8	*
NHOPI	44.0	*	*	*	45.5	*	*	*	46.4	*
Asian	24.0	21.0	12.9	12.6	24.9	22.1	35.3	33.8	23.2	20.2
Two or More Races	62.6	60.6	27.9	21.2	70.0	65.8	64.0	64.6	71.6	66.2
Hispanic or Latino	40.1	39.8	25.6	21.4	42.3	42.6	51.6	46.0	40.2	41.8
EDUCATION LEVEL
< High School	da	da	da	da	40.8	38.5	50.0	39.8	39.1	38.4
High School Graduate	da	da	da	da	49.2	50.4	52.1	48.5	48.6	50.8
Some College/Associate’s Degree	da	da	da	da	58.9	58.1	58.3	56.8	59.0	58.4
College Graduate	da	da	da	da	53.9	55.4	62.7	64.7	53.3	54.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	58.5	58.4	62.9	59.6	57.9	58.2
Part-Time	da	da	da	da	55.8	55.2	54.4	55.2	56.3	55.2
Unemployed	da	da	da	da	57.6	55.1	53.1	53.8	59.8	55.6
Other¹	da	da	da	da	42.3	44.8	45.4	42.5	42.0	45.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drug Use in Lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	57,203	59,277	4,279	3,436	52,924	55,841	13,193	12,398	39,731	43,443
GENDER
Male	31,742	31,069	2,103	1,610	29,639	29,459	6,823	6,094	22,817	23,365
Female	25,461	28,208	2,176	1,826	23,285	26,382	6,371	6,303	16,914	20,078
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	48,158	50,108	3,098	2,562	45,059	47,547	10,475	10,228	34,584	37,319
White	37,036	38,499	2,180	1,909	34,856	36,590	7,562	7,580	27,294	29,011
Black or African American	7,277	7,786	582	353	6,696	7,433	1,822	1,695	4,874	5,738
AIAN	393	536	49	*	344	487	88	*	256	*
NHOPI	173	80	*	*	154	68	*	*	103	*
Asian	1,581	1,569	77	145	1,504	1,424	523	395	981	1,029
Two or More Races	1,697	1,638	192	94	1,505	1,545	430	458	1,076	1,086
Hispanic or Latino	9,045	9,169	1,180	874	7,865	8,295	2,718	2,170	5,147	6,125
EDUCATION LEVEL
< High School	da	da	da	da	5,878	5,320	1,715	1,108	4,162	4,211
High School Graduate	da	da	da	da	12,518	14,976	3,906	3,398	8,612	11,578
Some College/Associate’s Degree	da	da	da	da	19,068	19,831	5,578	5,713	13,490	14,118
College Graduate	da	da	da	da	15,460	15,715	1,994	2,178	13,466	13,537
EMPLOYMENT STATUS
Full-Time	da	da	da	da	28,663	27,799	6,028	5,082	22,635	22,717
Part-Time	da	da	da	da	7,875	8,757	3,330	3,391	4,545	5,366
Unemployed	da	da	da	da	3,342	4,094	1,328	1,385	2,014	2,708
Other¹	da	da	da	da	13,044	15,191	2,507	2,540	10,537	12,651
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	20.8	21.4	17.2	13.8	21.1	22.2	39.1	37.0	18.3	19.9
GENDER
Male	23.8	23.1	16.6	12.7	24.5	24.2	40.4	36.3	21.9	22.3
Female	18.0	19.8	17.8	14.9	18.0	20.3	37.9	37.7	15.0	17.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21.1	21.9	16.6	13.7	21.6	22.7	40.2	39.7	18.9	20.3
White	21.7	22.5	17.0	14.9	22.1	23.2	41.9	42.3	19.5	20.7
Black or African American	21.9	23.2	17.3	11.3	22.4	24.4	39.3	36.9	19.3	22.2
AIAN	25.1	32.3	28.2	*	24.7	33.8	40.5	*	21.8	*
NHOPI	15.8	8.0	*	*	15.6	7.0	*	*	12.4	*
Asian	10.0	9.7	5.9	7.8	10.3	9.9	25.0	19.9	7.9	8.3
Two or More Races	31.9	30.9	20.5	15.2	34.3	32.9	45.8	44.3	31.2	29.7
Hispanic or Latino	19.1	19.0	19.0	13.9	19.1	19.7	35.5	28.1	15.3	17.8
EDUCATION LEVEL
< High School	da	da	da	da	19.5	18.4	36.6	29.0	16.3	16.8
High School Graduate	da	da	da	da	20.6	21.6	36.8	31.7	17.2	19.7
Some College/Associate’s Degree	da	da	da	da	24.7	25.9	41.3	40.9	21.2	22.6
College Graduate	da	da	da	da	18.8	20.4	40.4	43.9	17.4	18.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	23.1	23.8	42.0	40.0	20.6	21.9
Part-Time	da	da	da	da	24.2	28.0	39.9	39.6	18.7	23.6
Unemployed	da	da	da	da	33.7	31.8	40.3	40.9	30.3	28.6
Other¹	da	da	da	da	15.6	16.7	32.3	28.7	13.9	15.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	35,803	37,309	2,167	1,679	33,636	35,630	8,406	8,016	25,231	27,614
GENDER
Male	20,669	20,063	1,124	903	19,545	19,160	4,474	4,082	15,071	15,077
Female	15,135	17,245	1,043	776	14,091	16,470	3,932	3,933	10,160	12,537
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	30,528	31,978	1,540	1,241	28,988	30,737	6,726	6,625	22,262	24,112
White	23,228	24,317	1,086	915	22,142	23,402	4,766	4,845	17,376	18,557
Black or African American	4,866	5,299	287	168	4,579	5,131	1,280	1,251	3,299	3,880
AIAN	227	441	22	*	205	*	50	*	155	*
NHOPI	122	44	*	*	109	41	*	*	86	*
Asian	888	760	29	62	859	698	304	191	555	507
Two or More Races	1,197	1,117	103	50	1,094	1,067	303	297	791	770
Hispanic or Latino	5,275	5,331	627	438	4,648	4,893	1,680	1,390	2,969	3,502
EDUCATION LEVEL
< High School	da	da	da	da	3,818	3,558	1,151	771	2,667	2,788
High School Graduate	da	da	da	da	8,429	10,168	2,519	2,335	5,909	7,833
Some College/Associate’s Degree	da	da	da	da	12,505	12,957	3,589	3,620	8,916	9,338
College Graduate	da	da	da	da	8,884	8,946	1,146	1,291	7,739	7,655
EMPLOYMENT STATUS
Full-Time	da	da	da	da	17,793	17,293	3,897	3,318	13,896	13,976
Part-Time	da	da	da	da	4,883	5,462	2,044	2,062	2,839	3,400
Unemployed	da	da	da	da	2,455	2,985	913	1,004	1,542	1,981
Other¹	da	da	da	da	8,505	9,889	1,551	1,632	6,954	8,257
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	13.0	13.5	8.7	6.7	13.4	14.1	24.9	23.9	11.6	12.6
GENDER
Male	15.5	14.9	8.9	7.1	16.2	15.7	26.5	24.3	14.5	14.4
Female	10.7	12.1	8.5	6.3	10.9	12.6	23.4	23.5	9.0	11.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13.4	14.0	8.2	6.6	13.9	14.6	25.8	25.7	12.2	13.1
White	13.6	14.2	8.5	7.1	14.0	14.8	26.4	27.0	12.4	13.3
Black or African American	14.6	15.8	8.5	5.4	15.3	16.8	27.6	27.2	13.1	15.0
AIAN	14.5	26.6	12.8	*	14.8	*	23.0	*	13.2	*
NHOPI	11.1	4.4	*	*	11.0	4.3	*	*	10.3	*
Asian	5.6	4.7	2.2	3.4	5.9	4.9	14.5	9.6	4.4	4.1
Two or More Races	22.5	21.0	11.0	8.1	24.9	22.7	32.2	28.7	23.0	21.1
Hispanic or Latino	11.1	11.0	10.1	6.9	11.3	11.6	21.9	18.0	8.8	10.2
EDUCATION LEVEL
< High School	da	da	da	da	12.7	12.3	24.6	20.1	10.5	11.1
High School Graduate	da	da	da	da	13.9	14.6	23.7	21.8	11.8	13.3
Some College/Associate’s Degree	da	da	da	da	16.2	16.9	26.6	25.9	14.0	14.9
College Graduate	da	da	da	da	10.8	11.6	23.2	26.0	10.0	10.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	14.3	14.8	27.2	26.1	12.6	13.5
Part-Time	da	da	da	da	15.0	17.5	24.5	24.1	11.7	15.0
Unemployed	da	da	da	da	24.7	23.2	27.7	29.6	23.2	20.9
Other¹	da	da	da	da	10.2	10.8	20.0	18.5	9.2	10.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	127,139	126,504	3,947	3,103	123,192	123,401	17,450	16,604	105,742	106,797
GENDER
Male	67,085	64,536	1,985	1,438	65,099	63,097	8,753	8,046	56,346	55,051
Female	60,054	61,968	1,961	1,664	58,093	60,304	8,697	8,558	49,396	51,746
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	110,720	109,823	2,810	2,229	107,910	107,594	13,835	13,242	94,075	94,352
White	88,899	88,604	1,987	1,633	86,912	86,971	10,194	9,877	76,717	77,094
Black or African American	14,305	14,213	516	327	13,788	13,886	2,253	2,102	11,535	11,784
AIAN	770	913	44	*	726	*	126	*	600	*
NHOPI	444	*	*	*	422	*	*	*	366	*
Asian	3,211	2,812	73	122	3,138	2,690	648	530	2,490	2,160
Two or More Races	3,091	2,985	168	95	2,924	2,890	557	619	2,367	2,271
Hispanic or Latino	16,419	16,681	1,137	873	15,282	15,807	3,615	3,362	11,666	12,445
EDUCATION LEVEL
< High School	da	da	da	da	10,805	9,487	2,112	1,337	8,693	8,150
High School Graduate	da	da	da	da	28,233	32,844	5,135	4,858	23,099	27,985
Some College/Associate’s Degree	da	da	da	da	42,869	41,563	7,306	7,374	35,563	34,189
College Graduate	da	da	da	da	41,285	39,507	2,897	3,034	38,388	36,473
EMPLOYMENT STATUS
Full-Time	da	da	da	da	68,319	63,702	8,501	7,118	59,818	56,584
Part-Time	da	da	da	da	16,984	15,982	4,122	4,458	12,862	11,524
Unemployed	da	da	da	da	5,444	6,539	1,645	1,697	3,799	4,842
Other¹	da	da	da	da	32,444	37,178	3,182	3,331	29,262	33,847
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	46.2	45.7	15.8	12.4	49.2	49.0	51.7	49.6	48.8	48.9
GENDER
Male	50.2	48.0	15.7	11.3	53.9	51.9	51.8	48.0	54.2	52.5
Female	42.4	43.5	16.0	13.6	44.9	46.3	51.7	51.2	43.9	45.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	48.6	48.1	15.0	11.9	51.6	51.3	53.1	51.4	51.4	51.3
White	52.1	51.9	15.5	12.7	55.1	55.1	56.5	55.1	54.9	55.1
Black or African American	43.0	42.3	15.4	10.5	46.1	45.5	48.6	45.7	45.7	45.5
AIAN	49.2	55.0	25.3	*	52.2	*	57.9	*	51.1	*
NHOPI	40.7	*	*	*	42.7	*	*	*	44.1	*
Asian	20.2	17.4	5.5	6.6	21.5	18.8	31.0	26.7	19.9	17.5
Two or More Races	58.1	56.2	18.0	15.4	66.7	61.6	59.3	59.8	68.7	62.1
Hispanic or Latino	34.6	34.5	18.3	13.8	37.0	37.6	47.2	43.5	34.7	36.2
EDUCATION LEVEL
< High School	da	da	da	da	35.8	32.8	45.1	34.9	34.1	32.5
High School Graduate	da	da	da	da	46.5	47.3	48.4	45.3	46.1	47.6
Some College/Associate’s Degree	da	da	da	da	55.6	54.4	54.1	52.8	56.0	54.7
College Graduate	da	da	da	da	50.1	51.2	58.7	61.2	49.6	50.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	55.0	54.6	59.3	56.0	54.5	54.5
Part-Time	da	da	da	da	52.1	51.1	49.4	52.1	53.0	50.7
Unemployed	da	da	da	da	54.8	50.8	50.0	50.1	57.2	51.1
Other¹	da	da	da	da	38.8	40.8	41.0	37.7	38.6	41.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	48,242	49,634	3,284	2,531	44,958	47,103	11,952	11,566	33,007	35,537
GENDER
Male	27,222	26,773	1,649	1,205	25,573	25,568	6,173	5,730	19,400	19,838
Female	21,020	22,861	1,635	1,326	19,386	21,535	5,779	5,837	13,607	15,698
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	41,018	42,216	2,343	1,897	38,676	40,319	9,548	9,535	29,128	30,784
White	31,448	32,532	1,671	1,428	29,778	31,105	6,870	7,059	22,908	24,045
Black or African American	6,406	6,518	426	250	5,979	6,268	1,714	1,603	4,265	4,665
AIAN	314	436	31	*	283	*	72	*	211	*
NHOPI	162	67	*	*	144	55	*	*	101	*
Asian	1,207	1,216	52	93	1,155	1,123	453	374	702	749
Two or More Races	1,481	1,447	144	75	1,336	1,372	395	414	941	957
Hispanic or Latino	7,223	7,418	941	634	6,283	6,784	2,404	2,032	3,879	4,753
EDUCATION LEVEL
< High School	da	da	da	da	4,723	4,023	1,535	976	3,188	3,047
High School Graduate	da	da	da	da	10,638	12,818	3,530	3,207	7,109	9,611
Some College/Associate’s Degree	da	da	da	da	16,585	17,218	5,079	5,403	11,506	11,815
College Graduate	da	da	da	da	13,013	13,045	1,809	1,981	11,204	11,064
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24,661	23,655	5,520	4,671	19,141	18,984
Part-Time	da	da	da	da	6,832	7,442	2,982	3,257	3,850	4,185
Unemployed	da	da	da	da	2,913	3,771	1,223	1,344	1,690	2,428
Other¹	da	da	da	da	10,552	12,235	2,226	2,295	8,326	9,940
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	17.5	17.9	13.2	10.1	18.0	18.7	35.4	34.5	15.2	16.3
GENDER
Male	20.4	19.9	13.0	9.5	21.2	21.0	36.5	34.2	18.7	18.9
Female	14.8	16.0	13.4	10.8	15.0	16.5	34.3	34.9	12.1	13.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	18.0	18.5	12.5	10.2	18.5	19.2	36.6	37.0	15.9	16.7
White	18.4	19.1	13.0	11.1	18.9	19.7	38.1	39.4	16.4	17.2
Black or African American	19.3	19.4	12.7	8.0	20.0	20.6	37.0	34.9	16.9	18.0
AIAN	20.1	26.3	17.9	*	20.4	*	33.2	*	18.0	*
NHOPI	14.8	6.7	*	*	14.6	5.6	*	*	12.2	*
Asian	7.6	7.5	4.0	5.0	7.9	7.8	21.7	18.8	5.6	6.1
Two or More Races	27.8	27.3	15.4	12.2	30.5	29.2	42.1	40.0	27.3	26.2
Hispanic or Latino	15.2	15.3	15.2	10.0	15.2	16.1	31.4	26.3	11.5	13.8
EDUCATION LEVEL
< High School	da	da	da	da	15.7	13.9	32.8	25.5	12.5	12.2
High School Graduate	da	da	da	da	17.5	18.4	33.3	29.9	14.2	16.4
Some College/Associate’s Degree	da	da	da	da	21.5	22.5	37.6	38.6	18.1	18.9
College Graduate	da	da	da	da	15.8	16.9	36.6	39.9	14.5	15.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	19.9	20.3	38.5	36.8	17.4	18.3
Part-Time	da	da	da	da	21.0	23.8	35.7	38.0	15.9	18.4
Unemployed	da	da	da	da	29.3	29.3	37.2	39.7	25.5	25.6
Other¹	da	da	da	da	12.6	13.4	28.7	26.0	11.0	12.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	31,606	32,784	1,837	1,472	29,769	31,312	7,749	7,727	22,020	23,585
GENDER
Male	18,614	17,930	981	789	17,632	17,141	4,171	3,925	13,461	13,216
Female	12,993	14,854	856	683	12,137	14,171	3,578	3,802	8,559	10,369
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	27,085	28,133	1,307	1,060	25,778	27,073	6,234	6,386	19,544	20,687
White	20,464	21,274	934	801	19,531	20,472	4,397	4,647	15,133	15,825
Black or African American	4,565	4,788	238	118	4,327	4,670	1,248	1,216	3,078	3,454
AIAN	188	*	19	*	169	*	45	*	124	*
NHOPI	116	40	*	*	104	37	*	*	86	*
Asian	703	642	26	60	676	582	259	188	417	394
Two or More Races	1,049	1,025	77	48	972	977	266	294	706	682
Hispanic or Latino	4,521	4,651	531	411	3,991	4,240	1,515	1,341	2,475	2,899
EDUCATION LEVEL
< High School	da	da	da	da	3,368	2,942	1,052	728	2,316	2,215
High School Graduate	da	da	da	da	7,573	9,235	2,376	2,275	5,197	6,960
Some College/Associate’s Degree	da	da	da	da	11,239	11,534	3,315	3,524	7,924	8,010
College Graduate	da	da	da	da	7,590	7,601	1,007	1,201	6,583	6,400
EMPLOYMENT STATUS
Full-Time	da	da	da	da	15,908	15,068	3,614	3,171	12,293	11,897
Part-Time	da	da	da	da	4,429	4,853	1,894	2,029	2,535	2,824
Unemployed	da	da	da	da	2,100	2,827	845	962	1,254	1,865
Other¹	da	da	da	da	7,332	8,564	1,395	1,565	5,938	6,999
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	11.5	11.8	7.4	5.9	11.9	12.4	23.0	23.1	10.2	10.8
GENDER
Male	13.9	13.3	7.7	6.2	14.6	14.1	24.7	23.4	12.9	12.6
Female	9.2	10.4	7.0	5.6	9.4	10.9	21.3	22.7	7.6	9.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	11.9	12.3	7.0	5.7	12.3	12.9	23.9	24.8	10.7	11.2
White	12.0	12.5	7.3	6.3	12.4	13.0	24.4	25.9	10.8	11.3
Black or African American	13.7	14.2	7.1	3.8	14.5	15.3	26.9	26.5	12.2	13.3
AIAN	12.0	*	11.1	*	12.1	*	20.8	*	10.5	*
NHOPI	10.6	4.0	*	*	10.5	3.8	*	*	10.3	*
Asian	4.4	4.0	2.0	3.2	4.6	4.1	12.4	9.4	3.3	3.2
Two or More Races	19.7	19.3	8.3	7.7	22.2	20.8	28.3	28.5	20.5	18.7
Hispanic or Latino	9.5	9.6	8.6	6.5	9.7	10.1	19.8	17.4	7.4	8.4
EDUCATION LEVEL
< High School	da	da	da	da	11.2	10.2	22.5	19.0	9.1	8.8
High School Graduate	da	da	da	da	12.5	13.3	22.4	21.2	10.4	11.8
Some College/Associate’s Degree	da	da	da	da	14.6	15.1	24.6	25.2	12.5	12.8
College Graduate	da	da	da	da	9.2	9.9	20.4	24.2	8.5	8.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	12.8	12.9	25.2	25.0	11.2	11.5
Part-Time	da	da	da	da	13.6	15.5	22.7	23.7	10.5	12.4
Unemployed	da	da	da	da	21.1	22.0	25.7	28.4	18.9	19.7
Other¹	da	da	da	da	8.8	9.4	18.0	17.7	7.8	8.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	41,445	39,261	154	105	41,291	39,155	3,809	3,065	37,483	36,091
GENDER
Male	24,493	23,060	73	66	24,419	22,994	2,073	1,699	22,346	21,295
Female	16,952	16,200	80	39	16,872	16,161	1,736	1,366	15,136	14,796
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,131	34,135	109	70	36,022	34,064	3,018	2,523	33,004	31,541
White	31,300	29,498	86	50	31,214	29,448	2,587	2,237	28,627	27,211
Black or African American	2,829	2,926	10	*	2,820	2,926	133	135	2,687	2,792
AIAN	218	264	*	*	217	256	25	*	192	253
NHOPI	111	52	*	*	111	52	*	*	100	*
Asian	598	502	6	7	592	495	118	36	474	460
Two or More Races	1,075	892	7	6	1,068	886	144	112	924	774
Hispanic or Latino	5,313	5,126	44	35	5,269	5,091	790	541	4,479	4,550
EDUCATION LEVEL
< High School	da	da	da	da	3,885	3,431	391	193	3,494	3,238
High School Graduate	da	da	da	da	9,961	11,064	1,031	818	8,930	10,246
Some College/Associate’s Degree	da	da	da	da	14,752	13,767	1,597	1,316	13,156	12,451
College Graduate	da	da	da	da	12,693	10,893	790	737	11,903	10,156
EMPLOYMENT STATUS
Full-Time	da	da	da	da	22,774	20,390	2,082	1,565	20,693	18,825
Part-Time	da	da	da	da	5,373	4,880	805	548	4,568	4,332
Unemployed	da	da	da	da	1,982	2,308	355	396	1,627	1,913
Other¹	da	da	da	da	11,162	11,577	567	556	10,595	11,021
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	15.1	14.2	0.6	0.4	16.5	15.5	11.3	9.1	17.3	16.5
GENDER
Male	18.3	17.2	0.6	0.5	20.2	18.9	12.3	10.1	21.5	20.3
Female	12.0	11.4	0.7	0.3	13.0	12.4	10.3	8.2	13.4	13.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.9	14.9	0.6	0.4	17.2	16.2	11.6	9.8	18.0	17.1
White	18.3	17.3	0.7	0.4	19.8	18.6	14.3	12.5	20.5	19.4
Black or African American	8.5	8.7	0.3	*	9.4	9.6	2.9	2.9	10.6	10.8
AIAN	14.0	15.9	*	*	15.6	17.8	11.4	*	16.4	20.2
NHOPI	10.2	5.2	*	*	11.2	5.4	*	*	12.0	*
Asian	3.8	3.1	0.4	0.4	4.1	3.5	5.7	1.8	3.8	3.7
Two or More Races	20.2	16.8	0.7	1.0	24.4	18.9	15.4	10.8	26.8	21.2
Hispanic or Latino	11.2	10.6	0.7	0.5	12.8	12.1	10.3	7.0	13.3	13.2
EDUCATION LEVEL
< High School	da	da	da	da	12.9	11.9	8.4	5.1	13.7	12.9
High School Graduate	da	da	da	da	16.4	15.9	9.7	7.6	17.8	17.4
Some College/Associate’s Degree	da	da	da	da	19.1	18.0	11.8	9.4	20.7	19.9
College Graduate	da	da	da	da	15.4	14.1	16.0	14.9	15.4	14.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	18.3	17.5	14.5	12.3	18.8	18.1
Part-Time	da	da	da	da	16.5	15.6	9.6	6.4	18.8	19.1
Unemployed	da	da	da	da	20.0	17.9	10.8	11.7	24.5	20.2
Other¹	da	da	da	da	13.4	12.7	7.3	6.3	14.0	13.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5,468	5,172	97	84	5,371	5,088	1,789	1,441	3,582	3,646
GENDER
Male	3,382	3,315	46	51	3,336	3,263	1,014	802	2,322	2,461
Female	2,086	1,857	51	33	2,035	1,824	774	639	1,260	1,185
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,498	4,344	66	52	4,432	4,292	1,380	1,152	3,051	3,140
White	3,587	3,564	48	38	3,539	3,526	1,179	1,001	2,359	2,525
Black or African American	521	405	7	*	514	405	59	77	455	328
AIAN	22	50	*	*	22	*	6	*	15	*
NHOPI	31	0	*	*	31	0	*	*	27	*
Asian	174	149	6	4	168	145	62	4	106	140
Two or More Races	163	176	6	2	158	174	69	67	88	107
Hispanic or Latino	970	828	30	32	939	796	408	290	531	506
EDUCATION LEVEL
< High School	da	da	da	da	551	458	125	120	426	338
High School Graduate	da	da	da	da	1,362	1,280	447	410	915	870
Some College/Associate’s Degree	da	da	da	da	2,037	1,644	840	570	1,197	1,075
College Graduate	da	da	da	da	1,421	1,706	376	342	1,045	1,365
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,963	2,734	942	722	2,021	2,012
Part-Time	da	da	da	da	768	623	406	218	363	405
Unemployed	da	da	da	da	391	664	160	251	232	413
Other¹	da	da	da	da	1,249	1,067	282	250	967	817
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2.0	1.9	0.4	0.3	2.1	2.0	5.3	4.3	1.7	1.7
GENDER
Male	2.5	2.5	0.4	0.4	2.8	2.7	6.0	4.8	2.2	2.3
Female	1.5	1.3	0.4	0.3	1.6	1.4	4.6	3.8	1.1	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.0	1.9	0.4	0.3	2.1	2.0	5.3	4.5	1.7	1.7
White	2.1	2.1	0.4	0.3	2.2	2.2	6.5	5.6	1.7	1.8
Black or African American	1.6	1.2	0.2	*	1.7	1.3	1.3	1.7	1.8	1.3
AIAN	1.4	3.0	*	*	1.6	*	3.0	*	1.3	*
NHOPI	2.8	0.0	*	*	3.1	0.0	*	*	3.2	*
Asian	1.1	0.9	0.4	0.2	1.2	1.0	3.0	0.2	0.9	1.1
Two or More Races	3.1	3.3	0.6	0.3	3.6	3.7	7.4	6.5	2.6	2.9
Hispanic or Latino	2.0	1.7	0.5	0.5	2.3	1.9	5.3	3.7	1.6	1.5
EDUCATION LEVEL
< High School	da	da	da	da	1.8	1.6	2.7	3.1	1.7	1.3
High School Graduate	da	da	da	da	2.2	1.8	4.2	3.8	1.8	1.5
Some College/Associate’s Degree	da	da	da	da	2.6	2.2	6.2	4.1	1.9	1.7
College Graduate	da	da	da	da	1.7	2.2	7.6	6.9	1.3	1.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.4	2.3	6.6	5.7	1.8	1.9
Part-Time	da	da	da	da	2.4	2.0	4.9	2.5	1.5	1.8
Unemployed	da	da	da	da	3.9	5.2	4.8	7.4	3.5	4.4
Other¹	da	da	da	da	1.5	1.2	3.6	2.8	1.3	1.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,998	1,831	34	11	1,965	1,821	540	424	1,425	1,396
GENDER
Male	1,221	1,157	17	*	1,204	1,157	297	193	906	964
Female	777	674	16	10	761	664	242	231	519	433
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,655	1,500	20	11	1,635	1,490	416	324	1,219	1,166
White	1,245	1,119	14	10	1,231	1,109	352	288	879	821
Black or African American	292	154	3	*	289	154	21	12	268	142
AIAN	6	*	*	*	6	*	0	*	5	*
NHOPI	2	*	*	*	2	*	*	*	2	*
Asian	73	101	3	*	70	101	21	*	49	101
Two or More Races	38	108	*	1	38	108	23	*	15	85
Hispanic or Latino	343	331	14	*	329	331	123	101	206	230
EDUCATION LEVEL
< High School	da	da	da	da	201	225	34	46	167	179
High School Graduate	da	da	da	da	611	421	140	122	470	299
Some College/Associate’s Degree	da	da	da	da	668	554	274	132	394	422
College Graduate	da	da	da	da	485	621	91	125	394	497
EMPLOYMENT STATUS
Full-Time	da	da	da	da	995	1,039	285	250	710	788
Part-Time	da	da	da	da	319	243	137	80	182	163
Unemployed	da	da	da	da	154	191	33	58	121	134
Other¹	da	da	da	da	497	348	85	36	412	312
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.7	0.1	0.0	0.8	0.7	1.6	1.3	0.7	0.6
GENDER
Male	0.9	0.9	0.1	*	1.0	1.0	1.8	1.2	0.9	0.9
Female	0.5	0.5	0.1	0.1	0.6	0.5	1.4	1.4	0.5	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7	0.7	0.1	0.1	0.8	0.7	1.6	1.3	0.7	0.6
White	0.7	0.7	0.1	0.1	0.8	0.7	2.0	1.6	0.6	0.6
Black or African American	0.9	0.5	0.1	*	1.0	0.5	0.4	0.3	1.1	0.5
AIAN	0.4	*	*	*	0.4	*	0.2	*	0.4	*
NHOPI	0.2	*	*	*	0.2	*	*	*	0.3	*
Asian	0.5	0.6	0.2	*	0.5	0.7	1.0	*	0.4	0.8
Two or More Races	0.7	2.0	*	0.1	0.9	2.3	2.4	*	0.4	2.3
Hispanic or Latino	0.7	0.7	0.2	*	0.8	0.8	1.6	1.3	0.6	0.7
EDUCATION LEVEL
< High School	da	da	da	da	0.7	0.8	0.7	1.2	0.7	0.7
High School Graduate	da	da	da	da	1.0	0.6	1.3	1.1	0.9	0.5
Some College/Associate’s Degree	da	da	da	da	0.9	0.7	2.0	0.9	0.6	0.7
College Graduate	da	da	da	da	0.6	0.8	1.8	2.5	0.5	0.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.8	0.9	2.0	2.0	0.6	0.8
Part-Time	da	da	da	da	1.0	0.8	1.6	0.9	0.8	0.7
Unemployed	da	da	da	da	1.5	1.5	1.0	1.7	1.8	1.4
Other¹	da	da	da	da	0.6	0.4	1.1	0.4	0.5	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	9,375	9,356	20	3	9,355	9,354	339	247	9,016	9,107
GENDER
Male	6,009	5,748	12	1	5,997	5,747	181	138	5,817	5,609
Female	3,365	3,608	8	2	3,358	3,607	158	109	3,200	3,498
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,440	8,248	18	3	8,422	8,246	272	205	8,150	8,040
White	6,521	6,482	18	3	6,503	6,479	237	188	6,266	6,291
Black or African American	1,268	1,338	*	*	1,268	1,338	2	7	1,266	1,331
AIAN	64	139	*	*	64	139	6	*	59	*
NHOPI	39	13	*	*	39	13	*	*	38	*
Asian	99	46	*	*	99	46	4	2	96	44
Two or More Races	448	231	*	*	448	231	23	8	426	223
Hispanic or Latino	935	1,108	2	*	933	1,108	66	41	867	1,066
EDUCATION LEVEL
< High School	da	da	da	da	1,428	1,504	77	29	1,351	1,475
High School Graduate	da	da	da	da	3,001	3,394	151	132	2,850	3,263
Some College/Associate’s Degree	da	da	da	da	3,565	3,486	95	72	3,470	3,415
College Graduate	da	da	da	da	1,361	969	15	14	1,346	955
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,360	3,922	175	91	4,185	3,831
Part-Time	da	da	da	da	1,011	1,251	45	56	966	1,195
Unemployed	da	da	da	da	629	699	42	25	587	674
Other¹	da	da	da	da	3,355	3,482	77	75	3,278	3,407
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.4	3.4	0.1	0.0	3.7	3.7	1.0	0.7	4.2	4.2
GENDER
Male	4.5	4.3	0.1	0.0	5.0	4.7	1.1	0.8	5.6	5.3
Female	2.4	2.5	0.1	0.0	2.6	2.8	0.9	0.6	2.8	3.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.7	3.6	0.1	0.0	4.0	3.9	1.0	0.8	4.5	4.4
White	3.8	3.8	0.1	0.0	4.1	4.1	1.3	1.1	4.5	4.5
Black or African American	3.8	4.0	*	*	4.2	4.4	0.0	0.2	5.0	5.1
AIAN	4.1	8.4	*	*	4.6	9.7	2.7	*	5.0	*
NHOPI	3.5	1.3	*	*	3.9	1.4	*	*	4.5	*
Asian	0.6	0.3	*	*	0.7	0.3	0.2	0.1	0.8	0.4
Two or More Races	8.4	4.3	*	*	10.2	4.9	2.4	0.7	12.3	6.1
Hispanic or Latino	2.0	2.3	0.0	*	2.3	2.6	0.9	0.5	2.6	3.1
EDUCATION LEVEL
< High School	da	da	da	da	4.7	5.2	1.6	0.8	5.3	5.9
High School Graduate	da	da	da	da	4.9	4.9	1.4	1.2	5.7	5.6
Some College/Associate’s Degree	da	da	da	da	4.6	4.6	0.7	0.5	5.5	5.5
College Graduate	da	da	da	da	1.7	1.3	0.3	0.3	1.7	1.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.5	3.4	1.2	0.7	3.8	3.7
Part-Time	da	da	da	da	3.1	4.0	0.5	0.7	4.0	5.3
Unemployed	da	da	da	da	6.3	5.4	1.3	0.7	8.8	7.1
Other¹	da	da	da	da	4.0	3.8	1.0	0.9	4.3	4.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	778	657	11	2	766	655	61	49	706	606
GENDER
Male	499	411	7	*	491	411	38	25	453	386
Female	279	246	4	2	275	244	23	25	252	220
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	738	584	11	2	727	582	53	35	674	547
White	512	401	11	2	501	400	50	34	451	366
Black or African American	197	121	*	*	197	121	2	1	195	120
AIAN	*	0	*	*	*	0	*	*	*	*
NHOPI	10	*	*	*	10	*	*	*	*	*
Asian	2	9	*	*	2	9	*	*	2	9
Two or More Races	17	52	*	*	17	52	1	*	16	52
Hispanic or Latino	40	73	1	*	40	73	8	14	32	59
EDUCATION LEVEL
< High School	da	da	da	da	152	173	14	3	139	170
High School Graduate	da	da	da	da	316	205	34	42	282	163
Some College/Associate’s Degree	da	da	da	da	274	267	11	5	262	262
College Graduate	da	da	da	da	24	11	1	*	23	11
EMPLOYMENT STATUS
Full-Time	da	da	da	da	208	132	27	6	181	126
Part-Time	da	da	da	da	54	105	3	16	51	89
Unemployed	da	da	da	da	78	94	17	16	61	78
Other¹	da	da	da	da	427	325	14	12	413	313
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.3	0.2	0.0	0.0	0.3	0.3	0.2	0.1	0.3	0.3
GENDER
Male	0.4	0.3	0.1	*	0.4	0.3	0.2	0.1	0.4	0.4
Female	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.3	0.1	0.0	0.3	0.3	0.2	0.1	0.4	0.3
White	0.3	0.2	0.1	0.0	0.3	0.3	0.3	0.2	0.3	0.3
Black or African American	0.6	0.4	*	*	0.7	0.4	0.0	0.0	0.8	0.5
AIAN	*	0.0	*	*	*	0.0	*	*	*	*
NHOPI	0.9	*	*	*	1.0	*	*	*	*	*
Asian	0.0	0.1	*	*	0.0	0.1	*	*	0.0	0.1
Two or More Races	0.3	1.0	*	*	0.4	1.1	0.1	*	0.5	1.4
Hispanic or Latino	0.1	0.2	0.0	*	0.1	0.2	0.1	0.2	0.1	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.6	0.3	0.1	0.5	0.7
High School Graduate	da	da	da	da	0.5	0.3	0.3	0.4	0.6	0.3
Some College/Associate’s Degree	da	da	da	da	0.4	0.3	0.1	0.0	0.4	0.4
College Graduate	da	da	da	da	0.0	0.0	0.0	*	0.0	0.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.2	0.1	0.2	0.0	0.2	0.1
Part-Time	da	da	da	da	0.2	0.3	0.0	0.2	0.2	0.4
Unemployed	da	da	da	da	0.8	0.7	0.5	0.5	0.9	0.8
Other¹	da	da	da	da	0.5	0.4	0.2	0.1	0.5	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	378	335	5	2	372	333	18	35	355	298
GENDER
Male	244	232	5	*	239	232	6	12	233	219
Female	134	103	*	2	134	102	12	23	122	78
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	364	284	5	2	359	282	14	29	344	253
White	245	143	5	2	240	142	11	29	229	113
Black or African American	111	92	*	*	111	92	2	*	109	92
AIAN	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	*	9	*	*	*	9	*	*	1	9
Two or More Races	7	40	*	*	7	40	1	*	6	40
Hispanic or Latino	14	51	*	*	14	51	3	6	11	44
EDUCATION LEVEL
< High School	da	da	da	da	93	104	3	1	90	103
High School Graduate	da	da	da	da	143	141	14	30	129	111
Some College/Associate’s Degree	da	da	da	da	120	89	*	5	120	84
College Graduate	da	da	da	da	17	*	1	*	16	*
EMPLOYMENT STATUS
Full-Time	da	da	da	da	82	43	5	*	77	43
Part-Time	da	da	da	da	32	23	1	8	31	15
Unemployed	da	da	da	da	47	60	9	16	38	44
Other¹	da	da	da	da	211	208	3	11	208	197
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1
GENDER
Male	0.2	0.2	0.0	*	0.2	0.2	0.0	0.1	0.2	0.2
Female	0.1	0.1	*	0.0	0.1	0.1	0.1	0.1	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1
White	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1
Black or African American	0.3	0.3	*	*	0.4	0.3	0.0	*	0.4	0.4
AIAN	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	*	0.1	*	*	*	0.1	*	*	0.0	0.1
Two or More Races	0.1	0.7	*	*	0.2	0.8	0.1	*	0.2	1.1
Hispanic or Latino	0.0	0.1	*	*	0.0	0.1	0.0	0.1	0.0	0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.4	0.1	0.0	0.4	0.4
High School Graduate	da	da	da	da	0.2	0.2	0.1	0.3	0.3	0.2
Some College/Associate’s Degree	da	da	da	da	0.2	0.1	*	0.0	0.2	0.1
College Graduate	da	da	da	da	0.0	*	0.0	*	0.0	*
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.0	0.0	*	0.1	0.0
Part-Time	da	da	da	da	0.1	0.1	0.0	0.1	0.1	0.1
Unemployed	da	da	da	da	0.5	0.5	0.3	0.5	0.6	0.5
Other¹	da	da	da	da	0.3	0.2	0.0	0.1	0.3	0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	44,087	43,949	615	563	43,472	43,386	5,597	5,269	37,876	38,117
GENDER
Male	26,051	25,629	342	309	25,710	25,320	3,239	2,905	22,471	22,415
Female	18,036	18,320	273	254	17,763	18,066	2,358	2,365	15,405	15,701
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	38,978	38,823	462	420	38,516	38,403	4,558	4,392	33,958	34,011
White	33,659	33,522	345	281	33,314	33,241	3,673	3,734	29,641	29,507
Black or African American	2,431	2,393	52	27	2,379	2,366	369	278	2,010	2,088
AIAN	366	478	24	*	342	445	54	*	287	*
NHOPI	125	60	*	*	120	60	*	*	97	*
Asian	1,029	1,037	4	60	1,025	977	232	133	793	844
Two or More Races	1,367	1,333	31	19	1,337	1,314	207	197	1,130	1,117
Hispanic or Latino	5,110	5,127	153	144	4,957	4,983	1,039	878	3,917	4,105
EDUCATION LEVEL
< High School	da	da	da	da	3,458	3,252	587	399	2,871	2,854
High School Graduate	da	da	da	da	9,297	11,251	1,681	1,356	7,616	9,895
Some College/Associate’s Degree	da	da	da	da	16,147	15,418	2,323	2,434	13,825	12,984
College Graduate	da	da	da	da	14,570	13,465	1,006	1,081	13,564	12,384
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24,955	22,907	3,020	2,219	21,935	20,687
Part-Time	da	da	da	da	6,171	5,604	1,219	1,312	4,952	4,292
Unemployed	da	da	da	da	2,204	2,806	491	662	1,713	2,144
Other¹	da	da	da	da	10,142	12,069	866	1,077	9,276	10,993
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	16.0	15.9	2.5	2.3	17.4	17.2	16.6	15.7	17.5	17.5
GENDER
Male	19.5	19.1	2.7	2.4	21.3	20.8	19.2	17.3	21.6	21.4
Female	12.7	12.9	2.2	2.1	13.7	13.9	14.0	14.1	13.7	13.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17.1	17.0	2.5	2.2	18.4	18.3	17.5	17.0	18.6	18.5
White	19.7	19.6	2.7	2.2	21.1	21.0	20.4	20.8	21.2	21.1
Black or African American	7.3	7.1	1.6	0.9	8.0	7.8	8.0	6.0	8.0	8.1
AIAN	23.4	28.8	13.8	*	24.6	30.9	25.0	*	24.5	*
NHOPI	11.5	6.0	*	*	12.1	6.2	*	*	11.7	*
Asian	6.5	6.4	0.3	3.2	7.0	6.8	11.1	6.7	6.3	6.8
Two or More Races	25.7	25.1	3.3	3.1	30.5	28.0	22.0	19.0	32.8	30.5
Hispanic or Latino	10.8	10.6	2.5	2.3	12.0	11.8	13.6	11.4	11.7	12.0
EDUCATION LEVEL
< High School	da	da	da	da	11.5	11.3	12.5	10.4	11.3	11.4
High School Graduate	da	da	da	da	15.3	16.2	15.8	12.6	15.2	16.8
Some College/Associate’s Degree	da	da	da	da	21.0	20.2	17.2	17.4	21.8	20.8
College Graduate	da	da	da	da	17.7	17.5	20.4	21.8	17.5	17.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	20.1	19.6	21.1	17.5	20.0	19.9
Part-Time	da	da	da	da	18.9	17.9	14.6	15.3	20.4	18.9
Unemployed	da	da	da	da	22.2	21.8	14.9	19.5	25.8	22.6
Other¹	da	da	da	da	12.1	13.2	11.2	12.2	12.2	13.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	6,010	7,133	440	370	5,571	6,763	2,425	2,446	3,146	4,317
GENDER
Male	3,835	4,178	261	185	3,575	3,993	1,487	1,423	2,088	2,570
Female	2,175	2,955	179	185	1,996	2,770	938	1,023	1,058	1,747
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5,004	6,169	324	301	4,680	5,869	2,015	2,103	2,665	3,766
White	3,963	4,969	257	222	3,706	4,747	1,616	1,825	2,090	2,921
Black or African American	459	467	31	15	429	452	159	130	269	322
AIAN	61	82	13	*	48	53	23	*	25	52
NHOPI	23	2	*	*	22	2	*	*	*	*
Asian	260	372	1	19	259	354	124	55	135	298
Two or More Races	238	277	22	16	217	261	90	92	127	169
Hispanic or Latino	1,006	964	116	69	891	894	410	343	480	551
EDUCATION LEVEL
< High School	da	da	da	da	442	478	225	197	217	281
High School Graduate	da	da	da	da	1,145	1,261	700	501	445	760
Some College/Associate’s Degree	da	da	da	da	2,270	2,729	1,122	1,240	1,148	1,489
College Graduate	da	da	da	da	1,714	2,295	378	508	1,335	1,787
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,986	3,441	1,100	1,062	1,886	2,379
Part-Time	da	da	da	da	1,165	1,325	619	634	546	692
Unemployed	da	da	da	da	493	743	280	354	212	389
Other¹	da	da	da	da	927	1,253	426	395	501	858
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2.2	2.6	1.8	1.5	2.2	2.7	7.2	7.3	1.5	2.0
GENDER
Male	2.9	3.1	2.1	1.5	3.0	3.3	8.8	8.5	2.0	2.5
Female	1.5	2.1	1.5	1.5	1.5	2.1	5.6	6.1	0.9	1.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.2	2.7	1.7	1.6	2.2	2.8	7.7	8.2	1.5	2.0
White	2.3	2.9	2.0	1.7	2.3	3.0	9.0	10.2	1.5	2.1
Black or African American	1.4	1.4	0.9	0.5	1.4	1.5	3.4	2.8	1.1	1.2
AIAN	3.9	5.0	7.4	*	3.4	3.7	10.4	*	2.1	4.2
NHOPI	2.1	0.2	*	*	2.2	0.2	*	*	*	*
Asian	1.6	2.3	0.1	1.0	1.8	2.5	5.9	2.8	1.1	2.4
Two or More Races	4.5	5.2	2.3	2.6	4.9	5.6	9.6	8.9	3.7	4.6
Hispanic or Latino	2.1	2.0	1.9	1.1	2.2	2.1	5.4	4.4	1.4	1.6
EDUCATION LEVEL
< High School	da	da	da	da	1.5	1.7	4.8	5.1	0.9	1.1
High School Graduate	da	da	da	da	1.9	1.8	6.6	4.7	0.9	1.3
Some College/Associate’s Degree	da	da	da	da	2.9	3.6	8.3	8.9	1.8	2.4
College Graduate	da	da	da	da	2.1	3.0	7.7	10.2	1.7	2.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.4	3.0	7.7	8.4	1.7	2.3
Part-Time	da	da	da	da	3.6	4.2	7.4	7.4	2.3	3.0
Unemployed	da	da	da	da	5.0	5.8	8.5	10.5	3.2	4.1
Other¹	da	da	da	da	1.1	1.4	5.5	4.5	0.7	1.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,915	1,761	152	80	1,763	1,681	625	645	1,138	1,036
GENDER
Male	1,226	1,172	89	50	1,137	1,122	368	417	769	706
Female	689	589	63	30	626	559	257	229	369	330
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,655	1,533	105	67	1,550	1,466	508	547	1,042	919
White	1,284	1,184	85	45	1,199	1,139	390	440	809	699
Black or African American	150	168	7	4	143	164	34	63	109	102
AIAN	29	24	*	*	25	*	6	*	19	*
NHOPI	0	2	*	*	*	2	*	*	*	*
Asian	122	7	*	2	122	5	52	3	70	2
Two or More Races	68	148	8	8	60	140	26	41	34	99
Hispanic or Latino	260	228	47	12	213	216	117	98	96	117
EDUCATION LEVEL
< High School	da	da	da	da	169	186	71	64	99	122
High School Graduate	da	da	da	da	362	351	183	150	179	201
Some College/Associate’s Degree	da	da	da	da	626	619	256	307	370	312
College Graduate	da	da	da	da	605	525	114	125	491	400
EMPLOYMENT STATUS
Full-Time	da	da	da	da	886	872	259	271	627	601
Part-Time	da	da	da	da	386	252	171	172	214	80
Unemployed	da	da	da	da	147	261	79	105	68	156
Other¹	da	da	da	da	344	297	116	98	229	199
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.6	0.6	0.3	0.7	0.7	1.9	1.9	0.5	0.5
GENDER
Male	0.9	0.9	0.7	0.4	0.9	0.9	2.2	2.5	0.7	0.7
Female	0.5	0.4	0.5	0.2	0.5	0.4	1.5	1.4	0.3	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7	0.7	0.6	0.4	0.7	0.7	1.9	2.1	0.6	0.5
White	0.8	0.7	0.7	0.4	0.8	0.7	2.2	2.5	0.6	0.5
Black or African American	0.5	0.5	0.2	0.1	0.5	0.5	0.7	1.4	0.4	0.4
AIAN	1.9	1.4	*	*	1.8	*	2.9	*	1.6	*
NHOPI	0.0	0.2	*	*	*	0.2	*	*	*	*
Asian	0.8	0.0	*	0.1	0.8	0.0	2.5	0.1	0.6	0.0
Two or More Races	1.3	2.8	0.9	1.3	1.4	3.0	2.8	4.0	1.0	2.7
Hispanic or Latino	0.5	0.5	0.8	0.2	0.5	0.5	1.5	1.3	0.3	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.6	0.6	1.5	1.7	0.4	0.5
High School Graduate	da	da	da	da	0.6	0.5	1.7	1.4	0.4	0.3
Some College/Associate’s Degree	da	da	da	da	0.8	0.8	1.9	2.2	0.6	0.5
College Graduate	da	da	da	da	0.7	0.7	2.3	2.5	0.6	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.7	1.8	2.1	0.6	0.6
Part-Time	da	da	da	da	1.2	0.8	2.0	2.0	0.9	0.4
Unemployed	da	da	da	da	1.5	2.0	2.4	3.1	1.0	1.6
Other¹	da	da	da	da	0.4	0.3	1.5	1.1	0.3	0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	25,090	26,749	2,202	2,327	22,889	24,422	3,099	2,929	19,790	21,493
GENDER
Male	15,563	15,899	1,112	996	14,451	14,903	1,728	1,484	12,723	13,419
Female	9,528	10,850	1,090	1,331	8,438	9,519	1,370	1,445	7,067	8,074
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21,985	23,264	1,725	1,783	20,260	21,481	2,495	2,337	17,766	19,144
White	19,100	19,876	1,211	1,225	17,889	18,651	1,977	1,872	15,912	16,779
Black or African American	1,214	1,522	297	274	917	1,248	255	196	663	1,052
AIAN	137	276	21	*	116	189	22	*	94	160
NHOPI	80	29	*	*	65	29	*	*	61	*
Asian	623	855	78	138	545	717	90	113	455	604
Two or More Races	830	707	102	60	728	647	148	117	580	530
Hispanic or Latino	3,105	3,485	477	544	2,628	2,941	604	592	2,024	2,349
EDUCATION LEVEL
< High School	da	da	da	da	1,946	1,851	383	273	1,563	1,577
High School Graduate	da	da	da	da	4,607	5,544	878	787	3,729	4,756
Some College/Associate’s Degree	da	da	da	da	8,290	8,602	1,294	1,389	6,995	7,213
College Graduate	da	da	da	da	8,047	8,426	543	480	7,503	7,946
EMPLOYMENT STATUS
Full-Time	da	da	da	da	13,382	13,542	1,427	1,108	11,954	12,434
Part-Time	da	da	da	da	3,568	3,146	800	818	2,768	2,328
Unemployed	da	da	da	da	1,011	1,384	276	319	735	1,065
Other¹	da	da	da	da	4,928	6,350	596	683	4,333	5,666
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	9.1	9.7	8.8	9.3	9.1	9.7	9.2	8.7	9.1	9.8
GENDER
Male	11.7	11.8	8.8	7.8	12.0	12.2	10.2	8.9	12.2	12.8
Female	6.7	7.6	8.9	10.9	6.5	7.3	8.1	8.6	6.3	7.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.7	10.2	9.2	9.5	9.7	10.2	9.6	9.1	9.7	10.4
White	11.2	11.6	9.4	9.6	11.3	11.8	11.0	10.4	11.4	12.0
Black or African American	3.7	4.5	8.8	8.8	3.1	4.1	5.5	4.3	2.6	4.1
AIAN	8.8	16.6	12.4	*	8.3	13.1	10.1	*	8.0	12.8
NHOPI	7.3	2.9	*	*	6.6	3.0	*	*	7.4	*
Asian	3.9	5.3	6.0	7.4	3.7	5.0	4.3	5.7	3.6	4.9
Two or More Races	15.6	13.3	11.0	9.6	16.6	13.8	15.7	11.3	16.8	14.5
Hispanic or Latino	6.5	7.2	7.7	8.6	6.4	7.0	7.9	7.7	6.0	6.8
EDUCATION LEVEL
< High School	da	da	da	da	6.5	6.4	8.2	7.1	6.1	6.3
High School Graduate	da	da	da	da	7.6	8.0	8.3	7.3	7.4	8.1
Some College/Associate’s Degree	da	da	da	da	10.8	11.2	9.6	9.9	11.0	11.5
College Graduate	da	da	da	da	9.8	10.9	11.0	9.7	9.7	11.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	10.8	11.6	10.0	8.7	10.9	12.0
Part-Time	da	da	da	da	10.9	10.1	9.6	9.6	11.4	10.2
Unemployed	da	da	da	da	10.2	10.8	8.4	9.4	11.1	11.2
Other¹	da	da	da	da	5.9	7.0	7.7	7.7	5.7	6.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2,142	2,390	743	683	1,399	1,707	577	507	822	1,200
GENDER
Male	1,358	1,444	345	277	1,014	1,167	338	261	675	906
Female	784	946	398	407	386	539	239	246	147	294
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,725	1,869	561	522	1,164	1,347	452	375	713	972
White	1,253	1,411	418	403	835	1,008	355	292	480	716
Black or African American	203	195	76	35	126	159	46	22	80	137
AIAN	31	28	*	*	21	22	4	*	*	21
NHOPI	12	*	*	*	11	*	*	*	*	*
Asian	159	138	19	50	140	88	26	2	113	86
Two or More Races	68	88	36	27	32	60	17	48	15	12
Hispanic or Latino	417	521	182	162	235	359	125	131	110	228
EDUCATION LEVEL
< High School	da	da	da	da	153	194	69	80	84	114
High School Graduate	da	da	da	da	302	401	147	120	155	281
Some College/Associate’s Degree	da	da	da	da	447	459	263	205	184	254
College Graduate	da	da	da	da	497	653	97	102	399	551
EMPLOYMENT STATUS
Full-Time	da	da	da	da	787	867	214	171	572	696
Part-Time	da	da	da	da	267	323	191	137	76	186
Unemployed	da	da	da	da	89	197	42	105	47	92
Other¹	da	da	da	da	257	320	130	93	127	227
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.8	0.9	3.0	2.7	0.6	0.7	1.7	1.5	0.4	0.5
GENDER
Male	1.0	1.1	2.7	2.2	0.8	1.0	2.0	1.6	0.6	0.9
Female	0.6	0.7	3.3	3.3	0.3	0.4	1.4	1.5	0.1	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.8	3.0	2.8	0.6	0.6	1.7	1.5	0.4	0.5
White	0.7	0.8	3.3	3.1	0.5	0.6	2.0	1.6	0.3	0.5
Black or African American	0.6	0.6	2.3	1.1	0.4	0.5	1.0	0.5	0.3	0.5
AIAN	2.0	1.7	*	*	1.5	1.5	1.9	*	*	1.7
NHOPI	1.1	*	*	*	1.1	*	*	*	*	*
Asian	1.0	0.9	1.5	2.7	1.0	0.6	1.3	0.1	0.9	0.7
Two or More Races	1.3	1.6	3.9	4.4	0.7	1.3	1.8	4.7	0.4	0.3
Hispanic or Latino	0.9	1.1	2.9	2.6	0.6	0.9	1.6	1.7	0.3	0.7
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.7	1.5	2.1	0.3	0.5
High School Graduate	da	da	da	da	0.5	0.6	1.4	1.1	0.3	0.5
Some College/Associate’s Degree	da	da	da	da	0.6	0.6	1.9	1.5	0.3	0.4
College Graduate	da	da	da	da	0.6	0.8	2.0	2.0	0.5	0.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.6	0.7	1.5	1.3	0.5	0.7
Part-Time	da	da	da	da	0.8	1.0	2.3	1.6	0.3	0.8
Unemployed	da	da	da	da	0.9	1.5	1.3	3.1	0.7	1.0
Other¹	da	da	da	da	0.3	0.4	1.7	1.1	0.2	0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	807	904	216	106	591	797	157	160	434	637
GENDER
Male	598	639	94	65	504	574	90	72	414	502
Female	209	265	122	41	87	223	68	88	19	135
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	633	658	156	89	477	569	113	113	364	456
White	457	437	115	63	341	374	87	73	255	301
Black or African American	64	88	17	13	47	74	17	8	30	66
AIAN	4	26	*	*	4	21	0	*	4	21
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	74	62	3	3	72	60	5	2	67	*
Two or More Races	26	45	21	6	5	40	4	*	1	10
Hispanic or Latino	174	246	60	17	114	228	44	47	70	182
EDUCATION LEVEL
< High School	da	da	da	da	80	135	25	45	55	90
High School Graduate	da	da	da	da	113	193	34	50	79	142
Some College/Associate’s Degree	da	da	da	da	134	173	51	42	83	131
College Graduate	da	da	da	da	263	296	47	22	216	274
EMPLOYMENT STATUS
Full-Time	da	da	da	da	347	488	55	101	292	387
Part-Time	da	da	da	da	92	114	58	10	34	104
Unemployed	da	da	da	da	28	76	6	34	22	43
Other¹	da	da	da	da	125	119	39	16	86	103
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.3	0.3	0.9	0.4	0.2	0.3	0.5	0.5	0.2	0.3
GENDER
Male	0.4	0.5	0.7	0.5	0.4	0.5	0.5	0.4	0.4	0.5
Female	0.1	0.2	1.0	0.3	0.1	0.2	0.4	0.5	0.0	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3	0.3	0.8	0.5	0.2	0.3	0.4	0.4	0.2	0.2
White	0.3	0.3	0.9	0.5	0.2	0.2	0.5	0.4	0.2	0.2
Black or African American	0.2	0.3	0.5	0.4	0.2	0.2	0.4	0.2	0.1	0.3
AIAN	0.2	1.6	*	*	0.3	1.5	0.1	*	0.3	1.7
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	0.5	0.4	0.2	0.2	0.5	0.4	0.2	0.1	0.5	*
Two or More Races	0.5	0.8	2.2	0.9	0.1	0.8	0.4	*	0.0	0.3
Hispanic or Latino	0.4	0.5	1.0	0.3	0.3	0.5	0.6	0.6	0.2	0.5
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.5	0.5	1.2	0.2	0.4
High School Graduate	da	da	da	da	0.2	0.3	0.3	0.5	0.2	0.2
Some College/Associate’s Degree	da	da	da	da	0.2	0.2	0.4	0.3	0.1	0.2
College Graduate	da	da	da	da	0.3	0.4	1.0	0.4	0.3	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.4	0.4	0.8	0.3	0.4
Part-Time	da	da	da	da	0.3	0.4	0.7	0.1	0.1	0.5
Unemployed	da	da	da	da	0.3	0.6	0.2	1.0	0.3	0.4
Other¹	da	da	da	da	0.1	0.1	0.5	0.2	0.1	0.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	16,013	15,397	75	48	15,939	15,349	904	538	15,034	14,811
GENDER
Male	9,528	8,958	38	8	9,490	8,950	491	256	9,000	8,694
Female	6,485	6,439	37	40	6,448	6,399	414	282	6,035	6,117
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,177	13,300	52	48	14,126	13,252	730	394	13,396	12,858
White	12,828	11,623	42	21	12,786	11,602	630	367	12,155	11,235
Black or African American	476	735	5	26	471	709	41	1	429	708
AIAN	118	*	*	*	117	*	15	*	102	*
NHOPI	69	41	*	*	68	41	*	*	65	*
Asian	193	216	2	1	191	215	11	0	179	215
Two or More Races	494	460	1	*	494	460	28	22	466	439
Hispanic or Latino	1,836	2,097	23	*	1,813	2,097	174	144	1,638	1,953
EDUCATION LEVEL
< High School	da	da	da	da	2,037	1,702	237	80	1,800	1,622
High School Graduate	da	da	da	da	4,609	5,719	343	220	4,265	5,499
Some College/Associate’s Degree	da	da	da	da	6,118	5,436	264	202	5,854	5,234
College Graduate	da	da	da	da	3,175	2,493	60	37	3,116	2,456
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7,983	6,996	428	203	7,555	6,794
Part-Time	da	da	da	da	1,926	1,739	132	147	1,794	1,592
Unemployed	da	da	da	da	994	1,152	121	52	873	1,100
Other¹	da	da	da	da	5,036	5,462	223	136	4,812	5,326
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5.8	5.6	0.3	0.2	6.4	6.1	2.7	1.6	6.9	6.8
GENDER
Male	7.1	6.7	0.3	0.1	7.9	7.4	2.9	1.5	8.7	8.3
Female	4.6	4.5	0.3	0.3	5.0	4.9	2.5	1.7	5.4	5.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.2	5.8	0.3	0.3	6.8	6.3	2.8	1.5	7.3	7.0
White	7.5	6.8	0.3	0.2	8.1	7.3	3.5	2.0	8.7	8.0
Black or African American	1.4	2.2	0.2	0.8	1.6	2.3	0.9	0.0	1.7	2.7
AIAN	7.5	*	*	*	8.4	*	7.0	*	8.7	*
NHOPI	6.3	4.1	*	*	6.9	4.3	*	*	7.8	*
Asian	1.2	1.3	0.2	0.1	1.3	1.5	0.5	0.0	1.4	1.7
Two or More Races	9.3	8.7	0.1	*	11.3	9.8	3.0	2.1	13.5	12.0
Hispanic or Latino	3.9	4.3	0.4	*	4.4	5.0	2.3	1.9	4.9	5.7
EDUCATION LEVEL
< High School	da	da	da	da	6.8	5.9	5.1	2.1	7.1	6.5
High School Graduate	da	da	da	da	7.6	8.2	3.2	2.0	8.5	9.4
Some College/Associate’s Degree	da	da	da	da	7.9	7.1	2.0	1.4	9.2	8.4
College Graduate	da	da	da	da	3.9	3.2	1.2	0.7	4.0	3.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	6.4	6.0	3.0	1.6	6.9	6.5
Part-Time	da	da	da	da	5.9	5.6	1.6	1.7	7.4	7.0
Unemployed	da	da	da	da	10.0	9.0	3.7	1.5	13.2	11.6
Other¹	da	da	da	da	6.0	6.0	2.9	1.5	6.3	6.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,999	2,550	41	21	1,958	2,528	275	171	1,682	2,358
GENDER
Male	1,262	1,201	18	6	1,244	1,196	164	58	1,080	1,138
Female	737	1,348	23	16	714	1,333	112	113	602	1,220
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,711	2,166	32	21	1,679	2,145	224	125	1,455	2,019
White	1,508	1,876	30	10	1,478	1,866	194	118	1,284	1,747
Black or African American	81	92	1	10	80	82	7	1	73	80
AIAN	29	*	*	*	29	*	3	*	27	*
NHOPI	16	*	*	*	16	*	*	*	13	*
Asian	19	60	*	1	19	59	5	*	13	*
Two or More Races	58	85	1	*	57	85	12	3	45	82
Hispanic or Latino	288	384	10	*	279	384	51	45	228	338
EDUCATION LEVEL
< High School	da	da	da	da	307	399	78	23	229	376
High School Graduate	da	da	da	da	751	861	105	77	646	784
Some College/Associate’s Degree	da	da	da	da	700	997	92	68	608	930
College Graduate	da	da	da	da	199	271	*	4	199	268
EMPLOYMENT STATUS
Full-Time	da	da	da	da	765	750	111	37	655	713
Part-Time	da	da	da	da	168	399	37	36	131	363
Unemployed	da	da	da	da	347	303	51	33	297	269
Other¹	da	da	da	da	677	1,077	77	64	600	1,012
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.9	0.2	0.1	0.8	1.0	0.8	0.5	0.8	1.1
GENDER
Male	0.9	0.9	0.1	0.0	1.0	1.0	1.0	0.3	1.0	1.1
Female	0.5	0.9	0.2	0.1	0.6	1.0	0.7	0.7	0.5	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.9	0.2	0.1	0.8	1.0	0.9	0.5	0.8	1.1
White	0.9	1.1	0.2	0.1	0.9	1.2	1.1	0.7	0.9	1.2
Black or African American	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.3
AIAN	1.9	*	*	*	2.1	*	1.3	*	2.3	*
NHOPI	1.5	*	*	*	1.6	*	*	*	1.6	*
Asian	0.1	0.4	*	0.1	0.1	0.4	0.2	*	0.1	*
Two or More Races	1.1	1.6	0.1	*	1.3	1.8	1.3	0.3	1.3	2.2
Hispanic or Latino	0.6	0.8	0.2	*	0.7	0.9	0.7	0.6	0.7	1.0
EDUCATION LEVEL
< High School	da	da	da	da	1.0	1.4	1.7	0.6	0.9	1.5
High School Graduate	da	da	da	da	1.2	1.2	1.0	0.7	1.3	1.3
Some College/Associate’s Degree	da	da	da	da	0.9	1.3	0.7	0.5	1.0	1.5
College Graduate	da	da	da	da	0.2	0.4	*	0.1	0.3	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.6	0.6	0.8	0.3	0.6	0.7
Part-Time	da	da	da	da	0.5	1.3	0.4	0.4	0.5	1.6
Unemployed	da	da	da	da	3.5	2.4	1.5	1.0	4.5	2.8
Other¹	da	da	da	da	0.8	1.2	1.0	0.7	0.8	1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,173	1,722	11	7	1,161	1,715	110	74	1,051	1,641
GENDER
Male	721	789	4	6	717	783	58	19	659	764
Female	452	934	7	2	444	932	53	55	392	878
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	985	1,451	8	7	977	1,444	81	50	896	1,394
White	863	1,285	6	6	857	1,279	73	45	785	1,235
Black or African American	50	34	1	*	49	34	2	1	47	33
AIAN	16	20	*	*	16	20	1	*	15	*
NHOPI	12	*	*	*	12	*	*	*	*	*
Asian	13	60	*	1	13	59	*	*	13	*
Two or More Races	31	52	1	*	30	52	3	3	27	49
Hispanic or Latino	187	271	3	*	184	271	29	24	155	248
EDUCATION LEVEL
< High School	da	da	da	da	162	275	34	6	129	269
High School Graduate	da	da	da	da	488	601	48	44	440	557
Some College/Associate’s Degree	da	da	da	da	371	649	29	24	342	625
College Graduate	da	da	da	da	140	190	*	*	140	190
EMPLOYMENT STATUS
Full-Time	da	da	da	da	427	491	43	12	384	479
Part-Time	da	da	da	da	100	289	14	19	86	270
Unemployed	da	da	da	da	265	223	23	19	242	203
Other¹	da	da	da	da	369	713	30	23	339	690
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.4	0.6	0.0	0.0	0.5	0.7	0.3	0.2	0.5	0.8
GENDER
Male	0.5	0.6	0.0	0.0	0.6	0.6	0.3	0.1	0.6	0.7
Female	0.3	0.7	0.1	0.0	0.3	0.7	0.3	0.3	0.3	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.6	0.0	0.0	0.5	0.7	0.3	0.2	0.5	0.8
White	0.5	0.8	0.0	0.0	0.5	0.8	0.4	0.2	0.6	0.9
Black or African American	0.2	0.1	0.0	*	0.2	0.1	0.0	0.0	0.2	0.1
AIAN	1.0	1.2	*	*	1.2	1.4	0.3	*	1.3	*
NHOPI	1.1	*	*	*	1.2	*	*	*	*	*
Asian	0.1	0.4	*	0.1	0.1	0.4	*	*	0.1	*
Two or More Races	0.6	1.0	0.1	*	0.7	1.1	0.3	0.3	0.8	1.3
Hispanic or Latino	0.4	0.6	0.1	*	0.4	0.6	0.4	0.3	0.5	0.7
EDUCATION LEVEL
< High School	da	da	da	da	0.5	1.0	0.7	0.1	0.5	1.1
High School Graduate	da	da	da	da	0.8	0.9	0.5	0.4	0.9	0.9
Some College/Associate’s Degree	da	da	da	da	0.5	0.8	0.2	0.2	0.5	1.0
College Graduate	da	da	da	da	0.2	0.2	*	*	0.2	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.4	0.3	0.1	0.3	0.5
Part-Time	da	da	da	da	0.3	0.9	0.2	0.2	0.4	1.2
Unemployed	da	da	da	da	2.7	1.7	0.7	0.6	3.6	2.1
Other¹	da	da	da	da	0.4	0.8	0.4	0.3	0.4	0.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.44A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	82,559	75,198	3,980	3,079	78,579	72,118	8,357	6,858	70,222	65,261
GENDER
Male	37,510	33,689	1,898	1,544	35,612	32,146	3,602	2,890	32,010	29,256
Female	45,049	41,508	2,083	1,536	42,967	39,973	4,755	3,968	38,211	36,004
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	70,541	63,567	2,932	2,239	67,610	61,328	6,519	5,332	61,091	55,997
White	54,877	49,205	2,021	1,588	52,856	47,617	4,583	3,883	48,273	43,734
Black or African American	10,587	9,785	601	449	9,986	9,336	1,208	945	8,778	8,392
AIAN	582	482	30	*	552	*	63	*	488	*
NHOPI	218	*	*	*	213	*	*	*	172	*
Asian	2,593	2,231	128	91	2,464	2,140	364	219	2,100	1,922
Two or More Races	1,685	1,715	146	90	1,539	1,625	259	233	1,280	1,392
Hispanic or Latino	12,018	11,631	1,049	841	10,969	10,790	1,838	1,526	9,131	9,264
EDUCATION LEVEL
< High School	da	da	da	da	8,979	8,633	1,200	786	7,779	7,846
High School Graduate	da	da	da	da	19,289	20,669	2,548	2,171	16,740	18,498
Some College/Associate’s Degree	da	da	da	da	27,613	24,501	3,605	3,016	24,008	21,486
College Graduate	da	da	da	da	22,698	18,316	1,004	885	21,694	17,430
EMPLOYMENT STATUS
Full-Time	da	da	da	da	35,946	30,315	3,612	2,777	32,333	27,537
Part-Time	da	da	da	da	9,701	8,046	1,973	1,592	7,728	6,454
Unemployed	da	da	da	da	3,137	3,156	914	732	2,224	2,424
Other¹	da	da	da	da	29,795	30,602	1,858	1,757	27,937	28,845
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.44B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	30.0	27.2	16.0	12.3	31.4	28.6	24.8	20.5	32.4	29.9
GENDER
Male	28.1	25.1	15.0	12.1	29.5	26.4	21.3	17.2	30.8	27.9
Female	31.8	29.1	17.0	12.5	33.2	30.7	28.3	23.7	33.9	31.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	31.0	27.8	15.7	12.0	32.3	29.2	25.0	20.7	33.4	30.4
White	32.2	28.8	15.7	12.4	33.5	30.2	25.4	21.7	34.5	31.2
Black or African American	31.8	29.1	17.9	14.4	33.4	30.6	26.1	20.6	34.8	32.4
AIAN	37.2	29.0	17.4	*	39.6	*	29.0	*	41.6	*
NHOPI	20.0	*	*	*	21.5	*	*	*	20.6	*
Asian	16.3	13.8	9.8	4.9	16.9	14.9	17.4	11.0	16.8	15.6
Two or More Races	31.7	32.3	15.7	14.6	35.1	34.6	27.6	22.5	37.1	38.1
Hispanic or Latino	25.3	24.0	16.9	13.3	26.6	25.6	24.0	19.8	27.2	27.0
EDUCATION LEVEL
< High School	da	da	da	da	29.8	29.9	25.6	20.6	30.5	31.3
High School Graduate	da	da	da	da	31.7	29.8	24.0	20.2	33.4	31.5
Some College/Associate’s Degree	da	da	da	da	35.8	32.0	26.7	21.6	37.8	34.4
College Graduate	da	da	da	da	27.6	23.8	20.3	17.8	28.0	24.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	28.9	26.0	25.2	21.9	29.4	26.5
Part-Time	da	da	da	da	29.8	25.7	23.6	18.6	31.9	28.4
Unemployed	da	da	da	da	31.6	24.5	27.8	21.6	33.5	25.6
Other¹	da	da	da	da	35.6	33.6	24.0	19.9	36.8	35.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.45A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	9,724	9,254	567	396	9,158	8,858	1,754	1,361	7,404	7,498
GENDER
Male	5,134	4,213	254	215	4,880	3,998	895	616	3,985	3,382
Female	4,590	5,042	312	181	4,278	4,860	859	744	3,418	4,116
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,979	7,496	407	248	7,572	7,248	1,316	1,089	6,256	6,159
White	6,290	5,704	289	166	6,001	5,538	995	869	5,006	4,669
Black or African American	1,059	1,206	85	61	975	1,145	178	153	797	992
AIAN	79	52	5	*	74	48	14	*	60	31
NHOPI	23	6	*	*	22	6	*	*	20	*
Asian	262	390	3	4	259	386	66	21	193	365
Two or More Races	266	137	24	12	242	125	61	*	181	96
Hispanic or Latino	1,745	1,758	160	148	1,585	1,610	438	272	1,147	1,338
EDUCATION LEVEL
< High School	da	da	da	da	1,276	1,183	294	142	983	1,040
High School Graduate	da	da	da	da	2,240	2,406	546	412	1,694	1,994
Some College/Associate’s Degree	da	da	da	da	3,331	3,301	729	566	2,602	2,735
College Graduate	da	da	da	da	2,310	1,969	185	240	2,125	1,729
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,764	3,798	823	667	3,941	3,131
Part-Time	da	da	da	da	1,174	1,312	389	238	785	1,074
Unemployed	da	da	da	da	625	537	194	161	431	376
Other¹	da	da	da	da	2,594	3,212	348	295	2,246	2,916
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.45B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.5	3.3	2.3	1.6	3.7	3.5	5.2	4.1	3.4	3.4
GENDER
Male	3.8	3.1	2.0	1.7	4.0	3.3	5.3	3.7	3.8	3.2
Female	3.2	3.5	2.6	1.5	3.3	3.7	5.1	4.4	3.0	3.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.5	3.3	2.2	1.3	3.6	3.5	5.0	4.2	3.4	3.3
White	3.7	3.3	2.3	1.3	3.8	3.5	5.5	4.9	3.6	3.3
Black or African American	3.2	3.6	2.5	1.9	3.3	3.8	3.8	3.3	3.2	3.8
AIAN	5.0	3.2	2.9	*	5.3	3.3	6.4	*	5.1	2.4
NHOPI	2.1	0.6	*	*	2.3	0.6	*	*	2.5	*
Asian	1.6	2.4	0.3	0.2	1.8	2.7	3.2	1.1	1.5	3.0
Two or More Races	5.0	2.6	2.6	2.0	5.5	2.7	6.5	*	5.3	2.6
Hispanic or Latino	3.7	3.6	2.6	2.3	3.8	3.8	5.7	3.5	3.4	3.9
EDUCATION LEVEL
< High School	da	da	da	da	4.2	4.1	6.3	3.7	3.9	4.1
High School Graduate	da	da	da	da	3.7	3.5	5.1	3.8	3.4	3.4
Some College/Associate’s Degree	da	da	da	da	4.3	4.3	5.4	4.0	4.1	4.4
College Graduate	da	da	da	da	2.8	2.6	3.8	4.8	2.7	2.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.8	3.3	5.7	5.2	3.6	3.0
Part-Time	da	da	da	da	3.6	4.2	4.7	2.8	3.2	4.7
Unemployed	da	da	da	da	6.3	4.2	5.9	4.7	6.5	4.0
Other¹	da	da	da	da	3.1	3.5	4.5	3.3	3.0	3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.46A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2,819	2,536	165	96	2,654	2,440	420	288	2,234	2,152
GENDER
Male	1,450	1,133	68	61	1,382	1,072	183	133	1,199	939
Female	1,369	1,403	97	35	1,271	1,369	236	155	1,035	1,213
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,324	1,955	117	80	2,207	1,876	324	246	1,883	1,629
White	1,894	1,475	79	52	1,815	1,423	255	187	1,560	1,237
Black or African American	238	324	24	24	214	299	45	60	169	240
AIAN	15	28	*	*	15	28	3	*	12	28
NHOPI	*	1	*	*	*	1	*	*	*	*
Asian	77	106	*	0	77	106	5	*	72	106
Two or More Races	87	22	14	3	74	19	14	0	59	19
Hispanic or Latino	495	581	48	16	447	564	96	42	352	523
EDUCATION LEVEL
< High School	da	da	da	da	297	327	88	36	210	291
High School Graduate	da	da	da	da	714	610	113	93	601	518
Some College/Associate’s Degree	da	da	da	da	958	1,059	179	127	779	932
College Graduate	da	da	da	da	684	444	40	33	645	412
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,280	1,024	186	107	1,094	917
Part-Time	da	da	da	da	336	331	87	41	249	291
Unemployed	da	da	da	da	239	132	61	29	179	103
Other¹	da	da	da	da	798	953	85	112	713	841
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.46B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.0	0.9	0.7	0.4	1.1	1.0	1.2	0.9	1.0	1.0
GENDER
Male	1.1	0.8	0.5	0.5	1.1	0.9	1.1	0.8	1.2	0.9
Female	1.0	1.0	0.8	0.3	1.0	1.1	1.4	0.9	0.9	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	0.9	0.6	0.4	1.1	0.9	1.2	1.0	1.0	0.9
White	1.1	0.9	0.6	0.4	1.2	0.9	1.4	1.0	1.1	0.9
Black or African American	0.7	1.0	0.7	0.8	0.7	1.0	1.0	1.3	0.7	0.9
AIAN	1.0	1.7	*	*	1.1	1.9	1.2	*	1.1	2.2
NHOPI	*	0.1	*	*	*	0.1	*	*	*	*
Asian	0.5	0.7	*	0.0	0.5	0.7	0.2	*	0.6	0.9
Two or More Races	1.6	0.4	1.5	0.5	1.7	0.4	1.5	0.0	1.7	0.5
Hispanic or Latino	1.0	1.2	0.8	0.3	1.1	1.3	1.2	0.5	1.0	1.5
EDUCATION LEVEL
< High School	da	da	da	da	1.0	1.1	1.9	0.9	0.8	1.2
High School Graduate	da	da	da	da	1.2	0.9	1.1	0.9	1.2	0.9
Some College/Associate’s Degree	da	da	da	da	1.2	1.4	1.3	0.9	1.2	1.5
College Graduate	da	da	da	da	0.8	0.6	0.8	0.7	0.8	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.0	0.9	1.3	0.8	1.0	0.9
Part-Time	da	da	da	da	1.0	1.1	1.0	0.5	1.0	1.3
Unemployed	da	da	da	da	2.4	1.0	1.8	0.9	2.7	1.1
Other¹	da	da	da	da	1.0	1.0	1.1	1.3	0.9	1.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	18,290	18,332	1,837	1,593	16,453	16,739	4,320	3,773	12,133	12,966
GENDER
Male	8,575	8,276	1,117	962	7,458	7,314	2,322	1,978	5,136	5,336
Female	9,715	10,057	720	631	8,995	9,425	1,998	1,795	6,996	7,630
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	16,013	15,954	1,483	1,367	14,530	14,587	3,727	3,289	10,803	11,298
White	13,601	13,293	1,205	1,090	12,395	12,204	3,045	2,760	9,350	9,443
Black or African American	1,284	1,433	154	184	1,130	1,250	305	287	825	963
AIAN	80	*	8	*	71	*	28	*	43	*
NHOPI	53	6	*	*	47	6	*	*	25	*
Asian	552	712	29	54	523	659	156	138	368	520
Two or More Races	444	373	81	24	363	349	172	101	191	248
Hispanic or Latino	2,277	2,378	354	226	1,923	2,152	594	485	1,329	1,667
EDUCATION LEVEL
< High School	da	da	da	da	1,387	1,578	392	231	995	1,347
High School Graduate	da	da	da	da	3,063	3,638	990	915	2,073	2,723
Some College/Associate’s Degree	da	da	da	da	6,350	6,230	1,977	1,891	4,373	4,339
College Graduate	da	da	da	da	5,653	5,293	962	736	4,691	4,557
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8,900	8,005	1,864	1,521	7,036	6,484
Part-Time	da	da	da	da	2,555	2,619	1,198	1,041	1,357	1,578
Unemployed	da	da	da	da	954	1,006	430	318	523	688
Other¹	da	da	da	da	4,044	5,108	828	892	3,216	4,216
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	6.6	6.6	7.4	6.4	6.6	6.6	12.8	11.3	5.6	5.9
GENDER
Male	6.4	6.2	8.8	7.6	6.2	6.0	13.7	11.8	4.9	5.1
Female	6.9	7.1	5.9	5.1	6.9	7.2	11.9	10.7	6.2	6.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7.0	7.0	7.9	7.3	7.0	7.0	14.3	12.8	5.9	6.1
White	8.0	7.8	9.4	8.5	7.9	7.7	16.9	15.4	6.7	6.7
Black or African American	3.9	4.3	4.6	5.9	3.8	4.1	6.6	6.2	3.3	3.7
AIAN	5.1	*	4.8	*	5.1	*	12.8	*	3.7	*
NHOPI	4.8	0.6	*	*	4.7	0.6	*	*	3.0	*
Asian	3.5	4.4	2.2	2.9	3.6	4.6	7.4	7.0	2.9	4.2
Two or More Races	8.3	7.0	8.6	3.9	8.3	7.4	18.3	9.8	5.5	6.8
Hispanic or Latino	4.8	4.9	5.7	3.6	4.7	5.1	7.7	6.3	4.0	4.9
EDUCATION LEVEL
< High School	da	da	da	da	4.6	5.5	8.4	6.0	3.9	5.4
High School Graduate	da	da	da	da	5.0	5.2	9.3	8.5	4.1	4.6
Some College/Associate’s Degree	da	da	da	da	8.2	8.1	14.6	13.5	6.9	6.9
College Graduate	da	da	da	da	6.9	6.9	19.5	14.8	6.1	6.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7.2	6.9	13.0	12.0	6.4	6.2
Part-Time	da	da	da	da	7.8	8.4	14.4	12.2	5.6	6.9
Unemployed	da	da	da	da	9.6	7.8	13.1	9.4	7.9	7.3
Other¹	da	da	da	da	4.8	5.6	10.7	10.1	4.2	5.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	4,929	5,092	430	288	4,499	4,804	1,951	1,616	2,548	3,188
GENDER
Male	2,771	2,676	253	135	2,517	2,541	1,068	859	1,450	1,682
Female	2,158	2,417	176	154	1,982	2,263	883	757	1,098	1,507
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,334	4,468	326	242	4,008	4,226	1,691	1,388	2,318	2,839
White	3,743	3,903	263	201	3,480	3,702	1,399	1,216	2,081	2,486
Black or African American	251	274	22	26	229	247	111	81	118	167
AIAN	23	30	3	*	20	25	10	*	10	25
NHOPI	9	2	*	*	9	2	*	*	2	*
Asian	159	142	19	3	140	139	80	45	60	95
Two or More Races	149	117	18	6	131	111	84	46	47	64
Hispanic or Latino	595	625	104	47	491	578	260	228	230	350
EDUCATION LEVEL
< High School	da	da	da	da	291	349	169	32	122	318
High School Graduate	da	da	da	da	793	986	355	344	439	642
Some College/Associate’s Degree	da	da	da	da	1,897	1,767	943	855	954	912
College Graduate	da	da	da	da	1,518	1,702	484	385	1,034	1,317
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,614	2,581	865	694	1,748	1,887
Part-Time	da	da	da	da	910	889	604	410	307	479
Unemployed	da	da	da	da	328	411	171	147	157	265
Other¹	da	da	da	da	648	922	311	365	336	557
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.8	1.8	1.7	1.2	1.8	1.9	5.8	4.8	1.2	1.5
GENDER
Male	2.1	2.0	2.0	1.1	2.1	2.1	6.3	5.1	1.4	1.6
Female	1.5	1.7	1.4	1.3	1.5	1.7	5.2	4.5	1.0	1.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.9	2.0	1.7	1.3	1.9	2.0	6.5	5.4	1.3	1.5
White	2.2	2.3	2.0	1.6	2.2	2.3	7.8	6.8	1.5	1.8
Black or African American	0.8	0.8	0.7	0.8	0.8	0.8	2.4	1.8	0.5	0.6
AIAN	1.5	1.8	1.9	*	1.5	1.7	4.6	*	0.9	2.0
NHOPI	0.8	0.2	*	*	0.9	0.2	*	*	0.2	*
Asian	1.0	0.9	1.5	0.2	1.0	1.0	3.8	2.3	0.5	0.8
Two or More Races	2.8	2.2	1.9	1.0	3.0	2.4	9.0	4.5	1.4	1.8
Hispanic or Latino	1.3	1.3	1.7	0.7	1.2	1.4	3.4	2.9	0.7	1.0
EDUCATION LEVEL
< High School	da	da	da	da	1.0	1.2	3.6	0.8	0.5	1.3
High School Graduate	da	da	da	da	1.3	1.4	3.3	3.2	0.9	1.1
Some College/Associate’s Degree	da	da	da	da	2.5	2.3	7.0	6.1	1.5	1.5
College Graduate	da	da	da	da	1.8	2.2	9.8	7.8	1.3	1.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.1	2.2	6.0	5.5	1.6	1.8
Part-Time	da	da	da	da	2.8	2.8	7.2	4.8	1.3	2.1
Unemployed	da	da	da	da	3.3	3.2	5.2	4.3	2.4	2.8
Other¹	da	da	da	da	0.8	1.0	4.0	4.1	0.4	0.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,566	1,493	123	72	1,443	1,421	587	267	856	1,154
GENDER
Male	865	836	91	34	774	802	323	136	451	666
Female	701	657	32	39	668	619	264	131	405	488
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,369	1,361	85	68	1,284	1,294	514	223	770	1,070
White	1,187	1,181	74	50	1,114	1,132	417	200	697	932
Black or African American	50	45	4	13	46	31	28	1	18	30
AIAN	7	*	*	*	7	*	*	*	*	*
NHOPI	3	0	*	*	3	0	*	*	2	*
Asian	50	99	3	3	47	96	34	8	13	88
Two or More Races	72	23	4	*	68	21	33	14	36	7
Hispanic or Latino	198	132	39	5	159	127	73	43	86	84
EDUCATION LEVEL
< High School	da	da	da	da	92	54	57	5	36	49
High School Graduate	da	da	da	da	255	365	103	31	152	334
Some College/Associate’s Degree	da	da	da	da	628	498	289	159	338	339
College Graduate	da	da	da	da	468	504	138	72	330	432
EMPLOYMENT STATUS
Full-Time	da	da	da	da	778	796	222	102	556	694
Part-Time	da	da	da	da	268	314	185	84	83	230
Unemployed	da	da	da	da	135	109	48	18	87	92
Other¹	da	da	da	da	262	201	131	63	131	139
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.6	0.5	0.5	0.3	0.6	0.6	1.7	0.8	0.4	0.5
GENDER
Male	0.6	0.6	0.7	0.3	0.6	0.7	1.9	0.8	0.4	0.6
Female	0.5	0.5	0.3	0.3	0.5	0.5	1.6	0.8	0.4	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.6	0.5	0.4	0.6	0.6	2.0	0.9	0.4	0.6
White	0.7	0.7	0.6	0.4	0.7	0.7	2.3	1.1	0.5	0.7
Black or African American	0.1	0.1	0.1	0.4	0.2	0.1	0.6	0.0	0.1	0.1
AIAN	0.4	*	*	*	0.5	*	*	*	*	*
NHOPI	0.3	0.0	*	*	0.3	0.0	*	*	0.2	*
Asian	0.3	0.6	0.2	0.2	0.3	0.7	1.6	0.4	0.1	0.7
Two or More Races	1.4	0.4	0.4	*	1.6	0.4	3.5	1.4	1.0	0.2
Hispanic or Latino	0.4	0.3	0.6	0.1	0.4	0.3	1.0	0.6	0.3	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.2	1.2	0.1	0.1	0.2
High School Graduate	da	da	da	da	0.4	0.5	1.0	0.3	0.3	0.6
Some College/Associate’s Degree	da	da	da	da	0.8	0.7	2.1	1.1	0.5	0.5
College Graduate	da	da	da	da	0.6	0.7	2.8	1.4	0.4	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.6	0.7	1.5	0.8	0.5	0.7
Part-Time	da	da	da	da	0.8	1.0	2.2	1.0	0.3	1.0
Unemployed	da	da	da	da	1.4	0.9	1.5	0.5	1.3	1.0
Other¹	da	da	da	da	0.3	0.2	1.7	0.7	0.2	0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	44,051	43,001	1,370	936	42,682	42,065	3,995	3,805	38,687	38,261
GENDER
Male	16,396	16,761	597	407	15,799	16,355	1,608	1,662	14,191	14,692
Female	27,655	26,240	772	529	26,883	25,711	2,387	2,142	24,496	23,568
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	38,928	38,363	1,020	674	37,908	37,688	3,317	3,158	34,590	34,530
White	33,085	32,929	737	525	32,348	32,404	2,571	2,605	29,777	29,800
Black or African American	3,557	3,532	169	88	3,388	3,444	417	277	2,971	3,168
AIAN	264	198	8	*	256	188	20	*	236	*
NHOPI	50	*	*	*	47	*	*	*	36	*
Asian	1,125	740	44	25	1,081	714	176	66	905	648
Two or More Races	846	921	59	24	787	897	122	*	665	726
Hispanic or Latino	5,124	4,638	350	262	4,774	4,377	678	646	4,096	3,730
EDUCATION LEVEL
< High School	da	da	da	da	3,884	4,303	541	414	3,343	3,889
High School Graduate	da	da	da	da	9,203	10,958	1,073	1,009	8,130	9,948
Some College/Associate’s Degree	da	da	da	da	14,750	13,724	1,712	1,737	13,038	11,986
College Graduate	da	da	da	da	14,845	13,081	669	644	14,175	12,437
EMPLOYMENT STATUS
Full-Time	da	da	da	da	17,801	16,666	1,730	1,560	16,071	15,107
Part-Time	da	da	da	da	5,916	5,407	967	971	4,949	4,436
Unemployed	da	da	da	da	1,709	1,640	488	411	1,220	1,229
Other¹	da	da	da	da	17,256	18,352	810	863	16,447	17,489
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	16.0	15.5	5.5	3.7	17.1	16.7	11.8	11.4	17.9	17.5
GENDER
Male	12.3	12.5	4.7	3.2	13.1	13.4	9.5	9.9	13.7	14.0
Female	19.5	18.4	6.3	4.3	20.8	19.7	14.2	12.8	21.8	20.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17.1	16.8	5.5	3.6	18.1	18.0	12.7	12.3	18.9	18.8
White	19.4	19.3	5.7	4.1	20.5	20.5	14.3	14.5	21.3	21.3
Black or African American	10.7	10.5	5.0	2.8	11.3	11.3	9.0	6.0	11.8	12.2
AIAN	16.9	11.9	4.4	*	18.4	13.1	9.1	*	20.2	*
NHOPI	4.6	*	*	*	4.8	*	*	*	4.3	*
Asian	7.1	4.6	3.4	1.4	7.4	5.0	8.4	3.3	7.2	5.2
Two or More Races	15.9	17.4	6.3	3.9	17.9	19.1	13.0	*	19.3	19.9
Hispanic or Latino	10.8	9.6	5.6	4.1	11.6	10.4	8.8	8.4	12.2	10.9
EDUCATION LEVEL
< High School	da	da	da	da	12.9	14.9	11.5	10.8	13.1	15.5
High School Graduate	da	da	da	da	15.1	15.8	10.1	9.4	16.2	16.9
Some College/Associate’s Degree	da	da	da	da	19.1	17.9	12.7	12.4	20.5	19.2
College Graduate	da	da	da	da	18.0	17.0	13.6	13.0	18.3	17.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	14.3	14.3	12.1	12.3	14.6	14.5
Part-Time	da	da	da	da	18.1	17.3	11.6	11.3	20.4	19.5
Unemployed	da	da	da	da	17.2	12.7	14.8	12.1	18.4	13.0
Other¹	da	da	da	da	20.6	20.1	10.4	9.8	21.7	21.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5,895	6,205	436	226	5,459	5,979	1,409	1,237	4,050	4,742
GENDER
Male	2,859	2,784	191	87	2,667	2,696	690	600	1,978	2,096
Female	3,036	3,421	245	139	2,792	3,283	719	637	2,072	2,646
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,940	5,435	298	148	4,642	5,287	1,160	1,010	3,482	4,277
White	4,206	4,583	234	111	3,972	4,472	911	787	3,062	3,685
Black or African American	404	453	29	19	375	435	131	117	244	318
AIAN	20	65	3	*	17	65	7	*	10	*
NHOPI	19	4	*	*	19	4	*	*	*	*
Asian	147	109	6	8	141	101	55	25	86	76
Two or More Races	144	220	26	10	118	210	52	*	66	150
Hispanic or Latino	955	770	138	78	817	692	249	227	568	465
EDUCATION LEVEL
< High School	da	da	da	da	538	516	196	171	342	346
High School Graduate	da	da	da	da	1,110	1,526	406	307	704	1,219
Some College/Associate’s Degree	da	da	da	da	2,095	2,068	595	579	1,500	1,489
College Graduate	da	da	da	da	1,715	1,869	212	180	1,503	1,688
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,789	2,801	633	534	2,156	2,267
Part-Time	da	da	da	da	935	1,024	352	282	583	742
Unemployed	da	da	da	da	368	466	173	144	195	322
Other¹	da	da	da	da	1,368	1,687	251	277	1,117	1,410
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2.1	2.2	1.8	0.9	2.2	2.4	4.2	3.7	1.9	2.2
GENDER
Male	2.1	2.1	1.5	0.7	2.2	2.2	4.1	3.6	1.9	2.0
Female	2.1	2.4	2.0	1.1	2.2	2.5	4.3	3.8	1.8	2.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.2	2.4	1.6	0.8	2.2	2.5	4.4	3.9	1.9	2.3
White	2.5	2.7	1.8	0.9	2.5	2.8	5.0	4.4	2.2	2.6
Black or African American	1.2	1.3	0.9	0.6	1.3	1.4	2.8	2.5	1.0	1.2
AIAN	1.3	3.9	1.8	*	1.2	4.5	3.3	*	0.9	*
NHOPI	1.7	0.4	*	*	1.9	0.4	*	*	*	*
Asian	0.9	0.7	0.5	0.4	1.0	0.7	2.6	1.2	0.7	0.6
Two or More Races	2.7	4.2	2.8	1.6	2.7	4.5	5.5	*	1.9	4.1
Hispanic or Latino	2.0	1.6	2.2	1.2	2.0	1.6	3.3	2.9	1.7	1.4
EDUCATION LEVEL
< High School	da	da	da	da	1.8	1.8	4.2	4.5	1.3	1.4
High School Graduate	da	da	da	da	1.8	2.2	3.8	2.9	1.4	2.1
Some College/Associate’s Degree	da	da	da	da	2.7	2.7	4.4	4.1	2.4	2.4
College Graduate	da	da	da	da	2.1	2.4	4.3	3.6	1.9	2.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.2	2.4	4.4	4.2	2.0	2.2
Part-Time	da	da	da	da	2.9	3.3	4.2	3.3	2.4	3.3
Unemployed	da	da	da	da	3.7	3.6	5.2	4.2	2.9	3.4
Other¹	da	da	da	da	1.6	1.9	3.2	3.1	1.5	1.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,958	2,196	121	26	1,837	2,170	365	371	1,472	1,799
GENDER
Male	910	888	83	6	828	882	193	184	635	698
Female	1,048	1,309	39	21	1,009	1,288	171	187	838	1,101
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,688	1,917	79	21	1,608	1,896	300	280	1,308	1,616
White	1,499	1,659	60	21	1,439	1,638	240	219	1,199	1,419
Black or African American	100	114	11	*	90	114	22	27	67	87
AIAN	4	44	*	*	4	*	*	*	4	*
NHOPI	1	4	*	*	1	4	*	*	*	*
Asian	37	51	3	*	34	51	19	3	15	48
Two or More Races	46	46	5	0	41	45	18	*	23	21
Hispanic or Latino	271	279	42	5	229	274	64	91	164	183
EDUCATION LEVEL
< High School	da	da	da	da	162	258	56	48	106	210
High School Graduate	da	da	da	da	327	441	94	76	233	364
Some College/Associate’s Degree	da	da	da	da	785	842	150	189	636	653
College Graduate	da	da	da	da	563	630	65	58	498	572
EMPLOYMENT STATUS
Full-Time	da	da	da	da	856	922	135	169	722	753
Part-Time	da	da	da	da	339	363	88	70	251	293
Unemployed	da	da	da	da	182	167	74	68	108	99
Other¹	da	da	da	da	460	718	68	65	392	654
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.8	0.5	0.1	0.7	0.9	1.1	1.1	0.7	0.8
GENDER
Male	0.7	0.7	0.7	0.0	0.7	0.7	1.1	1.1	0.6	0.7
Female	0.7	0.9	0.3	0.2	0.8	1.0	1.0	1.1	0.7	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7	0.8	0.4	0.1	0.8	0.9	1.2	1.1	0.7	0.9
White	0.9	1.0	0.5	0.2	0.9	1.0	1.3	1.2	0.9	1.0
Black or African American	0.3	0.3	0.3	*	0.3	0.4	0.5	0.6	0.3	0.3
AIAN	0.3	2.6	*	*	0.3	*	*	*	0.4	*
NHOPI	0.1	0.4	*	*	0.1	0.4	*	*	*	*
Asian	0.2	0.3	0.2	*	0.2	0.4	0.9	0.1	0.1	0.4
Two or More Races	0.9	0.9	0.6	0.1	0.9	1.0	1.9	*	0.7	0.6
Hispanic or Latino	0.6	0.6	0.7	0.1	0.6	0.7	0.8	1.2	0.5	0.5
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.9	1.2	1.2	0.4	0.8
High School Graduate	da	da	da	da	0.5	0.6	0.9	0.7	0.5	0.6
Some College/Associate’s Degree	da	da	da	da	1.0	1.1	1.1	1.4	1.0	1.0
College Graduate	da	da	da	da	0.7	0.8	1.3	1.2	0.6	0.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.8	0.9	1.3	0.7	0.7
Part-Time	da	da	da	da	1.0	1.2	1.1	0.8	1.0	1.3
Unemployed	da	da	da	da	1.8	1.3	2.2	2.0	1.6	1.0
Other¹	da	da	da	da	0.6	0.8	0.9	0.7	0.5	0.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	35,601	35,018	1,010	588	34,591	34,430	3,419	3,338	31,172	31,092
GENDER
Male	12,603	13,006	435	238	12,168	12,768	1,350	1,404	10,818	11,364
Female	22,998	22,012	575	349	22,423	21,662	2,068	1,934	20,354	19,728
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	31,339	31,168	739	405	30,600	30,763	2,849	2,745	27,751	28,018
White	26,952	26,756	552	308	26,400	26,447	2,238	2,308	24,162	24,139
Black or African American	2,719	2,777	101	68	2,618	2,709	332	233	2,286	2,476
AIAN	223	176	7	*	216	173	15	*	201	*
NHOPI	46	*	*	*	44	*	*	*	36	*
Asian	712	627	35	12	677	615	143	61	534	554
Two or More Races	687	791	42	14	645	777	113	*	532	660
Hispanic or Latino	4,262	3,850	271	183	3,991	3,667	569	593	3,422	3,074
EDUCATION LEVEL
< High School	da	da	da	da	3,154	3,523	436	337	2,718	3,186
High School Graduate	da	da	da	da	7,336	9,102	940	881	6,396	8,221
Some College/Associate’s Degree	da	da	da	da	12,397	10,956	1,461	1,537	10,936	9,419
College Graduate	da	da	da	da	11,705	10,849	582	583	11,123	10,266
EMPLOYMENT STATUS
Full-Time	da	da	da	da	14,448	13,300	1,497	1,372	12,952	11,929
Part-Time	da	da	da	da	4,752	4,517	823	840	3,929	3,676
Unemployed	da	da	da	da	1,440	1,433	395	380	1,045	1,053
Other¹	da	da	da	da	13,951	15,180	704	746	13,247	14,434
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	12.9	12.6	4.1	2.4	13.8	13.7	10.1	10.0	14.4	14.2
GENDER
Male	9.4	9.7	3.4	1.9	10.1	10.5	8.0	8.4	10.4	10.8
Female	16.2	15.4	4.7	2.9	17.3	16.6	12.3	11.6	18.1	17.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13.8	13.6	3.9	2.2	14.6	14.7	10.9	10.7	15.2	15.2
White	15.8	15.7	4.3	2.4	16.7	16.7	12.4	12.9	17.3	17.2
Black or African American	8.2	8.3	3.0	2.2	8.8	8.9	7.2	5.1	9.0	9.6
AIAN	14.2	10.6	4.0	*	15.5	12.0	6.9	*	17.1	*
NHOPI	4.2	*	*	*	4.5	*	*	*	4.3	*
Asian	4.5	3.9	2.7	0.7	4.6	4.3	6.9	3.1	4.3	4.5
Two or More Races	12.9	14.9	4.5	2.3	14.7	16.6	12.0	*	15.4	18.1
Hispanic or Latino	9.0	8.0	4.4	2.9	9.7	8.7	7.4	7.7	10.2	9.0
EDUCATION LEVEL
< High School	da	da	da	da	10.5	12.2	9.3	8.8	10.7	12.7
High School Graduate	da	da	da	da	12.1	13.1	8.9	8.2	12.8	14.0
Some College/Associate’s Degree	da	da	da	da	16.1	14.3	10.8	11.0	17.2	15.1
College Graduate	da	da	da	da	14.2	14.1	11.8	11.8	14.4	14.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11.6	11.4	10.4	10.8	11.8	11.5
Part-Time	da	da	da	da	14.6	14.4	9.9	9.8	16.2	16.2
Unemployed	da	da	da	da	14.5	11.1	12.0	11.2	15.7	11.1
Other¹	da	da	da	da	16.7	16.6	9.1	8.4	17.5	17.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5,220	5,460	392	196	4,829	5,264	1,313	1,108	3,516	4,156
GENDER
Male	2,479	2,470	175	71	2,303	2,399	650	525	1,653	1,874
Female	2,741	2,990	216	125	2,525	2,865	663	583	1,863	2,282
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,321	4,779	262	120	4,059	4,660	1,081	891	2,977	3,769
White	3,726	4,064	207	83	3,519	3,981	861	718	2,659	3,263
Black or African American	340	370	27	19	313	351	126	108	187	243
AIAN	17	51	3	*	14	51	4	*	10	*
NHOPI	19	4	*	*	19	4	*	*	*	*
Asian	96	105	5	8	91	97	41	24	49	72
Two or More Races	122	186	20	10	103	176	45	*	58	142
Hispanic or Latino	900	680	130	76	770	604	231	217	539	387
EDUCATION LEVEL
< High School	da	da	da	da	455	386	196	116	260	269
High School Graduate	da	da	da	da	1,000	1,435	390	275	610	1,160
Some College/Associate’s Degree	da	da	da	da	1,893	1,808	522	544	1,371	1,263
College Graduate	da	da	da	da	1,481	1,636	206	173	1,275	1,463
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,434	2,418	594	488	1,839	1,930
Part-Time	da	da	da	da	836	945	319	262	517	682
Unemployed	da	da	da	da	339	403	167	119	172	284
Other¹	da	da	da	da	1,220	1,498	232	239	988	1,259
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.9	2.0	1.6	0.8	1.9	2.1	3.9	3.3	1.6	1.9
GENDER
Male	1.9	1.8	1.4	0.6	1.9	2.0	3.8	3.1	1.6	1.8
Female	1.9	2.1	1.8	1.0	2.0	2.2	3.9	3.5	1.7	2.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.9	2.1	1.4	0.6	1.9	2.2	4.1	3.5	1.6	2.0
White	2.2	2.4	1.6	0.6	2.2	2.5	4.8	4.0	1.9	2.3
Black or African American	1.0	1.1	0.8	0.6	1.0	1.2	2.7	2.4	0.7	0.9
AIAN	1.1	3.1	1.8	*	1.0	3.5	1.9	*	0.9	*
NHOPI	1.7	0.4	*	*	1.9	0.4	*	*	*	*
Asian	0.6	0.6	0.4	0.4	0.6	0.7	2.0	1.2	0.4	0.6
Two or More Races	2.3	3.5	2.1	1.6	2.3	3.7	4.8	*	1.7	3.9
Hispanic or Latino	1.9	1.4	2.1	1.2	1.9	1.4	3.0	2.8	1.6	1.1
EDUCATION LEVEL
< High School	da	da	da	da	1.5	1.3	4.2	3.0	1.0	1.1
High School Graduate	da	da	da	da	1.6	2.1	3.7	2.6	1.2	2.0
Some College/Associate’s Degree	da	da	da	da	2.5	2.4	3.9	3.9	2.2	2.0
College Graduate	da	da	da	da	1.8	2.1	4.2	3.5	1.6	2.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.0	2.1	4.1	3.8	1.7	1.9
Part-Time	da	da	da	da	2.6	3.0	3.8	3.1	2.1	3.0
Unemployed	da	da	da	da	3.4	3.1	5.1	3.5	2.6	3.0
Other¹	da	da	da	da	1.5	1.6	3.0	2.7	1.3	1.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,781	1,891	112	25	1,669	1,866	337	357	1,332	1,509
GENDER
Male	842	814	75	6	767	808	182	181	585	628
Female	939	1,077	37	19	901	1,058	155	176	746	881
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,528	1,646	75	20	1,453	1,626	273	266	1,180	1,360
White	1,367	1,425	57	20	1,310	1,405	228	206	1,081	1,199
Black or African American	92	102	10	*	82	102	22	26	60	77
AIAN	4	20	*	*	4	20	*	*	4	*
NHOPI	1	4	*	*	1	4	*	*	*	*
Asian	21	51	3	*	18	51	7	3	10	48
Two or More Races	43	44	5	0	38	44	15	*	23	*
Hispanic or Latino	253	245	37	5	216	240	63	91	152	149
EDUCATION LEVEL
< High School	da	da	da	da	142	216	56	47	86	170
High School Graduate	da	da	da	da	289	390	90	68	198	322
Some College/Associate’s Degree	da	da	da	da	743	714	129	188	614	526
College Graduate	da	da	da	da	496	546	62	54	434	492
EMPLOYMENT STATUS
Full-Time	da	da	da	da	802	723	135	164	668	559
Part-Time	da	da	da	da	304	339	74	65	231	274
Unemployed	da	da	da	da	167	155	65	68	102	87
Other¹	da	da	da	da	395	649	64	60	331	589
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.6	0.7	0.5	0.1	0.7	0.7	1.0	1.1	0.6	0.7
GENDER
Male	0.6	0.6	0.6	0.0	0.6	0.7	1.1	1.1	0.6	0.6
Female	0.7	0.8	0.3	0.2	0.7	0.8	0.9	1.1	0.7	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7	0.7	0.4	0.1	0.7	0.8	1.0	1.0	0.6	0.7
White	0.8	0.8	0.4	0.2	0.8	0.9	1.3	1.2	0.8	0.9
Black or African American	0.3	0.3	0.3	*	0.3	0.3	0.5	0.6	0.2	0.3
AIAN	0.3	1.2	*	*	0.3	1.4	*	*	0.4	*
NHOPI	0.1	0.4	*	*	0.1	0.4	*	*	*	*
Asian	0.1	0.3	0.2	*	0.1	0.4	0.4	0.1	0.1	0.4
Two or More Races	0.8	0.8	0.6	0.1	0.9	0.9	1.6	*	0.7	*
Hispanic or Latino	0.5	0.5	0.6	0.1	0.5	0.6	0.8	1.2	0.5	0.4
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.7	1.2	1.2	0.3	0.7
High School Graduate	da	da	da	da	0.5	0.6	0.9	0.6	0.4	0.5
Some College/Associate’s Degree	da	da	da	da	1.0	0.9	1.0	1.3	1.0	0.8
College Graduate	da	da	da	da	0.6	0.7	1.3	1.1	0.6	0.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.6	0.6	0.9	1.3	0.6	0.5
Part-Time	da	da	da	da	0.9	1.1	0.9	0.8	1.0	1.2
Unemployed	da	da	da	da	1.7	1.2	2.0	2.0	1.5	0.9
Other¹	da	da	da	da	0.5	0.7	0.8	0.7	0.4	0.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	15,636	15,364	545	429	15,091	14,935	1,051	1,066	14,040	13,869
GENDER
Male	6,394	6,418	238	193	6,156	6,225	426	475	5,729	5,751
Female	9,242	8,946	307	236	8,936	8,710	624	591	8,311	8,119
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13,938	13,636	416	333	13,522	13,302	877	932	12,645	12,370
White	11,707	11,824	291	252	11,416	11,572	653	768	10,764	10,804
Black or African American	1,287	1,267	82	48	1,204	1,218	114	63	1,090	1,155
AIAN	89	84	*	*	88	77	6	*	82	*
NHOPI	13	4	*	*	12	2	*	*	9	*
Asian	571	151	19	13	552	138	75	9	477	129
Two or More Races	271	306	22	*	249	296	25	*	224	218
Hispanic or Latino	1,698	1,729	129	96	1,569	1,633	174	133	1,395	1,499
EDUCATION LEVEL
< High School	da	da	da	da	1,370	1,681	160	135	1,211	1,546
High School Graduate	da	da	da	da	3,252	3,444	260	324	2,992	3,120
Some College/Associate’s Degree	da	da	da	da	4,878	5,387	470	438	4,408	4,949
College Graduate	da	da	da	da	5,591	4,423	162	169	5,429	4,254
EMPLOYMENT STATUS
Full-Time	da	da	da	da	6,081	5,684	409	392	5,672	5,292
Part-Time	da	da	da	da	1,880	1,771	256	266	1,624	1,504
Unemployed	da	da	da	da	575	475	161	134	415	341
Other¹	da	da	da	da	6,554	7,005	225	273	6,330	6,732
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5.7	5.5	2.2	1.7	6.0	5.9	3.1	3.2	6.5	6.3
GENDER
Male	4.8	4.8	1.9	1.5	5.1	5.1	2.5	2.8	5.5	5.5
Female	6.5	6.3	2.5	1.9	6.9	6.7	3.7	3.5	7.4	7.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.1	6.0	2.2	1.8	6.5	6.3	3.4	3.6	6.9	6.7
White	6.9	6.9	2.3	2.0	7.2	7.3	3.6	4.3	7.7	7.7
Black or African American	3.9	3.8	2.5	1.5	4.0	4.0	2.5	1.4	4.3	4.5
AIAN	5.7	5.1	*	*	6.3	5.4	2.7	*	7.0	*
NHOPI	1.2	0.4	*	*	1.3	0.2	*	*	1.0	*
Asian	3.6	0.9	1.5	0.7	3.8	1.0	3.6	0.4	3.8	1.0
Two or More Races	5.1	5.8	2.3	*	5.7	6.3	2.7	*	6.5	6.0
Hispanic or Latino	3.6	3.6	2.1	1.5	3.8	3.9	2.3	1.7	4.2	4.4
EDUCATION LEVEL
< High School	da	da	da	da	4.5	5.8	3.4	3.5	4.8	6.2
High School Graduate	da	da	da	da	5.4	5.0	2.4	3.0	6.0	5.3
Some College/Associate’s Degree	da	da	da	da	6.3	7.0	3.5	3.1	6.9	7.9
College Graduate	da	da	da	da	6.8	5.7	3.3	3.4	7.0	5.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.9	4.9	2.9	3.1	5.2	5.1
Part-Time	da	da	da	da	5.8	5.7	3.1	3.1	6.7	6.6
Unemployed	da	da	da	da	5.8	3.7	4.9	4.0	6.2	3.6
Other¹	da	da	da	da	7.8	7.7	2.9	3.1	8.3	8.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,098	1,240	82	35	1,016	1,205	175	251	841	954
GENDER
Male	545	549	43	21	502	527	66	121	436	406
Female	553	692	40	13	514	678	109	130	405	548
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	971	1,134	60	28	911	1,106	150	236	761	870
White	806	928	48	28	757	899	107	160	651	739
Black or African American	66	100	5	*	61	100	5	13	57	87
AIAN	5	46	*	*	5	*	*	*	1	*
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	66	4	1	*	65	4	22	0	43	4
Two or More Races	29	57	6	*	23	57	14	*	9	9
Hispanic or Latino	127	106	22	7	105	99	25	15	80	84
EDUCATION LEVEL
< High School	da	da	da	da	106	164	7	80	99	84
High School Graduate	da	da	da	da	180	232	42	64	138	168
Some College/Associate’s Degree	da	da	da	da	327	421	115	82	213	339
College Graduate	da	da	da	da	402	388	11	25	391	363
EMPLOYMENT STATUS
Full-Time	da	da	da	da	511	557	58	93	454	464
Part-Time	da	da	da	da	154	166	58	33	95	133
Unemployed	da	da	da	da	84	127	29	63	55	64
Other¹	da	da	da	da	267	356	29	62	237	294
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.4	0.4	0.3	0.1	0.4	0.5	0.5	0.7	0.4	0.4
GENDER
Male	0.4	0.4	0.3	0.2	0.4	0.4	0.4	0.7	0.4	0.4
Female	0.4	0.5	0.3	0.1	0.4	0.5	0.6	0.8	0.4	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.5	0.3	0.2	0.4	0.5	0.6	0.9	0.4	0.5
White	0.5	0.5	0.4	0.2	0.5	0.6	0.6	0.9	0.5	0.5
Black or African American	0.2	0.3	0.2	*	0.2	0.3	0.1	0.3	0.2	0.3
AIAN	0.3	2.8	*	*	0.3	*	*	*	0.1	*
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	0.4	0.0	0.1	*	0.4	0.0	1.1	0.0	0.3	0.0
Two or More Races	0.5	1.1	0.7	*	0.5	1.2	1.4	*	0.3	0.2
Hispanic or Latino	0.3	0.2	0.4	0.1	0.3	0.2	0.3	0.2	0.2	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.4	0.6	0.2	2.1	0.4	0.3
High School Graduate	da	da	da	da	0.3	0.3	0.4	0.6	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.4	0.6	0.8	0.6	0.3	0.5
College Graduate	da	da	da	da	0.5	0.5	0.2	0.5	0.5	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.4	0.5	0.4	0.7	0.4	0.4
Part-Time	da	da	da	da	0.5	0.5	0.7	0.4	0.4	0.6
Unemployed	da	da	da	da	0.8	1.0	0.9	1.9	0.8	0.7
Other¹	da	da	da	da	0.3	0.4	0.4	0.7	0.3	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	304	481	29	1	275	480	44	78	231	402
GENDER
Male	144	130	26	*	118	130	17	21	101	109
Female	160	351	3	1	157	350	27	57	130	293
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	269	442	13	1	255	440	43	78	212	363
White	240	380	12	1	228	379	27	52	201	326
Black or African American	8	16	1	*	7	16	*	5	7	11
AIAN	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	16	*	*	*	16	*	12	*	4	*
Two or More Races	5	22	*	*	5	22	5	*	*	1
Hispanic or Latino	35	39	15	*	20	39	1	*	19	39
EDUCATION LEVEL
< High School	da	da	da	da	26	62	7	*	20	40
High School Graduate	da	da	da	da	64	100	8	17	57	83
Some College/Associate’s Degree	da	da	da	da	60	210	27	35	33	175
College Graduate	da	da	da	da	125	108	3	4	122	104
EMPLOYMENT STATUS
Full-Time	da	da	da	da	111	255	*	36	111	220
Part-Time	da	da	da	da	59	32	16	13	43	19
Unemployed	da	da	da	da	37	32	20	*	17	12
Other¹	da	da	da	da	68	160	8	9	61	151
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2
GENDER
Male	0.1	0.1	0.2	*	0.1	0.1	0.1	0.1	0.1	0.1
Female	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.3	0.1	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.3	0.1	0.2
White	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.1	0.2
Black or African American	0.0	0.0	0.0	*	0.0	0.1	*	0.1	0.0	0.0
AIAN	*	*	*	*	*	*	*	*	*	*
NHOPI	*	*	*	*	*	*	*	*	*	*
Asian	0.1	*	*	*	0.1	*	0.6	*	0.0	*
Two or More Races	0.1	0.4	*	*	0.1	0.5	0.5	*	*	0.0
Hispanic or Latino	0.1	0.1	0.2	*	0.0	0.1	0.0	*	0.1	0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.1	0.2	0.1	*	0.1	0.2
High School Graduate	da	da	da	da	0.1	0.1	0.1	0.2	0.1	0.1
Some College/Associate’s Degree	da	da	da	da	0.1	0.3	0.2	0.3	0.1	0.3
College Graduate	da	da	da	da	0.2	0.1	0.1	0.1	0.2	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.2	*	0.3	0.1	0.2
Part-Time	da	da	da	da	0.2	0.1	0.2	0.2	0.2	0.1
Unemployed	da	da	da	da	0.4	0.2	0.6	*	0.3	0.1
Other¹	da	da	da	da	0.1	0.2	0.1	0.1	0.1	0.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	29,408	27,026	749	418	28,659	26,607	2,983	2,861	25,676	23,747
GENDER
Male	10,472	10,113	338	176	10,134	9,937	1,211	1,199	8,923	8,738
Female	18,935	16,912	411	242	18,525	16,670	1,771	1,662	16,753	15,008
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	26,010	24,100	538	274	25,472	23,826	2,486	2,335	22,986	21,491
White	22,519	20,806	418	233	22,100	20,573	1,979	1,920	20,121	18,653
Black or African American	2,074	2,071	70	17	2,004	2,054	287	227	1,718	1,827
AIAN	154	101	5	*	149	99	12	*	137	75
NHOPI	46	*	*	*	44	*	*	*	36	*
Asian	648	436	12	12	636	424	112	61	524	363
Two or More Races	569	646	31	9	538	637	88	*	450	533
Hispanic or Latino	3,398	2,925	211	144	3,187	2,782	496	525	2,690	2,256
EDUCATION LEVEL
< High School	da	da	da	da	2,446	2,693	394	302	2,052	2,390
High School Graduate	da	da	da	da	6,031	6,938	841	759	5,190	6,179
Some College/Associate’s Degree	da	da	da	da	10,241	8,539	1,232	1,335	9,008	7,204
College Graduate	da	da	da	da	9,941	8,438	515	465	9,426	7,974
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,879	10,066	1,326	1,160	10,553	8,906
Part-Time	da	da	da	da	4,103	3,630	708	736	3,394	2,894
Unemployed	da	da	da	da	1,283	1,146	353	320	930	827
Other¹	da	da	da	da	11,395	11,765	596	646	10,799	11,119
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	10.7	9.8	3.0	1.7	11.4	10.6	8.8	8.5	11.9	10.9
GENDER
Male	7.8	7.5	2.7	1.4	8.4	8.2	7.2	7.1	8.6	8.3
Female	13.4	11.9	3.4	2.0	14.3	12.8	10.5	9.9	14.9	13.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	11.4	10.5	2.9	1.5	12.2	11.4	9.5	9.1	12.6	11.7
White	13.2	12.2	3.3	1.8	14.0	13.0	11.0	10.7	14.4	13.3
Black or African American	6.2	6.2	2.1	0.6	6.7	6.7	6.2	4.9	6.8	7.1
AIAN	9.8	6.1	2.8	*	10.7	6.8	5.6	*	11.7	6.0
NHOPI	4.2	*	*	*	4.5	*	*	*	4.3	*
Asian	4.1	2.7	0.9	0.7	4.4	3.0	5.3	3.1	4.2	2.9
Two or More Races	10.7	12.2	3.3	1.5	12.3	13.6	9.4	*	13.1	14.6
Hispanic or Latino	7.2	6.0	3.4	2.3	7.7	6.6	6.5	6.8	8.0	6.6
EDUCATION LEVEL
< High School	da	da	da	da	8.1	9.3	8.4	7.9	8.1	9.5
High School Graduate	da	da	da	da	9.9	10.0	7.9	7.1	10.3	10.5
Some College/Associate’s Degree	da	da	da	da	13.3	11.2	9.1	9.5	14.2	11.5
College Graduate	da	da	da	da	12.1	10.9	10.4	9.4	12.2	11.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9.6	8.6	9.2	9.1	9.6	8.6
Part-Time	da	da	da	da	12.6	11.6	8.5	8.6	14.0	12.7
Unemployed	da	da	da	da	12.9	8.9	10.7	9.4	14.0	8.7
Other¹	da	da	da	da	13.6	12.9	7.7	7.3	14.2	13.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	4,841	4,779	381	157	4,460	4,622	1,266	1,097	3,194	3,526
GENDER
Male	2,287	2,245	173	59	2,114	2,186	630	526	1,484	1,660
Female	2,554	2,534	208	98	2,346	2,436	636	570	1,710	1,866
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	4,069	4,115	255	95	3,815	4,019	1,048	880	2,767	3,139
White	3,518	3,535	198	78	3,320	3,457	833	709	2,486	2,748
Black or African American	299	279	26	1	273	277	118	108	155	169
AIAN	17	27	3	*	14	27	4	*	10	*
NHOPI	19	4	*	*	19	4	*	*	*	*
Asian	96	88	5	8	91	79	41	*	49	56
Two or More Races	120	182	22	7	99	175	46	*	52	142
Hispanic or Latino	772	665	126	62	645	603	218	216	428	387
EDUCATION LEVEL
< High School	da	da	da	da	383	276	185	116	198	160
High School Graduate	da	da	da	da	937	1,304	376	274	560	1,030
Some College/Associate’s Degree	da	da	da	da	1,763	1,593	509	536	1,254	1,057
College Graduate	da	da	da	da	1,378	1,450	195	171	1,183	1,279
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,260	2,133	572	486	1,688	1,647
Part-Time	da	da	da	da	794	808	311	254	483	555
Unemployed	da	da	da	da	328	361	167	118	161	243
Other¹	da	da	da	da	1,078	1,320	216	239	862	1,081
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.8	1.7	1.5	0.6	1.8	1.8	3.8	3.3	1.5	1.6
GENDER
Male	1.7	1.7	1.4	0.5	1.7	1.8	3.7	3.1	1.4	1.6
Female	1.8	1.8	1.7	0.8	1.8	1.9	3.8	3.4	1.5	1.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.8	1.8	1.4	0.5	1.8	1.9	4.0	3.4	1.5	1.7
White	2.1	2.1	1.5	0.6	2.1	2.2	4.6	4.0	1.8	2.0
Black or African American	0.9	0.8	0.8	0.0	0.9	0.9	2.6	2.4	0.6	0.7
AIAN	1.1	1.6	1.8	*	1.0	1.9	1.9	*	0.9	*
NHOPI	1.7	0.4	*	*	1.9	0.4	*	*	*	*
Asian	0.6	0.5	0.4	0.4	0.6	0.6	2.0	*	0.4	0.5
Two or More Races	2.3	3.4	2.3	1.2	2.3	3.7	4.9	*	1.5	3.9
Hispanic or Latino	1.6	1.4	2.0	1.0	1.6	1.4	2.8	2.8	1.3	1.1
EDUCATION LEVEL
< High School	da	da	da	da	1.3	1.0	3.9	3.0	0.8	0.6
High School Graduate	da	da	da	da	1.5	1.9	3.5	2.6	1.1	1.8
Some College/Associate’s Degree	da	da	da	da	2.3	2.1	3.8	3.8	2.0	1.7
College Graduate	da	da	da	da	1.7	1.9	3.9	3.4	1.5	1.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.8	1.8	4.0	3.8	1.5	1.6
Part-Time	da	da	da	da	2.4	2.6	3.7	3.0	2.0	2.4
Unemployed	da	da	da	da	3.3	2.8	5.1	3.5	2.4	2.6
Other¹	da	da	da	da	1.3	1.4	2.8	2.7	1.1	1.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.61A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	10,065	9,490	567	396	9,499	9,094	1,776	1,376	7,723	7,717
GENDER
Male	5,420	4,375	254	215	5,166	4,160	903	630	4,263	3,530
Female	4,645	5,115	312	181	4,333	4,933	873	746	3,460	4,187
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,305	7,712	407	248	7,898	7,464	1,335	1,103	6,563	6,361
White	6,518	5,778	289	166	6,229	5,612	1,015	883	5,214	4,729
Black or African American	1,139	1,259	85	61	1,055	1,198	178	153	877	1,046
AIAN	80	106	5	*	75	101	14	*	61	*
NHOPI	30	6	*	*	30	6	*	*	28	*
Asian	262	390	3	4	259	386	66	21	193	365
Two or More Races	275	173	24	12	251	161	61	*	190	132
Hispanic or Latino	1,760	1,777	160	148	1,600	1,630	440	274	1,160	1,356
EDUCATION LEVEL
< High School	da	da	da	da	1,321	1,206	295	143	1,025	1,063
High School Graduate	da	da	da	da	2,406	2,551	556	418	1,850	2,134
Some College/Associate’s Degree	da	da	da	da	3,408	3,342	739	576	2,669	2,766
College Graduate	da	da	da	da	2,364	1,994	185	240	2,178	1,754
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,842	3,883	828	673	4,014	3,211
Part-Time	da	da	da	da	1,189	1,321	401	240	788	1,081
Unemployed	da	da	da	da	695	565	197	163	498	402
Other¹	da	da	da	da	2,773	3,324	349	301	2,423	3,023
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.61B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.7	3.4	2.3	1.6	3.8	3.6	5.3	4.1	3.6	3.5
GENDER
Male	4.1	3.3	2.0	1.7	4.3	3.4	5.3	3.8	4.1	3.4
Female	3.3	3.6	2.6	1.5	3.3	3.8	5.2	4.5	3.1	3.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.6	3.4	2.2	1.3	3.8	3.6	5.1	4.3	3.6	3.5
White	3.8	3.4	2.3	1.3	3.9	3.6	5.6	4.9	3.7	3.4
Black or African American	3.4	3.7	2.5	1.9	3.5	3.9	3.8	3.3	3.5	4.0
AIAN	5.1	6.4	2.9	*	5.4	7.0	6.4	*	5.2	*
NHOPI	2.8	0.6	*	*	3.0	0.6	*	*	3.4	*
Asian	1.6	2.4	0.3	0.2	1.8	2.7	3.2	1.1	1.5	3.0
Two or More Races	5.2	3.3	2.6	2.0	5.7	3.4	6.5	*	5.5	3.6
Hispanic or Latino	3.7	3.7	2.6	2.3	3.9	3.9	5.7	3.5	3.5	3.9
EDUCATION LEVEL
< High School	da	da	da	da	4.4	4.2	6.3	3.7	4.0	4.2
High School Graduate	da	da	da	da	4.0	3.7	5.2	3.9	3.7	3.6
Some College/Associate’s Degree	da	da	da	da	4.4	4.4	5.5	4.1	4.2	4.4
College Graduate	da	da	da	da	2.9	2.6	3.8	4.8	2.8	2.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.9	3.3	5.8	5.3	3.7	3.1
Part-Time	da	da	da	da	3.6	4.2	4.8	2.8	3.2	4.8
Unemployed	da	da	da	da	7.0	4.4	6.0	4.8	7.5	4.2
Other¹	da	da	da	da	3.3	3.6	4.5	3.4	3.2	3.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.62A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3,101	2,885	165	96	2,936	2,789	439	296	2,497	2,493
GENDER
Male	1,676	1,258	68	61	1,609	1,197	198	140	1,411	1,057
Female	1,425	1,627	97	35	1,328	1,592	242	156	1,086	1,436
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,582	2,275	117	80	2,465	2,195	343	253	2,122	1,942
White	2,061	1,701	79	52	1,982	1,649	274	193	1,708	1,456
Black or African American	319	401	24	24	294	376	45	60	249	316
AIAN	16	28	*	*	16	28	3	*	14	28
NHOPI	*	1	*	*	*	1	*	*	*	*
Asian	77	106	*	0	77	106	5	*	72	106
Two or More Races	96	39	14	3	82	36	14	0	68	36
Hispanic or Latino	519	610	48	16	472	594	97	43	375	551
EDUCATION LEVEL
< High School	da	da	da	da	329	417	91	36	238	381
High School Graduate	da	da	da	da	867	677	127	100	740	578
Some College/Associate’s Degree	da	da	da	da	1,007	1,237	181	127	826	1,110
College Graduate	da	da	da	da	733	457	40	33	693	424
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,335	1,082	193	107	1,142	974
Part-Time	da	da	da	da	339	368	90	41	249	327
Unemployed	da	da	da	da	317	147	67	29	250	118
Other¹	da	da	da	da	945	1,192	89	118	856	1,074
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.62B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.1	1.0	0.7	0.4	1.2	1.1	1.3	0.9	1.2	1.1
GENDER
Male	1.3	0.9	0.5	0.5	1.3	1.0	1.2	0.8	1.4	1.0
Female	1.0	1.1	0.8	0.3	1.0	1.2	1.4	0.9	1.0	1.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.1	1.0	0.6	0.4	1.2	1.0	1.3	1.0	1.2	1.1
White	1.2	1.0	0.6	0.4	1.3	1.0	1.5	1.1	1.2	1.0
Black or African American	1.0	1.2	0.7	0.8	1.0	1.2	1.0	1.3	1.0	1.2
AIAN	1.0	1.7	*	*	1.2	1.9	1.2	*	1.2	2.2
NHOPI	*	0.1	*	*	*	0.1	*	*	*	*
Asian	0.5	0.7	*	0.0	0.5	0.7	0.2	*	0.6	0.9
Two or More Races	1.8	0.7	1.5	0.5	1.9	0.8	1.5	0.0	2.0	1.0
Hispanic or Latino	1.1	1.3	0.8	0.3	1.1	1.4	1.3	0.6	1.1	1.6
EDUCATION LEVEL
< High School	da	da	da	da	1.1	1.4	2.0	0.9	0.9	1.5
High School Graduate	da	da	da	da	1.4	1.0	1.2	0.9	1.5	1.0
Some College/Associate’s Degree	da	da	da	da	1.3	1.6	1.3	0.9	1.3	1.8
College Graduate	da	da	da	da	0.9	0.6	0.8	0.7	0.9	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.1	0.9	1.3	0.8	1.0	0.9
Part-Time	da	da	da	da	1.0	1.2	1.1	0.5	1.0	1.4
Unemployed	da	da	da	da	3.2	1.1	2.0	0.9	3.8	1.2
Other¹	da	da	da	da	1.1	1.3	1.2	1.3	1.1	1.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.63A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	10,136	10,306	499	346	9,638	9,960	3,205	2,567	6,433	7,393
GENDER
Male	5,991	5,854	286	179	5,705	5,674	1,792	1,397	3,914	4,278
Female	4,145	4,452	213	166	3,932	4,286	1,413	1,171	2,519	3,115
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,567	8,859	370	270	8,197	8,589	2,610	2,144	5,587	6,445
White	7,080	7,531	289	216	6,791	7,314	2,171	1,841	4,619	5,474
Black or African American	751	701	29	26	722	674	156	156	566	518
AIAN	62	116	3	*	59	103	17	*	42	*
NHOPI	45	6	*	*	44	6	*	*	32	*
Asian	311	223	25	8	286	215	122	45	164	170
Two or More Races	318	283	24	7	295	276	132	98	163	177
Hispanic or Latino	1,570	1,447	129	76	1,441	1,371	595	423	846	948
EDUCATION LEVEL
< High School	da	da	da	da	971	976	311	150	660	827
High School Graduate	da	da	da	da	2,314	2,535	706	630	1,608	1,904
Some College/Associate’s Degree	da	da	da	da	3,759	3,397	1,488	1,203	2,271	2,194
College Graduate	da	da	da	da	2,593	3,053	700	585	1,893	2,468
EMPLOYMENT STATUS
Full-Time	da	da	da	da	5,146	5,039	1,538	1,210	3,607	3,829
Part-Time	da	da	da	da	1,499	1,518	832	521	667	997
Unemployed	da	da	da	da	895	1,022	308	330	588	692
Other¹	da	da	da	da	2,098	2,381	527	506	1,571	1,875
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.63B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.7	3.7	2.0	1.4	3.9	4.0	9.5	7.7	3.0	3.4
GENDER
Male	4.5	4.4	2.3	1.4	4.7	4.7	10.6	8.3	3.8	4.1
Female	2.9	3.1	1.7	1.4	3.0	3.3	8.4	7.0	2.2	2.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.8	3.9	2.0	1.4	3.9	4.1	10.0	8.3	3.1	3.5
White	4.1	4.4	2.3	1.7	4.3	4.6	12.0	10.3	3.3	3.9
Black or African American	2.3	2.1	0.9	0.8	2.4	2.2	3.4	3.4	2.2	2.0
AIAN	4.0	7.0	1.9	*	4.2	7.2	7.7	*	3.6	*
NHOPI	4.1	0.6	*	*	4.5	0.6	*	*	3.9	*
Asian	2.0	1.4	1.9	0.4	2.0	1.5	5.8	2.3	1.3	1.4
Two or More Races	6.0	5.3	2.5	1.1	6.7	5.9	14.0	9.5	4.7	4.9
Hispanic or Latino	3.3	3.0	2.1	1.2	3.5	3.3	7.8	5.5	2.5	2.8
EDUCATION LEVEL
< High School	da	da	da	da	3.2	3.4	6.6	3.9	2.6	3.3
High School Graduate	da	da	da	da	3.8	3.6	6.7	5.9	3.2	3.2
Some College/Associate’s Degree	da	da	da	da	4.9	4.4	11.0	8.6	3.6	3.5
College Graduate	da	da	da	da	3.1	4.0	14.2	11.8	2.4	3.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.1	4.3	10.7	9.5	3.3	3.7
Part-Time	da	da	da	da	4.6	4.9	10.0	6.1	2.7	4.4
Unemployed	da	da	da	da	9.0	7.9	9.3	9.8	8.9	7.3
Other¹	da	da	da	da	2.5	2.6	6.8	5.7	2.1	2.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.64A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	4,264	4,483	160	87	4,103	4,396	1,127	682	2,976	3,714
GENDER
Male	2,524	2,513	106	40	2,418	2,474	623	322	1,795	2,152
Female	1,740	1,970	55	47	1,685	1,922	504	360	1,181	1,562
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,591	3,865	105	82	3,486	3,783	930	544	2,556	3,239
White	2,908	3,319	87	62	2,822	3,257	764	481	2,058	2,776
Black or African American	367	225	8	13	359	211	48	15	310	196
AIAN	28	36	*	*	28	36	2	*	26	35
NHOPI	17	0	*	*	17	0	*	*	12	*
Asian	135	136	6	4	129	132	54	8	75	125
Two or More Races	136	148	4	3	131	146	56	39	76	107
Hispanic or Latino	672	618	55	5	617	613	198	139	419	475
EDUCATION LEVEL
< High School	da	da	da	da	432	487	118	52	315	434
High School Graduate	da	da	da	da	1,154	1,233	256	169	898	1,065
Some College/Associate’s Degree	da	da	da	da	1,480	1,439	529	277	951	1,162
College Graduate	da	da	da	da	1,037	1,237	224	184	812	1,053
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,025	2,211	511	348	1,514	1,863
Part-Time	da	da	da	da	611	659	305	154	306	505
Unemployed	da	da	da	da	512	450	99	78	413	371
Other¹	da	da	da	da	956	1,077	213	102	743	974
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.64B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.5	1.6	0.6	0.3	1.6	1.7	3.3	2.0	1.4	1.7
GENDER
Male	1.9	1.9	0.8	0.3	2.0	2.0	3.7	1.9	1.7	2.1
Female	1.2	1.4	0.4	0.4	1.3	1.5	3.0	2.2	1.0	1.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.6	1.7	0.6	0.4	1.7	1.8	3.6	2.1	1.4	1.8
White	1.7	1.9	0.7	0.5	1.8	2.1	4.2	2.7	1.5	2.0
Black or African American	1.1	0.7	0.2	0.4	1.2	0.7	1.0	0.3	1.2	0.8
AIAN	1.8	2.2	*	*	2.0	2.5	1.1	*	2.2	2.8
NHOPI	1.5	0.0	*	*	1.7	0.0	*	*	1.4	*
Asian	0.9	0.8	0.5	0.2	0.9	0.9	2.6	0.4	0.6	1.0
Two or More Races	2.5	2.8	0.5	0.4	3.0	3.1	5.9	3.7	2.2	2.9
Hispanic or Latino	1.4	1.3	0.9	0.1	1.5	1.5	2.6	1.8	1.2	1.4
EDUCATION LEVEL
< High School	da	da	da	da	1.4	1.7	2.5	1.4	1.2	1.7
High School Graduate	da	da	da	da	1.9	1.8	2.4	1.6	1.8	1.8
Some College/Associate’s Degree	da	da	da	da	1.9	1.9	3.9	2.0	1.5	1.9
College Graduate	da	da	da	da	1.3	1.6	4.5	3.7	1.0	1.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.6	1.9	3.6	2.7	1.4	1.8
Part-Time	da	da	da	da	1.9	2.1	3.7	1.8	1.3	2.2
Unemployed	da	da	da	da	5.2	3.5	3.0	2.3	6.2	3.9
Other¹	da	da	da	da	1.1	1.2	2.7	1.2	1.0	1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.65A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	23,588	23,962	1,862	1,507	21,727	22,455	5,791	5,169	15,936	17,286
GENDER
Male	13,083	12,370	894	704	12,189	11,667	3,187	2,757	9,002	8,910
Female	10,505	11,592	968	803	9,537	10,788	2,604	2,411	6,934	8,377
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	19,544	20,313	1,375	1,106	18,169	19,207	4,620	4,338	13,550	14,869
White	15,577	16,334	994	819	14,584	15,515	3,617	3,546	10,967	11,970
Black or African American	2,231	2,364	220	125	2,011	2,239	470	455	1,541	1,784
AIAN	177	204	31	*	146	164	46	*	100	136
NHOPI	61	26	*	*	59	26	*	*	40	*
Asian	802	770	38	76	763	694	253	108	510	586
Two or More Races	696	614	91	47	606	568	215	191	391	377
Hispanic or Latino	4,045	3,649	487	401	3,558	3,248	1,172	830	2,386	2,418
EDUCATION LEVEL
< High School	da	da	da	da	2,461	2,397	681	494	1,780	1,903
High School Graduate	da	da	da	da	5,037	5,334	1,576	1,247	3,461	4,086
Some College/Associate’s Degree	da	da	da	da	8,012	7,844	2,549	2,356	5,463	5,488
College Graduate	da	da	da	da	6,217	6,880	985	1,071	5,231	5,809
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,531	10,837	2,696	2,306	8,835	8,532
Part-Time	da	da	da	da	3,349	3,654	1,505	1,222	1,844	2,433
Unemployed	da	da	da	da	1,591	1,725	597	605	995	1,120
Other¹	da	da	da	da	5,255	6,238	994	1,036	4,262	5,202
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.65B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	8.6	8.7	7.5	6.0	8.7	8.9	17.2	15.4	7.4	7.9
GENDER
Male	9.8	9.2	7.0	5.5	10.1	9.6	18.9	16.4	8.7	8.5
Female	7.4	8.1	7.9	6.6	7.4	8.3	15.5	14.4	6.2	7.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.6	8.9	7.3	5.9	8.7	9.2	17.7	16.8	7.4	8.1
White	9.1	9.6	7.7	6.4	9.2	9.8	20.1	19.8	7.8	8.5
Black or African American	6.7	7.0	6.5	4.0	6.7	7.3	10.1	9.9	6.1	6.9
AIAN	11.3	12.3	17.7	*	10.5	11.4	21.0	*	8.6	10.9
NHOPI	5.6	2.6	*	*	5.9	2.7	*	*	4.8	*
Asian	5.0	4.8	2.9	4.1	5.2	4.8	12.1	5.5	4.1	4.7
Two or More Races	13.1	11.6	9.7	7.5	13.8	12.1	22.9	18.5	11.3	10.3
Hispanic or Latino	8.5	7.5	7.9	6.4	8.6	7.7	15.3	10.7	7.1	7.0
EDUCATION LEVEL
< High School	da	da	da	da	8.2	8.3	14.5	12.9	7.0	7.6
High School Graduate	da	da	da	da	8.3	7.7	14.9	11.6	6.9	7.0
Some College/Associate’s Degree	da	da	da	da	10.4	10.3	18.9	16.9	8.6	8.8
College Graduate	da	da	da	da	7.5	8.9	20.0	21.6	6.8	8.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9.3	9.3	18.8	18.1	8.0	8.2
Part-Time	da	da	da	da	10.3	11.7	18.0	14.3	7.6	10.7
Unemployed	da	da	da	da	16.0	13.4	18.1	17.9	15.0	11.8
Other¹	da	da	da	da	6.3	6.8	12.8	11.7	5.6	6.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.66A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	9,333	9,305	598	305	8,735	9,000	2,059	1,600	6,676	7,400
GENDER
Male	5,281	4,974	291	163	4,991	4,812	1,116	924	3,875	3,888
Female	4,052	4,331	307	142	3,744	4,189	943	676	2,801	3,512
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,844	7,908	419	269	7,425	7,640	1,650	1,283	5,775	6,356
White	6,267	6,391	303	179	5,964	6,212	1,307	1,058	4,657	5,154
Black or African American	834	855	61	55	772	800	133	130	639	670
AIAN	68	114	*	*	64	101	10	*	53	93
NHOPI	31	7	*	*	30	7	*	*	22	*
Asian	344	263	9	8	335	255	98	12	237	242
Two or More Races	300	278	40	14	260	265	94	74	166	191
Hispanic or Latino	1,489	1,397	179	36	1,310	1,361	409	317	901	1,044
EDUCATION LEVEL
< High School	da	da	da	da	918	1,134	282	177	636	957
High School Graduate	da	da	da	da	2,228	2,151	514	376	1,714	1,775
Some College/Associate’s Degree	da	da	da	da	3,092	3,235	892	721	2,200	2,515
College Graduate	da	da	da	da	2,498	2,480	371	327	2,126	2,153
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,326	4,343	886	752	3,440	3,591
Part-Time	da	da	da	da	1,306	1,317	548	335	758	982
Unemployed	da	da	da	da	842	781	224	207	619	574
Other¹	da	da	da	da	2,261	2,558	401	306	1,860	2,252
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210604

Table 1.66B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2019 and 2020
Demographic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.4	3.4	2.4	1.2	3.5	3.6	6.1	4.8	3.1	3.4
GENDER
Male	4.0	3.7	2.3	1.3	4.1	4.0	6.6	5.5	3.7	3.7
Female	2.9	3.0	2.5	1.2	2.9	3.2	5.6	4.0	2.5	3.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.4	3.5	2.2	1.4	3.6	3.6	6.3	5.0	3.2	3.5
White	3.7	3.7	2.4	1.4	3.8	3.9	7.2	5.9	3.3	3.7
Black or African American	2.5	2.5	1.8	1.8	2.6	2.6	2.9	2.8	2.5	2.6
AIAN	4.4	6.9	*	*	4.6	7.0	4.7	*	4.5	7.4
NHOPI	2.8	0.7	*	*	3.0	0.7	*	*	2.7	*
Asian	2.2	1.6	0.7	0.4	2.3	1.8	4.7	0.6	1.9	2.0
Two or More Races	5.6	5.2	4.3	2.2	5.9	5.6	10.0	7.1	4.8	5.2
Hispanic or Latino	3.1	2.9	2.9	0.6	3.2	3.2	5.3	4.1	2.7	3.0
EDUCATION LEVEL
< High School	da	da	da	da	3.0	3.9	6.0	4.6	2.5	3.8
High School Graduate	da	da	da	da	3.7	3.1	4.8	3.5	3.4	3.0
Some College/Associate’s Degree	da	da	da	da	4.0	4.2	6.6	5.2	3.5	4.0
College Graduate	da	da	da	da	3.0	3.2	7.5	6.6	2.7	3.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.5	3.7	6.2	5.9	3.1	3.5
Part-Time	da	da	da	da	4.0	4.2	6.6	3.9	3.1	4.3
Unemployed	da	da	da	da	8.5	6.1	6.8	6.1	9.3	6.1
Other¹	da	da	da	da	2.7	2.8	5.2	3.5	2.5	2.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.67A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	57,203	59,277	4,279	3,436	52,924	55,841	13,193	12,398	39,731	43,443
GEOGRAPHIC REGION
Northeast	10,280	10,856	690	581	9,590	10,275	2,406	2,066	7,184	8,209
Midwest	11,543	12,278	899	760	10,644	11,518	2,876	2,943	7,768	8,575
South	18,915	19,040	1,504	1,163	17,411	17,877	4,429	4,114	12,981	13,763
West	16,466	17,103	1,186	931	15,280	16,172	3,482	3,275	11,798	12,896
COUNTY TYPE
Large Metro	33,771	33,255	2,326	1,852	31,445	31,402	7,782	6,651	23,663	24,751
Small Metro	17,113	18,499	1,439	1,029	15,674	17,470	3,991	4,155	11,683	13,315
Nonmetro	6,319	7,524	514	555	5,805	6,969	1,420	1,591	4,385	5,378
Urbanized	3,013	3,401	249	233	2,764	3,167	741	785	2,024	2,383
Less Urbanized	2,687	3,677	208	289	2,479	3,388	554	721	1,925	2,668
Completely Rural	619	446	57	*	562	413	125	86	437	327
POVERTY LEVEL¹
Less Than 100%	9,707	10,931	926	705	8,782	10,225	3,084	3,105	5,698	7,120
100-199%	11,834	10,817	938	584	10,896	10,233	2,892	2,852	8,004	7,381
200% or More	35,246	37,318	2,415	2,147	32,831	35,171	6,802	6,229	26,030	28,942
HEALTH INSURANCE²
Private	33,623	34,700	2,297	2,007	31,326	32,693	8,200	7,615	23,126	25,078
Medicaid/CHIP	12,840	13,687	1,766	1,204	11,074	12,483	2,743	2,653	8,331	9,830
Other³	8,849	10,494	214	198	8,635	10,296	957	926	7,678	9,370
No Coverage	7,642	7,544	207	207	7,434	7,337	1,769	1,729	5,665	5,608
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.67B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	20.8	21.4	17.2	13.8	21.1	22.2	39.1	37.0	18.3	19.9
GEOGRAPHIC REGION
Northeast	21.5	22.8	17.4	14.8	21.9	23.5	41.7	36.5	18.9	21.5
Midwest	20.1	21.4	17.1	14.4	20.5	22.1	40.1	41.5	17.3	19.0
South	18.1	18.0	15.5	11.9	18.3	18.6	34.8	32.4	15.8	16.5
West	25.1	25.9	19.8	15.4	25.7	26.9	43.0	40.8	22.9	24.8
COUNTY TYPE
Large Metro	22.0	22.0	17.1	13.1	22.4	22.9	41.4	37.5	19.5	20.8
Small Metro	20.5	21.8	18.6	13.4	20.7	22.7	37.6	37.8	18.0	20.2
Nonmetro	16.6	18.2	14.3	17.3	16.8	18.3	32.8	33.3	14.6	16.1
Urbanized	19.0	20.6	16.2	17.6	19.3	20.9	36.6	35.6	16.4	18.4
Less Urbanized	15.1	18.7	12.6	17.9	15.3	18.7	28.7	32.5	13.5	16.8
Completely Rural	14.2	8.8	13.9	*	14.3	8.6	33.2	24.4	12.3	7.3
POVERTY LEVEL¹
Less Than 100%	25.9	26.1	18.2	15.3	27.2	27.4	39.1	38.2	23.3	24.4
100-199%	22.4	21.4	17.6	12.9	22.9	22.3	37.4	37.0	20.1	19.3
200% or More	19.2	20.3	16.7	13.5	19.4	20.9	40.1	36.0	17.1	19.2
HEALTH INSURANCE²
Private	18.7	20.0	16.1	13.4	18.9	20.6	40.2	38.9	15.9	18.0
Medicaid/CHIP	28.4	28.1	18.8	14.4	31.0	31.0	37.8	34.0	29.2	30.2
Other³	12.6	13.7	17.4	11.9	12.5	13.8	37.7	38.1	11.6	13.0
No Coverage	28.3	26.5	17.8	14.1	28.7	27.2	36.7	32.8	26.9	25.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.68A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	35,803	37,309	2,167	1,679	33,636	35,630	8,406	8,016	25,231	27,614
GEOGRAPHIC REGION
Northeast	6,403	7,153	385	351	6,019	6,802	1,600	1,472	4,419	5,331
Midwest	7,122	7,738	429	361	6,693	7,376	1,841	1,853	4,852	5,523
South	11,420	11,437	715	475	10,705	10,962	2,619	2,483	8,086	8,479
West	10,859	10,980	639	492	10,220	10,489	2,346	2,207	7,873	8,282
COUNTY TYPE
Large Metro	21,422	20,397	1,209	874	20,212	19,523	5,029	4,462	15,183	15,061
Small Metro	10,350	12,104	707	547	9,644	11,557	2,480	2,619	7,164	8,938
Nonmetro	4,031	4,808	251	258	3,781	4,550	897	934	2,884	3,615
Urbanized	2,017	2,165	119	98	1,898	2,067	520	460	1,378	1,607
Less Urbanized	1,623	2,350	103	147	1,520	2,203	313	417	1,207	1,786
Completely Rural	392	293	29	13	363	280	65	58	298	222
POVERTY LEVEL¹
Less Than 100%	6,304	7,528	487	301	5,817	7,227	2,023	2,066	3,794	5,161
100-199%	7,519	7,266	521	324	6,998	6,942	1,851	1,865	5,146	5,077
200% or More	21,741	22,403	1,159	1,054	20,582	21,349	4,292	3,973	16,290	17,376
HEALTH INSURANCE²
Private	20,095	20,469	1,128	1,009	18,966	19,460	5,060	4,769	13,906	14,691
Medicaid/CHIP	8,384	9,471	917	610	7,466	8,860	1,866	1,814	5,600	7,047
Other³	5,586	6,747	106	60	5,480	6,688	603	586	4,878	6,101
No Coverage	5,266	5,264	112	75	5,154	5,189	1,186	1,189	3,969	4,000
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.68B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	13.0	13.5	8.7	6.7	13.4	14.1	24.9	23.9	11.6	12.6
GEOGRAPHIC REGION
Northeast	13.4	15.0	9.7	8.9	13.7	15.5	27.7	26.0	11.6	14.0
Midwest	12.4	13.5	8.1	6.9	12.9	14.1	25.7	26.1	10.8	12.3
South	10.9	10.8	7.4	4.9	11.3	11.4	20.6	19.5	9.8	10.2
West	16.6	16.6	10.6	8.2	17.2	17.5	29.0	27.5	15.3	15.9
COUNTY TYPE
Large Metro	13.9	13.5	8.9	6.2	14.4	14.3	26.8	25.2	12.5	12.6
Small Metro	12.4	14.3	9.1	7.1	12.7	15.0	23.4	23.8	11.0	13.5
Nonmetro	10.6	11.6	7.0	8.1	11.0	11.9	20.7	19.6	9.6	10.9
Urbanized	12.7	13.1	7.7	7.4	13.2	13.6	25.7	20.9	11.2	12.4
Less Urbanized	9.1	11.9	6.2	9.1	9.4	12.2	16.2	18.8	8.5	11.2
Completely Rural	9.0	5.8	7.2	4.9	9.2	5.8	17.2	16.3	8.4	5.0
POVERTY LEVEL¹
Less Than 100%	16.8	18.0	9.6	6.5	18.0	19.4	25.6	25.4	15.5	17.7
100-199%	14.2	14.4	9.8	7.2	14.7	15.1	23.9	24.2	12.9	13.3
200% or More	11.8	12.2	8.0	6.6	12.2	12.7	25.3	23.0	10.7	11.5
HEALTH INSURANCE²
Private	11.2	11.8	7.9	6.7	11.5	12.2	24.8	24.3	9.6	10.5
Medicaid/CHIP	18.6	19.4	9.7	7.3	20.9	22.0	25.7	23.3	19.6	21.7
Other³	8.0	8.8	8.7	3.6	7.9	9.0	23.7	24.1	7.3	8.4
No Coverage	19.5	18.5	9.6	5.1	19.9	19.2	24.6	22.6	18.8	18.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.69A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	48,242	49,634	3,284	2,531	44,958	47,103	11,952	11,566	33,007	35,537
GEOGRAPHIC REGION
Northeast	8,724	9,181	563	453	8,162	8,728	2,217	1,944	5,945	6,784
Midwest	9,678	10,493	670	552	9,008	9,941	2,634	2,738	6,374	7,203
South	15,583	15,135	1,101	828	14,482	14,307	3,913	3,794	10,569	10,514
West	14,257	14,825	950	698	13,307	14,127	3,188	3,091	10,119	11,036
COUNTY TYPE
Large Metro	28,739	27,927	1,791	1,396	26,948	26,531	7,084	6,230	19,864	20,301
Small Metro	14,087	15,640	1,093	739	12,994	14,900	3,551	3,895	9,443	11,005
Nonmetro	5,416	6,068	400	396	5,017	5,672	1,317	1,441	3,700	4,231
Urbanized	2,612	2,833	197	154	2,415	2,679	682	697	1,732	1,982
Less Urbanized	2,280	2,851	165	217	2,116	2,634	519	671	1,596	1,963
Completely Rural	524	384	38	*	486	359	115	73	371	286
POVERTY LEVEL¹
Less Than 100%	8,006	9,084	678	450	7,328	8,635	2,767	2,891	4,561	5,743
100-199%	9,818	9,042	740	471	9,077	8,571	2,642	2,713	6,435	5,857
200% or More	30,047	31,298	1,865	1,610	28,182	29,688	6,171	5,752	22,011	23,936
HEALTH INSURANCE²
Private	28,599	29,215	1,757	1,560	26,842	27,655	7,468	7,062	19,373	20,593
Medicaid/CHIP	10,686	11,352	1,350	830	9,336	10,521	2,461	2,537	6,874	7,985
Other³	6,961	8,328	153	117	6,809	8,212	873	880	5,936	7,332
No Coverage	6,612	6,306	185	135	6,427	6,172	1,583	1,596	4,844	4,576
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.69B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	17.5	17.9	13.2	10.1	18.0	18.7	35.4	34.5	15.2	16.3
GEOGRAPHIC REGION
Northeast	18.3	19.3	14.2	11.5	18.6	19.9	38.5	34.3	15.6	17.8
Midwest	16.9	18.3	12.7	10.5	17.3	19.1	36.8	38.6	14.2	16.0
South	14.9	14.3	11.4	8.5	15.3	14.9	30.8	29.8	12.9	12.6
West	21.7	22.4	15.8	11.6	22.3	23.5	39.4	38.5	19.7	21.2
COUNTY TYPE
Large Metro	18.7	18.5	13.2	9.9	19.2	19.4	37.7	35.2	16.4	17.0
Small Metro	16.9	18.5	14.1	9.6	17.2	19.4	33.5	35.4	14.5	16.7
Nonmetro	14.2	14.7	11.1	12.3	14.6	14.9	30.4	30.2	12.3	12.7
Urbanized	16.4	17.2	12.8	11.7	16.8	17.6	33.7	31.6	14.1	15.3
Less Urbanized	12.8	14.5	9.9	13.4	13.1	14.6	26.9	30.3	11.2	12.4
Completely Rural	12.1	7.6	9.4	*	12.3	7.5	30.7	20.8	10.4	6.4
POVERTY LEVEL¹
Less Than 100%	21.4	21.7	13.3	9.8	22.7	23.1	35.0	35.5	18.7	19.7
100-199%	18.5	17.9	13.9	10.4	19.1	18.7	34.2	35.2	16.1	15.3
200% or More	16.4	17.0	12.9	10.1	16.7	17.6	36.4	33.3	14.5	15.8
HEALTH INSURANCE²
Private	15.9	16.8	12.3	10.4	16.2	17.4	36.6	36.1	13.3	14.8
Medicaid/CHIP	23.7	23.3	14.4	9.9	26.1	26.1	34.0	32.6	24.1	24.5
Other³	9.9	10.9	12.4	7.0	9.9	11.0	34.4	36.2	8.9	10.1
No Coverage	24.5	22.2	15.9	9.2	24.8	22.9	32.8	30.3	23.0	21.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.70A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	31,606	32,784	1,837	1,472	29,769	31,312	7,749	7,727	22,020	23,585
GEOGRAPHIC REGION
Northeast	5,803	6,209	341	307	5,461	5,902	1,502	1,415	3,960	4,486
Midwest	6,188	6,909	359	294	5,829	6,616	1,701	1,797	4,127	4,818
South	10,021	9,818	584	405	9,437	9,412	2,398	2,383	7,039	7,030
West	9,595	9,848	553	465	9,042	9,383	2,149	2,131	6,893	7,252
COUNTY TYPE
Large Metro	18,846	17,913	1,030	774	17,816	17,139	4,623	4,290	13,193	12,848
Small Metro	9,166	10,573	594	470	8,572	10,103	2,282	2,551	6,290	7,552
Nonmetro	3,595	4,298	213	228	3,381	4,070	845	886	2,536	3,185
Urbanized	1,837	2,036	103	84	1,734	1,952	489	440	1,245	1,513
Less Urbanized	1,425	1,978	87	137	1,338	1,841	296	392	1,042	1,449
Completely Rural	333	284	24	*	309	277	60	54	250	222
POVERTY LEVEL¹
Less Than 100%	5,527	6,729	418	257	5,109	6,471	1,845	1,997	3,265	4,474
100-199%	6,684	6,388	422	305	6,262	6,082	1,740	1,779	4,522	4,303
200% or More	19,168	19,557	998	909	18,170	18,648	3,937	3,839	14,233	14,808
HEALTH INSURANCE²
Private	17,794	17,947	956	873	16,838	17,075	4,661	4,579	12,177	12,496
Medicaid/CHIP	7,314	8,319	767	538	6,546	7,781	1,700	1,767	4,846	6,014
Other³	4,762	5,785	86	51	4,676	5,734	559	570	4,117	5,164
No Coverage	4,770	4,745	108	73	4,662	4,672	1,105	1,147	3,557	3,525
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.70B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	11.5	11.8	7.4	5.9	11.9	12.4	23.0	23.1	10.2	10.8
GEOGRAPHIC REGION
Northeast	12.1	13.0	8.6	7.8	12.5	13.5	26.0	25.0	10.4	11.8
Midwest	10.8	12.0	6.8	5.6	11.2	12.7	23.7	25.3	9.2	10.7
South	9.6	9.3	6.0	4.2	9.9	9.8	18.9	18.7	8.6	8.4
West	14.6	14.9	9.2	7.7	15.2	15.6	26.6	26.6	13.4	13.9
COUNTY TYPE
Large Metro	12.3	11.9	7.6	5.5	12.7	12.5	24.6	24.2	10.9	10.8
Small Metro	11.0	12.5	7.7	6.1	11.3	13.1	21.5	23.2	9.7	11.4
Nonmetro	9.4	10.4	5.9	7.1	9.8	10.7	19.5	18.6	8.4	9.6
Urbanized	11.6	12.3	6.7	6.3	12.1	12.9	24.1	20.0	10.1	11.7
Less Urbanized	8.0	10.0	5.2	8.4	8.3	10.2	15.3	17.7	7.3	9.1
Completely Rural	7.7	5.6	5.8	*	7.9	5.7	15.9	15.3	7.0	5.0
POVERTY LEVEL¹
Less Than 100%	14.8	16.1	8.2	5.6	15.8	17.3	23.4	24.5	13.4	15.3
100-199%	12.6	12.7	7.9	6.8	13.2	13.2	22.5	23.1	11.3	11.3
200% or More	10.4	10.6	6.9	5.7	10.7	11.1	23.2	22.2	9.3	9.8
HEALTH INSURANCE²
Private	9.9	10.3	6.7	5.8	10.2	10.7	22.8	23.4	8.4	9.0
Medicaid/CHIP	16.2	17.1	8.2	6.4	18.3	19.3	23.4	22.7	17.0	18.5
Other³	6.8	7.6	7.0	3.1	6.8	7.7	22.0	23.5	6.2	7.1
No Coverage	17.6	16.7	9.3	5.0	18.0	17.3	22.9	21.8	16.9	16.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.71A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5,468	5,172	97	84	5,371	5,088	1,789	1,441	3,582	3,646
GEOGRAPHIC REGION
Northeast	949	1,155	4	4	945	1,152	341	262	604	889
Midwest	1,035	1,027	23	2	1,012	1,025	324	300	688	725
South	1,797	1,532	27	37	1,769	1,495	504	410	1,266	1,085
West	1,688	1,458	42	41	1,645	1,416	621	468	1,025	948
COUNTY TYPE
Large Metro	3,456	3,219	47	50	3,410	3,169	1,101	833	2,309	2,336
Small Metro	1,535	1,528	40	26	1,495	1,502	541	464	954	1,038
Nonmetro	476	425	10	8	466	416	147	145	320	272
Urbanized	307	174	5	*	303	174	100	78	203	96
Less Urbanized	143	231	4	*	139	223	44	59	95	164
Completely Rural	26	20	1	0	25	20	4	*	21	12
POVERTY LEVEL¹
Less Than 100%	1,042	979	25	15	1,017	964	366	336	651	628
100-199%	1,083	993	26	*	1,058	993	315	316	743	678
200% or More	3,302	3,194	46	69	3,256	3,125	1,068	784	2,188	2,341
HEALTH INSURANCE²
Private	3,128	2,826	45	47	3,083	2,779	1,316	977	1,766	1,803
Medicaid/CHIP	1,333	1,136	48	33	1,285	1,103	268	194	1,018	909
Other³	510	561	5	*	505	561	82	63	423	498
No Coverage	938	1,009	4	8	934	1,001	194	236	741	765
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.71B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2.0	1.9	0.4	0.3	2.1	2.0	5.3	4.3	1.7	1.7
GEOGRAPHIC REGION
Northeast	2.0	2.4	0.1	0.1	2.2	2.6	5.9	4.6	1.6	2.3
Midwest	1.8	1.8	0.4	0.0	1.9	2.0	4.5	4.2	1.5	1.6
South	1.7	1.4	0.3	0.4	1.9	1.6	4.0	3.2	1.5	1.3
West	2.6	2.2	0.7	0.7	2.8	2.4	7.7	5.8	2.0	1.8
COUNTY TYPE
Large Metro	2.2	2.1	0.3	0.4	2.4	2.3	5.9	4.7	1.9	2.0
Small Metro	1.8	1.8	0.5	0.3	2.0	2.0	5.1	4.2	1.5	1.6
Nonmetro	1.3	1.0	0.3	0.3	1.4	1.1	3.4	3.0	1.1	0.8
Urbanized	1.9	1.1	0.3	*	2.1	1.1	4.9	3.5	1.6	0.7
Less Urbanized	0.8	1.2	0.3	*	0.9	1.2	2.3	2.7	0.7	1.0
Completely Rural	0.6	0.4	0.2	0.2	0.6	0.4	0.9	*	0.6	0.3
POVERTY LEVEL¹
Less Than 100%	2.8	2.3	0.5	0.3	3.1	2.6	4.6	4.1	2.7	2.2
100-199%	2.0	2.0	0.5	*	2.2	2.2	4.1	4.1	1.9	1.8
200% or More	1.8	1.7	0.3	0.4	1.9	1.9	6.3	4.5	1.4	1.5
HEALTH INSURANCE²
Private	1.7	1.6	0.3	0.3	1.9	1.7	6.4	5.0	1.2	1.3
Medicaid/CHIP	3.0	2.3	0.5	0.4	3.6	2.7	3.7	2.5	3.6	2.8
Other³	0.7	0.7	0.4	*	0.7	0.8	3.2	2.6	0.6	0.7
No Coverage	3.5	3.5	0.3	0.5	3.6	3.7	4.0	4.5	3.5	3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.72A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,998	1,831	34	11	1,965	1,821	540	424	1,425	1,396
GEOGRAPHIC REGION
Northeast	381	457	1	*	380	457	102	69	278	388
Midwest	372	307	7	*	365	307	101	65	264	242
South	730	565	13	2	717	563	167	194	550	369
West	515	503	12	9	503	494	169	97	333	397
COUNTY TYPE
Large Metro	1,327	1,293	15	8	1,312	1,285	316	254	997	1,031
Small Metro	501	447	16	2	485	445	180	163	305	281
Nonmetro	170	91	3	*	167	91	44	7	123	84
Urbanized	103	31	3	*	100	31	24	4	76	27
Less Urbanized	52	61	0	0	52	61	17	3	35	58
Completely Rural	15	*	*	*	15	*	2	*	13	*
POVERTY LEVEL¹
Less Than 100%	443	353	11	2	432	351	136	96	297	255
100-199%	398	326	9	*	389	326	103	92	287	234
200% or More	1,147	1,149	14	9	1,133	1,140	291	233	842	908
HEALTH INSURANCE²
Private	1,100	1,000	15	8	1,086	992	390	274	696	717
Medicaid/CHIP	493	437	18	2	475	435	68	40	406	395
Other³	176	115	0	*	175	115	27	23	148	92
No Coverage	386	355	0	*	386	355	73	100	313	255
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.72B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.7	0.1	0.0	0.8	0.7	1.6	1.3	0.7	0.6
GEOGRAPHIC REGION
Northeast	0.8	1.0	0.0	*	0.9	1.0	1.8	1.2	0.7	1.0
Midwest	0.7	0.5	0.1	*	0.7	0.6	1.4	0.9	0.6	0.5
South	0.7	0.5	0.1	0.0	0.8	0.6	1.3	1.5	0.7	0.4
West	0.8	0.8	0.2	0.1	0.8	0.8	2.1	1.2	0.6	0.8
COUNTY TYPE
Large Metro	0.9	0.9	0.1	0.1	0.9	0.9	1.7	1.4	0.8	0.9
Small Metro	0.6	0.5	0.2	0.0	0.6	0.6	1.7	1.5	0.5	0.4
Nonmetro	0.4	0.2	0.1	*	0.5	0.2	1.0	0.1	0.4	0.3
Urbanized	0.6	0.2	0.2	*	0.7	0.2	1.2	0.2	0.6	0.2
Less Urbanized	0.3	0.3	0.0	0.0	0.3	0.3	0.9	0.1	0.2	0.4
Completely Rural	0.3	*	*	*	0.4	*	0.6	*	0.4	*
POVERTY LEVEL¹
Less Than 100%	1.2	0.8	0.2	0.0	1.3	0.9	1.7	1.2	1.2	0.9
100-199%	0.8	0.6	0.2	*	0.8	0.7	1.3	1.2	0.7	0.6
200% or More	0.6	0.6	0.1	0.1	0.7	0.7	1.7	1.3	0.6	0.6
HEALTH INSURANCE²
Private	0.6	0.6	0.1	0.1	0.7	0.6	1.9	1.4	0.5	0.5
Medicaid/CHIP	1.1	0.9	0.2	0.0	1.3	1.1	0.9	0.5	1.4	1.2
Other³	0.3	0.2	0.0	*	0.3	0.2	1.1	0.9	0.2	0.1
No Coverage	1.4	1.2	0.0	*	1.5	1.3	1.5	1.9	1.5	1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.73A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	9,375	9,356	778	657	378	335
GEOGRAPHIC REGION
Northeast	1,450	1,829	154	145	80	87
Midwest	2,112	2,151	281	198	116	93
South	3,210	3,060	256	243	152	142
West	2,602	2,316	87	71	29	13
COUNTY TYPE
Large Metro	5,042	4,148	448	312	261	213
Small Metro	2,852	3,613	244	283	83	90
Nonmetro	1,481	1,595	86	62	34	32
Urbanized	676	617	43	8	8	8
Less Urbanized	650	941	35	52	22	24
Completely Rural	155	36	7	1	4	*
POVERTY LEVEL¹
Less Than 100%	2,150	2,575	310	273	174	119
100-199%	2,271	2,045	218	238	74	118
200% or More	4,954	4,736	250	146	130	98
HEALTH INSURANCE²
Private	4,298	3,530	224	89	119	51
Medicaid/CHIP	2,861	3,254	428	400	194	190
Other³	2,054	2,614	174	169	49	49
No Coverage	1,493	1,552	142	129	78	84
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.73B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	3.4	3.4	0.3	0.2	0.1	0.1
GEOGRAPHIC REGION
Northeast	3.0	3.8	0.3	0.3	0.2	0.2
Midwest	3.7	3.7	0.5	0.3	0.2	0.2
South	3.1	2.9	0.2	0.2	0.1	0.1
West	4.0	3.5	0.1	0.1	0.0	0.0
COUNTY TYPE
Large Metro	3.3	2.7	0.3	0.2	0.2	0.1
Small Metro	3.4	4.3	0.3	0.3	0.1	0.1
Nonmetro	3.9	3.9	0.2	0.1	0.1	0.1
Urbanized	4.3	3.7	0.3	0.1	0.1	0.0
Less Urbanized	3.6	4.8	0.2	0.3	0.1	0.1
Completely Rural	3.6	0.7	0.2	0.0	0.1	*
POVERTY LEVEL¹
Less Than 100%	5.7	6.1	0.8	0.7	0.5	0.3
100-199%	4.3	4.1	0.4	0.5	0.1	0.2
200% or More	2.7	2.6	0.1	0.1	0.1	0.1
HEALTH INSURANCE²
Private	2.4	2.0	0.1	0.1	0.1	0.0
Medicaid/CHIP	6.3	6.7	0.9	0.8	0.4	0.4
Other³	2.9	3.4	0.2	0.2	0.1	0.1
No Coverage	5.5	5.5	0.5	0.5	0.3	0.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.74A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	44,087	43,949	6,010	7,133	1,915	1,761
GEOGRAPHIC REGION
Northeast	7,452	7,472	841	1,234	232	354
Midwest	8,996	9,498	1,170	1,476	366	396
South	13,599	13,832	1,803	1,994	579	455
West	14,040	13,147	2,196	2,429	738	556
COUNTY TYPE
Large Metro	25,202	23,566	3,618	4,248	1,083	1,066
Small Metro	13,403	14,032	1,762	2,170	644	541
Nonmetro	5,483	6,351	630	715	187	155
Urbanized	2,721	2,980	424	348	117	45
Less Urbanized	2,211	2,872	163	348	57	109
Completely Rural	551	500	43	19	13	1
POVERTY LEVEL¹
Less Than 100%	5,239	6,164	1,072	1,450	302	409
100-199%	7,968	7,538	1,275	1,297	396	323
200% or More	30,803	30,209	3,598	4,357	1,203	1,009
HEALTH INSURANCE²
Private	28,443	26,663	3,697	4,226	1,148	966
Medicaid/CHIP	7,347	8,090	1,164	1,523	405	376
Other³	8,176	9,477	482	598	147	124
No Coverage	5,067	5,693	915	1,206	288	395
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.74B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Lifetime (2019)	Lifetime (2020)	Past Year (2019)	Past Year (2020)	Past Month (2019)	Past Month (2020)
TOTAL	16.0	15.9	2.2	2.6	0.7	0.6
GEOGRAPHIC REGION
Northeast	15.6	15.7	1.8	2.6	0.5	0.7
Midwest	15.7	16.5	2.0	2.6	0.6	0.7
South	13.0	13.1	1.7	1.9	0.6	0.4
West	21.4	19.9	3.3	3.7	1.1	0.8
COUNTY TYPE
Large Metro	16.4	15.6	2.4	2.8	0.7	0.7
Small Metro	16.1	16.6	2.1	2.6	0.8	0.6
Nonmetro	14.4	15.4	1.7	1.7	0.5	0.4
Urbanized	17.1	18.0	2.7	2.1	0.7	0.3
Less Urbanized	12.4	14.6	0.9	1.8	0.3	0.6
Completely Rural	12.7	9.8	1.0	0.4	0.3	0.0
POVERTY LEVEL¹
Less Than 100%	14.0	14.7	2.9	3.5	0.8	1.0
100-199%	15.1	14.9	2.4	2.6	0.7	0.6
200% or More	16.8	16.4	2.0	2.4	0.7	0.5
HEALTH INSURANCE²
Private	15.8	15.3	2.1	2.4	0.6	0.6
Medicaid/CHIP	16.3	16.6	2.6	3.1	0.9	0.8
Other³	11.6	12.4	0.7	0.8	0.2	0.2
No Coverage	18.7	20.0	3.4	4.2	1.1	1.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.75A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2,142	2,390	743	683	1,399	1,707	577	507	822	1,200
GEOGRAPHIC REGION
Northeast	356	590	111	87	245	502	107	87	138	415
Midwest	412	492	153	166	260	326	108	93	151	233
South	729	726	292	259	437	468	188	147	248	321
West	645	582	187	171	458	410	173	179	285	231
COUNTY TYPE
Large Metro	1,354	1,621	392	362	962	1,259	376	361	586	899
Small Metro	578	533	254	211	324	321	139	86	184	236
Nonmetro	211	236	97	110	114	126	62	60	52	66
Urbanized	103	104	40	50	63	54	34	33	29	21
Less Urbanized	81	118	45	48	37	70	20	25	17	45
Completely Rural	27	15	12	*	14	2	8	2	6	*
POVERTY LEVEL¹
Less Than 100%	408	467	162	140	246	327	143	174	103	153
100-199%	376	357	147	96	229	261	108	112	121	149
200% or More	1,326	1,565	434	447	892	1,118	294	220	599	898
HEALTH INSURANCE²
Private	1,342	1,251	418	394	923	857	388	273	535	583
Medicaid/CHIP	488	713	282	282	207	431	99	86	107	345
Other³	248	165	36	66	212	98	46	15	166	83
No Coverage	162	381	25	12	137	368	64	135	73	233
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.75B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.8	0.9	3.0	2.7	0.6	0.7	1.7	1.5	0.4	0.5
GEOGRAPHIC REGION
Northeast	0.7	1.2	2.8	2.2	0.6	1.1	1.9	1.5	0.4	1.1
Midwest	0.7	0.9	2.9	3.1	0.5	0.6	1.5	1.3	0.3	0.5
South	0.7	0.7	3.0	2.6	0.5	0.5	1.5	1.2	0.3	0.4
West	1.0	0.9	3.1	2.8	0.8	0.7	2.1	2.2	0.6	0.4
COUNTY TYPE
Large Metro	0.9	1.1	2.9	2.6	0.7	0.9	2.0	2.0	0.5	0.8
Small Metro	0.7	0.6	3.3	2.8	0.4	0.4	1.3	0.8	0.3	0.4
Nonmetro	0.6	0.6	2.7	3.4	0.3	0.3	1.4	1.3	0.2	0.2
Urbanized	0.6	0.6	2.6	3.8	0.4	0.4	1.7	1.5	0.2	0.2
Less Urbanized	0.5	0.6	2.7	3.0	0.2	0.4	1.0	1.1	0.1	0.3
Completely Rural	0.6	0.3	3.0	*	0.4	0.1	2.2	0.7	0.2	*
POVERTY LEVEL¹
Less Than 100%	1.1	1.1	3.2	3.0	0.8	0.9	1.8	2.1	0.4	0.5
100-199%	0.7	0.7	2.8	2.1	0.5	0.6	1.4	1.5	0.3	0.4
200% or More	0.7	0.8	3.0	2.8	0.5	0.7	1.7	1.3	0.4	0.6
HEALTH INSURANCE²
Private	0.7	0.7	2.9	2.6	0.6	0.5	1.9	1.4	0.4	0.4
Medicaid/CHIP	1.1	1.5	3.0	3.4	0.6	1.1	1.4	1.1	0.4	1.1
Other³	0.4	0.2	2.9	4.0	0.3	0.1	1.8	0.6	0.3	0.1
No Coverage	0.6	1.3	2.1	0.8	0.5	1.4	1.3	2.6	0.3	1.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.76A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	807	904	216	106	591	797	157	160	434	637
GEOGRAPHIC REGION
Northeast	151	289	37	24	114	265	32	29	82	235
Midwest	155	129	49	28	106	101	31	14	76	87
South	259	294	78	43	180	251	37	77	143	174
West	242	192	52	11	190	181	57	40	133	141
COUNTY TYPE
Large Metro	592	672	125	68	467	604	111	95	356	508
Small Metro	162	153	70	27	92	126	36	38	56	88
Nonmetro	53	80	21	12	32	68	10	26	22	41
Urbanized	26	33	9	5	17	28	8	*	9	10
Less Urbanized	25	39	10	1	15	38	1	7	13	31
Completely Rural	2	7	2	*	*	1	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	106	102	40	20	66	82	38	50	29	32
100-199%	174	163	71	10	103	153	39	42	64	111
200% or More	522	639	106	76	417	562	76	67	341	495
HEALTH INSURANCE²
Private	488	512	116	73	372	439	108	94	264	345
Medicaid/CHIP	174	230	90	45	84	185	25	23	59	162
Other³	124	65	9	*	115	65	8	1	107	64
No Coverage	60	142	5	*	54	142	17	43	37	100
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.76B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.3	0.3	0.9	0.4	0.2	0.3	0.5	0.5	0.2	0.3
GEOGRAPHIC REGION
Northeast	0.3	0.6	0.9	0.6	0.3	0.6	0.6	0.5	0.2	0.6
Midwest	0.3	0.2	0.9	0.5	0.2	0.2	0.4	0.2	0.2	0.2
South	0.2	0.3	0.8	0.4	0.2	0.3	0.3	0.6	0.2	0.2
West	0.4	0.3	0.9	0.2	0.3	0.3	0.7	0.5	0.3	0.3
COUNTY TYPE
Large Metro	0.4	0.4	0.9	0.5	0.3	0.4	0.6	0.5	0.3	0.4
Small Metro	0.2	0.2	0.9	0.3	0.1	0.2	0.3	0.3	0.1	0.1
Nonmetro	0.1	0.2	0.6	0.4	0.1	0.2	0.2	0.6	0.1	0.1
Urbanized	0.2	0.2	0.6	0.4	0.1	0.2	0.4	*	0.1	0.1
Less Urbanized	0.1	0.2	0.6	0.1	0.1	0.2	0.1	0.3	0.1	0.2
Completely Rural	0.1	0.1	0.6	*	*	0.0	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.3	0.2	0.8	0.4	0.2	0.2	0.5	0.6	0.1	0.1
100-199%	0.3	0.3	1.3	0.2	0.2	0.3	0.5	0.5	0.2	0.3
200% or More	0.3	0.3	0.7	0.5	0.2	0.3	0.4	0.4	0.2	0.3
HEALTH INSURANCE²
Private	0.3	0.3	0.8	0.5	0.2	0.3	0.5	0.5	0.2	0.2
Medicaid/CHIP	0.4	0.5	1.0	0.5	0.2	0.5	0.3	0.3	0.2	0.5
Other³	0.2	0.1	0.7	*	0.2	0.1	0.3	0.1	0.2	0.1
No Coverage	0.2	0.5	0.5	*	0.2	0.5	0.4	0.8	0.2	0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.77A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,999	2,550	41	21	1,958	2,528	275	171	1,682	2,358
GEOGRAPHIC REGION
Northeast	145	139	7	*	138	139	28	22	110	117
Midwest	448	479	8	14	441	464	70	42	371	422
South	691	973	12	6	679	967	101	64	578	902
West	715	959	14	1	701	958	77	42	624	916
COUNTY TYPE
Large Metro	941	837	21	4	920	833	132	81	788	752
Small Metro	586	1,322	13	13	572	1,309	84	56	489	1,253
Nonmetro	473	391	8	4	465	386	60	33	405	353
Urbanized	226	139	6	*	220	134	29	6	191	128
Less Urbanized	205	238	1	*	204	238	26	24	178	214
Completely Rural	41	13	*	*	41	13	5	*	36	11
POVERTY LEVEL¹
Less Than 100%	599	912	7	2	592	911	69	41	523	870
100-199%	655	660	7	1	649	658	96	75	552	583
200% or More	744	975	27	19	717	956	109	52	607	904
HEALTH INSURANCE²
Private	553	704	27	14	526	690	119	84	407	606
Medicaid/CHIP	810	1,118	14	7	797	1,111	80	80	717	1,030
Other³	323	696	4	*	320	696	19	10	300	686
No Coverage	545	507	*	*	545	507	67	19	478	488
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.77B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.9	0.2	0.1	0.8	1.0	0.8	0.5	0.8	1.1
GEOGRAPHIC REGION
Northeast	0.3	0.3	0.2	*	0.3	0.3	0.5	0.4	0.3	0.3
Midwest	0.8	0.8	0.1	0.3	0.8	0.9	1.0	0.6	0.8	0.9
South	0.7	0.9	0.1	0.1	0.7	1.0	0.8	0.5	0.7	1.1
West	1.1	1.5	0.2	0.0	1.2	1.6	1.0	0.5	1.2	1.8
COUNTY TYPE
Large Metro	0.6	0.6	0.2	0.0	0.7	0.6	0.7	0.5	0.6	0.6
Small Metro	0.7	1.6	0.2	0.2	0.8	1.7	0.8	0.5	0.8	1.9
Nonmetro	1.2	0.9	0.2	0.1	1.3	1.0	1.4	0.7	1.3	1.1
Urbanized	1.4	0.8	0.4	*	1.5	0.9	1.4	0.3	1.5	1.0
Less Urbanized	1.2	1.2	0.1	*	1.3	1.3	1.4	1.1	1.2	1.3
Completely Rural	0.9	0.3	*	*	1.0	0.3	1.3	*	1.0	0.2
POVERTY LEVEL¹
Less Than 100%	1.6	2.2	0.1	0.0	1.8	2.4	0.9	0.5	2.1	3.0
100-199%	1.2	1.3	0.1	0.0	1.4	1.4	1.2	1.0	1.4	1.5
200% or More	0.4	0.5	0.2	0.1	0.4	0.6	0.6	0.3	0.4	0.6
HEALTH INSURANCE²
Private	0.3	0.4	0.2	0.1	0.3	0.4	0.6	0.4	0.3	0.4
Medicaid/CHIP	1.8	2.3	0.1	0.1	2.2	2.8	1.1	1.0	2.5	3.2
Other³	0.5	0.9	0.3	*	0.5	0.9	0.8	0.4	0.5	0.9
No Coverage	2.0	1.8	*	*	2.1	1.9	1.4	0.4	2.3	2.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.78A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,173	1,722	11	7	1,161	1,715	110	74	1,051	1,641
GEOGRAPHIC REGION
Northeast	53	57	3	*	50	57	6	9	44	48
Midwest	276	316	3	*	274	316	33	16	240	299
South	363	654	5	6	359	649	46	38	313	611
West	480	695	1	1	479	694	25	11	454	683
COUNTY TYPE
Large Metro	633	623	7	*	626	623	48	33	578	590
Small Metro	311	852	4	3	306	849	38	27	268	822
Nonmetro	229	248	0	4	229	243	24	14	205	229
Urbanized	132	90	0	*	132	85	12	6	120	79
Less Urbanized	91	147	*	*	91	147	12	8	79	140
Completely Rural	6	11	*	*	6	11	*	*	6	11
POVERTY LEVEL¹
Less Than 100%	379	688	4	2	376	687	31	4	345	682
100-199%	378	418	*	1	378	417	51	31	328	386
200% or More	414	615	7	4	406	611	28	37	378	573
HEALTH INSURANCE²
Private	246	505	8	*	238	505	41	46	197	459
Medicaid/CHIP	495	712	3	7	491	705	38	21	453	684
Other³	177	381	0	*	177	381	12	6	164	375
No Coverage	351	391	*	*	351	391	27	15	324	376
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.78B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.4	0.6	0.0	0.0	0.5	0.7	0.3	0.2	0.5	0.8
GEOGRAPHIC REGION
Northeast	0.1	0.1	0.1	*	0.1	0.1	0.1	0.2	0.1	0.1
Midwest	0.5	0.5	0.1	*	0.5	0.6	0.5	0.2	0.5	0.7
South	0.3	0.6	0.0	0.1	0.4	0.7	0.4	0.3	0.4	0.7
West	0.7	1.1	0.0	0.0	0.8	1.2	0.3	0.1	0.9	1.3
COUNTY TYPE
Large Metro	0.4	0.4	0.0	*	0.4	0.5	0.3	0.2	0.5	0.5
Small Metro	0.4	1.0	0.1	0.0	0.4	1.1	0.4	0.2	0.4	1.2
Nonmetro	0.6	0.6	0.0	0.1	0.7	0.6	0.6	0.3	0.7	0.7
Urbanized	0.8	0.5	0.0	*	0.9	0.6	0.6	0.3	1.0	0.6
Less Urbanized	0.5	0.7	*	*	0.6	0.8	0.6	0.3	0.6	0.9
Completely Rural	0.1	0.2	*	*	0.1	0.2	*	*	0.2	0.2
POVERTY LEVEL¹
Less Than 100%	1.0	1.6	0.1	0.0	1.2	1.8	0.4	0.1	1.4	2.3
100-199%	0.7	0.8	*	0.0	0.8	0.9	0.7	0.4	0.8	1.0
200% or More	0.2	0.3	0.1	0.0	0.2	0.4	0.2	0.2	0.2	0.4
HEALTH INSURANCE²
Private	0.1	0.3	0.1	*	0.1	0.3	0.2	0.2	0.1	0.3
Medicaid/CHIP	1.1	1.5	0.0	0.1	1.4	1.7	0.5	0.3	1.6	2.1
Other³	0.3	0.5	0.0	*	0.3	0.5	0.5	0.3	0.2	0.5
No Coverage	1.3	1.4	*	*	1.4	1.4	0.6	0.3	1.5	1.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.79A – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	82,559	75,198	3,980	3,079	78,579	72,118	8,357	6,858	70,222	65,261
GEOGRAPHIC REGION
Northeast	12,396	11,685	552	357	11,844	11,328	1,238	1,094	10,606	10,235
Midwest	17,550	15,012	795	666	16,755	14,347	1,822	1,316	14,933	13,030
South	32,479	30,506	1,612	1,403	30,867	29,103	3,209	2,801	27,658	26,302
West	20,134	17,994	1,021	653	19,112	17,341	2,087	1,647	17,025	15,693
COUNTY TYPE
Large Metro	43,623	38,079	2,052	1,521	41,571	36,558	4,543	3,409	37,028	33,149
Small Metro	26,925	25,231	1,324	1,127	25,600	24,104	2,691	2,324	22,909	21,780
Nonmetro	12,011	11,888	604	431	11,408	11,456	1,123	1,124	10,285	10,332
Urbanized	5,037	4,966	255	178	4,783	4,789	558	550	4,225	4,239
Less Urbanized	5,560	5,433	275	193	5,285	5,240	467	538	4,817	4,702
Completely Rural	1,414	1,488	74	*	1,340	1,428	98	37	1,242	1,391
POVERTY LEVEL¹
Less Than 100%	11,567	13,045	907	636	10,660	12,408	1,883	1,586	8,777	10,822
100-199%	16,296	14,097	882	545	15,414	13,552	1,944	1,701	13,470	11,851
200% or More	54,407	47,937	2,191	1,898	52,216	46,039	4,241	3,451	47,975	42,588
HEALTH INSURANCE²
Private	52,152	44,978	2,161	1,729	49,991	43,249	4,988	3,956	45,003	39,294
Medicaid/CHIP	15,284	15,295	1,629	1,061	13,655	14,233	1,909	1,854	11,746	12,380
Other³	26,242	26,624	245	186	25,998	26,438	625	554	25,373	25,884
No Coverage	6,636	6,925	143	285	6,494	6,640	1,189	929	5,305	5,711
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.79B – Any Use of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	30.0	27.2	16.0	12.3	31.4	28.6	24.8	20.5	32.4	29.9
GEOGRAPHIC REGION
Northeast	26.0	24.5	13.9	9.1	27.0	25.9	21.5	19.3	27.9	26.9
Midwest	30.6	26.2	15.1	12.6	32.2	27.5	25.4	18.6	33.3	28.9
South	31.1	28.8	16.7	14.4	32.5	30.3	25.2	22.0	33.6	31.6
West	30.7	27.2	17.0	10.8	32.1	28.9	25.8	20.5	33.1	30.2
COUNTY TYPE
Large Metro	28.4	25.2	15.1	10.8	29.7	26.7	24.2	19.2	30.5	27.8
Small Metro	32.3	29.8	17.1	14.7	33.8	31.3	25.4	21.1	35.2	33.0
Nonmetro	31.6	28.8	16.8	13.4	33.1	30.1	25.9	23.6	34.1	31.0
Urbanized	31.7	30.1	16.6	13.4	33.3	31.5	27.5	25.0	34.3	32.7
Less Urbanized	31.2	27.6	16.6	12.0	32.7	29.0	24.2	24.3	33.8	29.6
Completely Rural	32.5	29.3	18.0	*	34.1	29.7	26.1	10.4	34.9	31.2
POVERTY LEVEL¹
Less Than 100%	30.9	31.1	17.8	13.8	33.0	33.3	23.9	19.5	35.9	37.1
100-199%	30.8	27.9	16.5	12.1	32.4	29.5	25.1	22.1	33.8	31.0
200% or More	29.6	26.0	15.1	12.0	30.9	27.4	25.0	20.0	31.5	28.2
HEALTH INSURANCE²
Private	29.0	25.9	15.2	11.5	30.2	27.2	24.4	20.2	31.0	28.2
Medicaid/CHIP	33.8	31.4	17.3	12.7	38.2	35.3	26.3	23.8	41.2	38.1
Other³	37.4	34.9	20.0	11.2	37.7	35.4	24.6	22.8	38.2	35.8
No Coverage	24.5	24.3	12.3	19.5	25.1	24.6	24.7	17.6	25.2	26.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.80A – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	9,724	9,254	567	396	9,158	8,858	1,754	1,361	7,404	7,498
GEOGRAPHIC REGION
Northeast	1,352	1,631	57	65	1,295	1,566	234	206	1,062	1,360
Midwest	2,072	1,686	126	84	1,945	1,602	408	313	1,537	1,290
South	3,703	3,307	232	126	3,472	3,181	655	501	2,817	2,680
West	2,597	2,630	152	121	2,445	2,509	457	341	1,988	2,167
COUNTY TYPE
Large Metro	5,240	4,684	286	190	4,954	4,494	969	679	3,985	3,815
Small Metro	3,326	3,198	215	148	3,110	3,050	579	419	2,532	2,631
Nonmetro	1,159	1,372	66	58	1,093	1,314	206	262	887	1,051
Urbanized	537	584	28	24	509	560	121	120	388	440
Less Urbanized	495	754	24	33	471	721	64	132	407	589
Completely Rural	127	34	14	1	113	33	22	11	92	22
POVERTY LEVEL¹
Less Than 100%	1,926	2,436	129	141	1,797	2,296	434	344	1,363	1,952
100-199%	2,171	1,775	144	55	2,028	1,721	419	336	1,609	1,385
200% or More	5,597	5,003	294	201	5,303	4,803	871	642	4,432	4,161
HEALTH INSURANCE²
Private	5,055	4,578	288	170	4,767	4,408	973	748	3,794	3,660
Medicaid/CHIP	2,429	2,724	240	173	2,189	2,551	401	352	1,788	2,199
Other³	1,741	1,927	43	20	1,698	1,906	114	106	1,584	1,800
No Coverage	1,605	1,494	10	*	1,595	1,437	333	233	1,262	1,203
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.80B – Misuse of Prescription Pain Relievers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.5	3.3	2.3	1.6	3.7	3.5	5.2	4.1	3.4	3.4
GEOGRAPHIC REGION
Northeast	2.8	3.4	1.4	1.7	3.0	3.6	4.1	3.6	2.8	3.6
Midwest	3.6	2.9	2.4	1.6	3.7	3.1	5.7	4.4	3.4	2.9
South	3.5	3.1	2.4	1.3	3.7	3.3	5.2	3.9	3.4	3.2
West	4.0	4.0	2.5	2.0	4.1	4.2	5.7	4.3	3.9	4.2
COUNTY TYPE
Large Metro	3.4	3.1	2.1	1.3	3.5	3.3	5.2	3.8	3.3	3.2
Small Metro	4.0	3.8	2.8	1.9	4.1	4.0	5.5	3.8	3.9	4.0
Nonmetro	3.0	3.3	1.8	1.8	3.2	3.4	4.8	5.5	2.9	3.2
Urbanized	3.4	3.5	1.8	1.8	3.5	3.7	6.0	5.4	3.1	3.4
Less Urbanized	2.8	3.8	1.5	2.0	2.9	4.0	3.3	6.0	2.9	3.7
Completely Rural	2.9	0.7	3.4	0.6	2.9	0.7	5.8	3.0	2.6	0.5
POVERTY LEVEL¹
Less Than 100%	5.1	5.8	2.5	3.1	5.6	6.2	5.5	4.2	5.6	6.7
100-199%	4.1	3.5	2.7	1.2	4.3	3.7	5.4	4.4	4.0	3.6
200% or More	3.0	2.7	2.0	1.3	3.1	2.9	5.1	3.7	2.9	2.8
HEALTH INSURANCE²
Private	2.8	2.6	2.0	1.1	2.9	2.8	4.8	3.8	2.6	2.6
Medicaid/CHIP	5.4	5.6	2.6	2.1	6.1	6.3	5.5	4.5	6.3	6.8
Other³	2.5	2.5	3.5	1.2	2.5	2.6	4.5	4.4	2.4	2.5
No Coverage	5.9	5.3	0.8	*	6.2	5.3	6.9	4.4	6.0	5.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.81A – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2,819	2,536	165	96	2,654	2,440	420	288	2,234	2,152
GEOGRAPHIC REGION
Northeast	409	386	13	19	395	368	58	54	337	313
Midwest	626	459	44	27	581	432	95	69	486	362
South	1,045	877	63	36	982	841	154	111	828	730
West	739	814	44	14	695	800	112	54	583	746
COUNTY TYPE
Large Metro	1,541	1,253	79	51	1,462	1,203	225	143	1,237	1,060
Small Metro	922	969	65	34	857	935	127	79	730	855
Nonmetro	355	313	21	11	334	303	67	66	267	237
Urbanized	133	118	7	*	125	113	38	*	87	100
Less Urbanized	181	195	8	6	172	190	24	53	148	137
Completely Rural	42	*	5	*	37	*	5	*	31	*
POVERTY LEVEL¹
Less Than 100%	538	794	32	16	505	778	98	105	407	673
100-199%	584	479	41	12	543	467	101	58	442	409
200% or More	1,685	1,244	91	68	1,594	1,176	208	106	1,385	1,070
HEALTH INSURANCE²
Private	1,354	988	95	50	1,259	938	221	135	1,038	803
Medicaid/CHIP	766	911	62	38	705	872	120	117	584	756
Other³	474	562	7	7	467	555	12	16	455	539
No Coverage	565	459	2	2	563	457	80	41	484	416
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.81B – Misuse of Prescription Pain Relievers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.0	0.9	0.7	0.4	1.1	1.0	1.2	0.9	1.0	1.0
GEOGRAPHIC REGION
Northeast	0.9	0.8	0.3	0.5	0.9	0.8	1.0	1.0	0.9	0.8
Midwest	1.1	0.8	0.8	0.5	1.1	0.8	1.3	1.0	1.1	0.8
South	1.0	0.8	0.7	0.4	1.0	0.9	1.2	0.9	1.0	0.9
West	1.1	1.2	0.7	0.2	1.2	1.3	1.4	0.7	1.1	1.4
COUNTY TYPE
Large Metro	1.0	0.8	0.6	0.4	1.0	0.9	1.2	0.8	1.0	0.9
Small Metro	1.1	1.1	0.8	0.4	1.1	1.2	1.2	0.7	1.1	1.3
Nonmetro	0.9	0.8	0.6	0.3	1.0	0.8	1.6	1.4	0.9	0.7
Urbanized	0.8	0.7	0.5	*	0.9	0.7	1.9	*	0.7	0.8
Less Urbanized	1.0	1.0	0.5	0.3	1.1	1.0	1.2	2.4	1.0	0.9
Completely Rural	1.0	*	1.3	*	0.9	*	1.4	*	0.9	*
POVERTY LEVEL¹
Less Than 100%	1.4	1.9	0.6	0.4	1.6	2.1	1.2	1.3	1.7	2.3
100-199%	1.1	0.9	0.8	0.3	1.1	1.0	1.3	0.8	1.1	1.1
200% or More	0.9	0.7	0.6	0.4	0.9	0.7	1.2	0.6	0.9	0.7
HEALTH INSURANCE²
Private	0.8	0.6	0.7	0.3	0.8	0.6	1.1	0.7	0.7	0.6
Medicaid/CHIP	1.7	1.9	0.7	0.5	2.0	2.2	1.7	1.5	2.0	2.3
Other³	0.7	0.7	0.5	0.4	0.7	0.7	0.5	0.7	0.7	0.7
No Coverage	2.1	1.6	0.2	0.1	2.2	1.7	1.6	0.8	2.3	1.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.82A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	18,290	18,332	1,837	1,593	16,453	16,739	4,320	3,773	12,133	12,966
GEOGRAPHIC REGION
Northeast	2,900	3,061	251	215	2,649	2,846	823	687	1,826	2,159
Midwest	4,246	4,077	434	367	3,812	3,710	1,109	1,008	2,704	2,702
South	7,368	7,194	758	740	6,610	6,455	1,554	1,268	5,056	5,187
West	3,776	4,000	394	272	3,382	3,728	835	810	2,547	2,918
COUNTY TYPE
Large Metro	10,377	10,232	1,015	924	9,363	9,308	2,459	1,957	6,904	7,351
Small Metro	5,658	5,811	578	507	5,080	5,304	1,368	1,320	3,713	3,984
Nonmetro	2,254	2,289	244	163	2,010	2,126	494	496	1,516	1,631
Urbanized	1,038	1,075	102	54	936	1,021	270	301	666	721
Less Urbanized	1,020	1,058	111	73	909	986	192	183	717	803
Completely Rural	197	156	32	*	165	119	32	12	133	107
POVERTY LEVEL¹
Less Than 100%	2,546	2,916	302	229	2,244	2,687	941	730	1,303	1,957
100-199%	3,107	3,286	345	180	2,762	3,106	754	893	2,008	2,213
200% or More	12,480	12,074	1,189	1,184	11,291	10,890	2,470	2,095	8,821	8,795
HEALTH INSURANCE²
Private	12,481	11,455	1,098	1,073	11,383	10,382	3,226	2,708	8,157	7,674
Medicaid/CHIP	3,118	3,668	654	468	2,464	3,200	617	566	1,847	2,633
Other³	2,825	3,283	131	158	2,694	3,124	290	204	2,404	2,920
No Coverage	1,600	1,885	53	23	1,547	1,862	350	446	1,197	1,416
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.82B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	6.6	6.6	7.4	6.4	6.6	6.6	12.8	11.3	5.6	5.9
GEOGRAPHIC REGION
Northeast	6.1	6.4	6.3	5.5	6.0	6.5	14.3	12.1	4.8	5.7
Midwest	7.4	7.1	8.2	7.0	7.3	7.1	15.5	14.2	6.0	6.0
South	7.0	6.8	7.8	7.6	7.0	6.7	12.2	10.0	6.2	6.2
West	5.8	6.1	6.6	4.5	5.7	6.2	10.3	10.1	4.9	5.6
COUNTY TYPE
Large Metro	6.7	6.8	7.5	6.6	6.7	6.8	13.1	11.0	5.7	6.2
Small Metro	6.8	6.9	7.5	6.6	6.7	6.9	12.9	12.0	5.7	6.0
Nonmetro	5.9	5.5	6.8	5.1	5.8	5.6	11.4	10.4	5.0	4.9
Urbanized	6.5	6.5	6.7	4.1	6.5	6.7	13.3	13.6	5.4	5.6
Less Urbanized	5.7	5.4	6.7	4.5	5.6	5.4	9.9	8.3	5.0	5.1
Completely Rural	4.5	3.1	7.7	*	4.2	2.5	8.6	3.3	3.7	2.4
POVERTY LEVEL¹
Less Than 100%	6.8	7.0	5.9	5.0	6.9	7.2	11.9	9.0	5.3	6.7
100-199%	5.9	6.5	6.5	4.0	5.8	6.8	9.7	11.6	5.0	5.8
200% or More	6.8	6.6	8.2	7.5	6.7	6.5	14.6	12.1	5.8	5.8
HEALTH INSURANCE²
Private	6.9	6.6	7.7	7.2	6.9	6.5	15.8	13.8	5.6	5.5
Medicaid/CHIP	6.9	7.5	6.9	5.6	6.9	7.9	8.5	7.3	6.5	8.1
Other³	4.0	4.3	10.7	9.6	3.9	4.2	11.4	8.4	3.6	4.0
No Coverage	5.9	6.6	4.6	1.6	6.0	6.9	7.3	8.5	5.7	6.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.83A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	4,929	5,092	430	288	4,499	4,804	1,951	1,616	2,548	3,188
GEOGRAPHIC REGION
Northeast	881	1,032	51	41	830	991	402	251	428	740
Midwest	1,254	1,133	93	72	1,161	1,061	547	436	614	625
South	1,712	1,855	186	87	1,525	1,768	629	536	896	1,232
West	1,082	1,073	99	89	982	984	373	392	609	592
COUNTY TYPE
Large Metro	2,915	3,053	256	163	2,659	2,890	1,197	909	1,462	1,981
Small Metro	1,510	1,654	126	99	1,384	1,555	567	590	817	965
Nonmetro	504	385	48	27	456	358	187	116	270	242
Urbanized	232	162	29	13	203	148	97	33	106	115
Less Urbanized	238	216	15	13	223	204	72	78	151	125
Completely Rural	34	7	4	0	30	7	17	5	13	2
POVERTY LEVEL¹
Less Than 100%	844	862	60	34	784	828	483	333	301	495
100-199%	783	832	81	32	702	799	328	353	374	447
200% or More	3,231	3,355	289	222	2,942	3,133	1,069	886	1,873	2,247
HEALTH INSURANCE²
Private	3,360	3,417	284	193	3,075	3,224	1,498	1,215	1,578	2,009
Medicaid/CHIP	853	914	135	101	718	813	235	157	483	656
Other³	348	254	26	6	322	248	105	69	218	179
No Coverage	605	814	10	9	595	805	158	233	437	572
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.83B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.8	1.8	1.7	1.2	1.8	1.9	5.8	4.8	1.2	1.5
GEOGRAPHIC REGION
Northeast	1.8	2.2	1.3	1.0	1.9	2.3	7.0	4.4	1.1	1.9
Midwest	2.2	2.0	1.8	1.4	2.2	2.0	7.6	6.1	1.4	1.4
South	1.6	1.8	1.9	0.9	1.6	1.8	4.9	4.2	1.1	1.5
West	1.6	1.6	1.7	1.5	1.6	1.6	4.6	4.9	1.2	1.1
COUNTY TYPE
Large Metro	1.9	2.0	1.9	1.2	1.9	2.1	6.4	5.1	1.2	1.7
Small Metro	1.8	2.0	1.6	1.3	1.8	2.0	5.3	5.4	1.3	1.5
Nonmetro	1.3	0.9	1.3	0.8	1.3	0.9	4.3	2.4	0.9	0.7
Urbanized	1.5	1.0	1.9	1.0	1.4	1.0	4.8	1.5	0.9	0.9
Less Urbanized	1.3	1.1	0.9	0.8	1.4	1.1	3.7	3.5	1.1	0.8
Completely Rural	0.8	0.1	0.9	0.2	0.8	0.1	4.6	1.3	0.4	0.0
POVERTY LEVEL¹
Less Than 100%	2.3	2.1	1.2	0.7	2.4	2.2	6.1	4.1	1.2	1.7
100-199%	1.5	1.6	1.5	0.7	1.5	1.7	4.2	4.6	0.9	1.2
200% or More	1.8	1.8	2.0	1.4	1.7	1.9	6.3	5.1	1.2	1.5
HEALTH INSURANCE²
Private	1.9	2.0	2.0	1.3	1.9	2.0	7.3	6.2	1.1	1.4
Medicaid/CHIP	1.9	1.9	1.4	1.2	2.0	2.0	3.2	2.0	1.7	2.0
Other³	0.5	0.3	2.1	0.4	0.5	0.3	4.1	2.8	0.3	0.2
No Coverage	2.2	2.9	0.9	0.6	2.3	3.0	3.3	4.4	2.1	2.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.84A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,566	1,493	123	72	1,443	1,421	587	267	856	1,154
GEOGRAPHIC REGION
Northeast	261	392	13	18	248	374	118	40	130	334
Midwest	348	370	27	12	321	358	153	87	167	270
South	556	520	55	34	502	486	219	73	283	413
West	401	211	28	8	373	203	96	67	277	136
COUNTY TYPE
Large Metro	1,006	945	80	35	926	910	384	174	542	736
Small Metro	413	431	30	35	384	397	152	59	231	338
Nonmetro	147	117	14	2	133	114	50	34	83	81
Urbanized	73	43	11	1	62	42	29	2	33	40
Less Urbanized	64	72	2	2	62	70	19	29	44	41
Completely Rural	10	2	1	*	9	2	*	*	6	*
POVERTY LEVEL¹
Less Than 100%	300	218	12	4	288	214	169	45	120	170
100-199%	171	175	13	*	159	175	79	63	80	112
200% or More	1,067	1,098	99	69	969	1,030	312	157	657	873
HEALTH INSURANCE²
Private	1,082	960	91	58	991	903	446	186	545	717
Medicaid/CHIP	209	324	29	10	180	313	63	43	116	270
Other³	104	45	9	2	96	43	43	20	52	23
No Coverage	230	241	0	2	230	239	48	38	182	201
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.84B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.6	0.5	0.5	0.3	0.6	0.6	1.7	0.8	0.4	0.5
GEOGRAPHIC REGION
Northeast	0.5	0.8	0.3	0.4	0.6	0.9	2.0	0.7	0.3	0.9
Midwest	0.6	0.6	0.5	0.2	0.6	0.7	2.1	1.2	0.4	0.6
South	0.5	0.5	0.6	0.3	0.5	0.5	1.7	0.6	0.3	0.5
West	0.6	0.3	0.5	0.1	0.6	0.3	1.2	0.8	0.5	0.3
COUNTY TYPE
Large Metro	0.7	0.6	0.6	0.3	0.7	0.7	2.0	1.0	0.4	0.6
Small Metro	0.5	0.5	0.4	0.4	0.5	0.5	1.4	0.5	0.4	0.5
Nonmetro	0.4	0.3	0.4	0.1	0.4	0.3	1.2	0.7	0.3	0.2
Urbanized	0.5	0.3	0.7	0.0	0.4	0.3	1.4	0.1	0.3	0.3
Less Urbanized	0.4	0.4	0.1	0.1	0.4	0.4	1.0	1.3	0.3	0.3
Completely Rural	0.2	0.0	0.2	*	0.2	0.0	*	*	0.2	*
POVERTY LEVEL¹
Less Than 100%	0.8	0.5	0.2	0.1	0.9	0.6	2.1	0.5	0.5	0.6
100-199%	0.3	0.3	0.2	*	0.3	0.4	1.0	0.8	0.2	0.3
200% or More	0.6	0.6	0.7	0.4	0.6	0.6	1.8	0.9	0.4	0.6
HEALTH INSURANCE²
Private	0.6	0.6	0.6	0.4	0.6	0.6	2.2	0.9	0.4	0.5
Medicaid/CHIP	0.5	0.7	0.3	0.1	0.5	0.8	0.9	0.6	0.4	0.8
Other³	0.1	0.1	0.7	0.1	0.1	0.1	1.7	0.8	0.1	0.0
No Coverage	0.9	0.8	0.0	0.1	0.9	0.9	1.0	0.7	0.9	0.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.85A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	44,051	43,001	1,370	936	42,682	42,065	3,995	3,805	38,687	38,261
GEOGRAPHIC REGION
Northeast	7,664	7,711	195	149	7,469	7,562	662	586	6,807	6,976
Midwest	9,214	9,045	278	190	8,936	8,855	956	854	7,980	8,001
South	17,162	16,867	571	354	16,591	16,513	1,417	1,512	15,174	15,002
West	10,012	9,378	326	243	9,685	9,135	961	852	8,724	8,282
COUNTY TYPE
Large Metro	24,203	22,653	751	422	23,452	22,231	2,280	1,827	21,172	20,404
Small Metro	13,588	14,053	419	375	13,169	13,678	1,203	1,341	11,966	12,337
Nonmetro	6,260	6,295	200	139	6,060	6,156	512	637	5,548	5,520
Urbanized	2,479	2,686	83	39	2,396	2,646	280	343	2,116	2,303
Less Urbanized	3,065	3,015	85	96	2,980	2,920	189	282	2,790	2,638
Completely Rural	716	594	31	*	685	590	43	12	642	578
POVERTY LEVEL¹
Less Than 100%	5,402	5,993	353	223	5,049	5,770	867	884	4,182	4,886
100-199%	8,061	7,691	281	142	7,781	7,549	856	919	6,925	6,629
200% or More	30,482	29,285	736	571	29,746	28,714	2,166	1,968	27,579	26,746
HEALTH INSURANCE²
Private	28,892	26,611	704	537	28,188	26,075	2,541	2,414	25,647	23,661
Medicaid/CHIP	7,742	8,551	574	378	7,169	8,173	847	852	6,322	7,321
Other³	14,865	14,964	90	39	14,775	14,925	304	177	14,471	14,748
No Coverage	2,846	3,206	65	35	2,781	3,171	464	513	2,317	2,658
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.85B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	16.0	15.5	5.5	3.7	17.1	16.7	11.8	11.4	17.9	17.5
GEOGRAPHIC REGION
Northeast	16.0	16.2	4.9	3.8	17.1	17.3	11.5	10.4	17.9	18.3
Midwest	16.1	15.8	5.3	3.6	17.2	17.0	13.3	12.0	17.8	17.8
South	16.4	16.0	5.9	3.6	17.5	17.2	11.1	11.9	18.5	18.0
West	15.3	14.2	5.4	4.0	16.3	15.2	11.9	10.6	16.9	15.9
COUNTY TYPE
Large Metro	15.7	15.0	5.5	3.0	16.7	16.2	12.1	10.3	17.4	17.1
Small Metro	16.3	16.6	5.4	4.9	17.4	17.8	11.3	12.2	18.4	18.7
Nonmetro	16.4	15.2	5.5	4.3	17.6	16.2	11.8	13.3	18.4	16.6
Urbanized	15.6	16.3	5.4	3.0	16.7	17.4	13.8	15.6	17.2	17.7
Less Urbanized	17.2	15.3	5.2	5.9	18.4	16.1	9.8	12.7	19.6	16.6
Completely Rural	16.5	11.7	7.6	*	17.4	12.3	11.4	3.3	18.0	13.0
POVERTY LEVEL¹
Less Than 100%	14.4	14.3	6.9	4.8	15.6	15.5	11.0	10.9	17.1	16.7
100-199%	15.2	15.2	5.3	3.2	16.3	16.4	11.1	11.9	17.4	17.3
200% or More	16.6	15.9	5.1	3.6	17.6	17.1	12.8	11.4	18.1	17.7
HEALTH INSURANCE²
Private	16.1	15.3	4.9	3.6	17.0	16.4	12.4	12.3	17.7	17.0
Medicaid/CHIP	17.1	17.6	6.1	4.5	20.0	20.3	11.7	10.9	22.2	22.5
Other³	21.2	19.6	7.3	2.4	21.4	20.0	12.0	7.3	21.8	20.4
No Coverage	10.5	11.3	5.6	2.4	10.7	11.7	9.6	9.7	11.0	12.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.86A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5,895	6,205	436	226	5,459	5,979	1,409	1,237	4,050	4,742
GEOGRAPHIC REGION
Northeast	1,057	824	31	41	1,025	784	227	133	798	650
Midwest	1,116	1,334	103	36	1,014	1,298	307	311	707	987
South	2,213	2,472	154	73	2,059	2,399	536	483	1,523	1,917
West	1,509	1,574	148	76	1,361	1,498	339	310	1,022	1,188
COUNTY TYPE
Large Metro	3,551	2,981	224	98	3,328	2,883	797	665	2,531	2,218
Small Metro	1,754	2,365	166	112	1,588	2,253	423	408	1,165	1,845
Nonmetro	589	859	46	16	543	843	189	164	354	680
Urbanized	285	288	24	3	261	285	129	85	132	201
Less Urbanized	259	551	20	12	240	539	49	77	190	461
Completely Rural	45	20	3	0	42	19	10	1	32	18
POVERTY LEVEL¹
Less Than 100%	1,038	1,206	95	69	943	1,138	327	314	616	824
100-199%	1,066	1,070	103	14	963	1,056	278	322	685	734
200% or More	3,752	3,919	238	143	3,514	3,776	765	592	2,749	3,184
HEALTH INSURANCE²
Private	3,370	3,551	214	111	3,156	3,440	914	720	2,242	2,720
Medicaid/CHIP	1,447	1,425	195	107	1,252	1,317	256	293	996	1,024
Other³	793	1,122	25	2	768	1,120	73	60	695	1,060
No Coverage	792	938	17	15	775	923	216	218	560	705
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.86B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	2.1	2.2	1.8	0.9	2.2	2.4	4.2	3.7	1.9	2.2
GEOGRAPHIC REGION
Northeast	2.2	1.7	0.8	1.0	2.3	1.8	3.9	2.4	2.1	1.7
Midwest	1.9	2.3	1.9	0.7	1.9	2.5	4.3	4.4	1.6	2.2
South	2.1	2.3	1.6	0.7	2.2	2.5	4.2	3.8	1.9	2.3
West	2.3	2.4	2.5	1.3	2.3	2.5	4.2	3.9	2.0	2.3
COUNTY TYPE
Large Metro	2.3	2.0	1.6	0.7	2.4	2.1	4.2	3.8	2.1	1.9
Small Metro	2.1	2.8	2.1	1.5	2.1	2.9	4.0	3.7	1.8	2.8
Nonmetro	1.5	2.1	1.3	0.5	1.6	2.2	4.4	3.4	1.2	2.0
Urbanized	1.8	1.7	1.5	0.2	1.8	1.9	6.4	3.9	1.1	1.5
Less Urbanized	1.5	2.8	1.2	0.8	1.5	3.0	2.6	3.5	1.3	2.9
Completely Rural	1.0	0.4	0.7	0.2	1.1	0.4	2.8	0.4	0.9	0.4
POVERTY LEVEL¹
Less Than 100%	2.8	2.9	1.9	1.5	2.9	3.0	4.1	3.9	2.5	2.8
100-199%	2.0	2.1	1.9	0.3	2.0	2.3	3.6	4.2	1.7	1.9
200% or More	2.0	2.1	1.6	0.9	2.1	2.2	4.5	3.4	1.8	2.1
HEALTH INSURANCE²
Private	1.9	2.0	1.5	0.7	1.9	2.2	4.5	3.7	1.5	2.0
Medicaid/CHIP	3.2	2.9	2.1	1.3	3.5	3.3	3.5	3.8	3.5	3.1
Other³	1.1	1.5	2.0	0.1	1.1	1.5	2.9	2.5	1.0	1.5
No Coverage	2.9	3.3	1.4	1.0	3.0	3.4	4.5	4.1	2.7	3.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.87A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,958	2,196	121	26	1,837	2,170	365	371	1,472	1,799
GEOGRAPHIC REGION
Northeast	329	306	8	9	321	297	67	36	254	261
Midwest	382	382	29	1	353	380	85	69	268	311
South	667	936	41	2	626	935	113	151	513	783
West	581	572	44	14	537	558	100	114	437	444
COUNTY TYPE
Large Metro	1,171	947	59	21	1,112	926	216	181	896	746
Small Metro	576	1,003	56	5	519	998	104	132	416	866
Nonmetro	211	246	5	0	206	246	45	58	161	187
Urbanized	88	72	5	0	83	72	31	33	52	39
Less Urbanized	104	174	1	*	103	174	14	25	89	148
Completely Rural	20	*	*	*	20	*	*	*	20	*
POVERTY LEVEL¹
Less Than 100%	360	572	13	2	348	570	67	96	281	474
100-199%	289	335	31	1	259	334	66	125	193	209
200% or More	1,300	1,289	78	23	1,222	1,266	223	150	999	1,116
HEALTH INSURANCE²
Private	1,017	1,132	75	19	942	1,113	242	189	700	924
Medicaid/CHIP	498	508	47	8	451	500	68	102	383	398
Other³	295	453	4	*	291	453	14	9	277	444
No Coverage	292	404	1	*	292	404	58	83	233	321
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.87B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.7	0.8	0.5	0.1	0.7	0.9	1.1	1.1	0.7	0.8
GEOGRAPHIC REGION
Northeast	0.7	0.6	0.2	0.2	0.7	0.7	1.2	0.6	0.7	0.7
Midwest	0.7	0.7	0.5	0.0	0.7	0.7	1.2	1.0	0.6	0.7
South	0.6	0.9	0.4	0.0	0.7	1.0	0.9	1.2	0.6	0.9
West	0.9	0.9	0.7	0.2	0.9	0.9	1.2	1.4	0.8	0.9
COUNTY TYPE
Large Metro	0.8	0.6	0.4	0.1	0.8	0.7	1.1	1.0	0.7	0.6
Small Metro	0.7	1.2	0.7	0.1	0.7	1.3	1.0	1.2	0.6	1.3
Nonmetro	0.6	0.6	0.2	0.0	0.6	0.6	1.0	1.2	0.5	0.6
Urbanized	0.6	0.4	0.3	0.0	0.6	0.5	1.5	1.5	0.4	0.3
Less Urbanized	0.6	0.9	0.1	*	0.6	1.0	0.7	1.1	0.6	0.9
Completely Rural	0.5	*	*	*	0.5	*	*	*	0.6	*
POVERTY LEVEL¹
Less Than 100%	1.0	1.4	0.2	0.0	1.1	1.5	0.8	1.2	1.1	1.6
100-199%	0.5	0.7	0.6	0.0	0.5	0.7	0.9	1.6	0.5	0.5
200% or More	0.7	0.7	0.5	0.1	0.7	0.8	1.3	0.9	0.7	0.7
HEALTH INSURANCE²
Private	0.6	0.7	0.5	0.1	0.6	0.7	1.2	1.0	0.5	0.7
Medicaid/CHIP	1.1	1.0	0.5	0.1	1.3	1.2	0.9	1.3	1.3	1.2
Other³	0.4	0.6	0.3	*	0.4	0.6	0.5	0.4	0.4	0.6
No Coverage	1.1	1.4	0.1	*	1.1	1.5	1.2	1.6	1.1	1.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.88A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	35,601	35,018	1,010	588	34,591	34,430	3,419	3,338	31,172	31,092
GEOGRAPHIC REGION
Northeast	6,387	6,519	125	87	6,262	6,432	578	546	5,685	5,886
Midwest	7,460	7,376	221	131	7,239	7,245	819	735	6,421	6,510
South	13,851	13,784	422	197	13,429	13,586	1,219	1,282	12,209	12,304
West	7,903	7,339	243	172	7,660	7,167	803	775	6,857	6,392
COUNTY TYPE
Large Metro	19,449	18,548	557	267	18,892	18,280	1,931	1,605	16,961	16,675
Small Metro	11,120	11,471	324	239	10,796	11,232	1,035	1,198	9,762	10,033
Nonmetro	5,032	4,999	129	81	4,903	4,918	453	535	4,450	4,384
Urbanized	2,047	1,945	63	25	1,984	1,920	265	279	1,719	1,640
Less Urbanized	2,415	2,492	52	52	2,363	2,440	153	244	2,210	2,196
Completely Rural	570	563	14	*	556	559	36	11	520	547
POVERTY LEVEL¹
Less Than 100%	4,575	5,135	251	165	4,324	4,970	755	823	3,568	4,147
100-199%	6,614	6,595	204	86	6,410	6,510	739	831	5,671	5,679
200% or More	24,338	23,267	555	337	23,783	22,931	1,850	1,664	21,933	21,266
HEALTH INSURANCE²
Private	23,204	21,294	518	318	22,686	20,975	2,196	2,094	20,490	18,882
Medicaid/CHIP	6,494	7,176	415	263	6,079	6,914	740	751	5,339	6,162
Other³	11,372	11,727	66	31	11,306	11,696	235	164	11,072	11,532
No Coverage	2,441	2,827	49	19	2,392	2,808	394	461	1,997	2,347
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.88B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	12.9	12.6	4.1	2.4	13.8	13.7	10.1	10.0	14.4	14.2
GEOGRAPHIC REGION
Northeast	13.4	13.7	3.2	2.2	14.3	14.7	10.0	9.6	14.9	15.4
Midwest	13.0	12.8	4.2	2.5	13.9	13.9	11.4	10.4	14.3	14.5
South	13.2	13.0	4.4	2.0	14.1	14.2	9.6	10.1	14.9	14.8
West	12.1	11.1	4.0	2.9	12.9	11.9	9.9	9.7	13.3	12.3
COUNTY TYPE
Large Metro	12.6	12.3	4.1	1.9	13.5	13.4	10.3	9.1	14.0	14.0
Small Metro	13.3	13.5	4.2	3.1	14.3	14.6	9.8	10.9	15.0	15.2
Nonmetro	13.2	12.1	3.6	2.5	14.2	12.9	10.5	11.2	14.8	13.2
Urbanized	12.9	11.8	4.1	1.9	13.8	12.6	13.1	12.7	13.9	12.6
Less Urbanized	13.5	12.6	3.1	3.2	14.6	13.5	7.9	11.0	15.5	13.8
Completely Rural	13.1	11.1	3.5	*	14.1	11.6	9.5	3.2	14.6	12.3
POVERTY LEVEL¹
Less Than 100%	12.2	12.3	4.9	3.6	13.4	13.3	9.6	10.1	14.6	14.2
100-199%	12.5	13.1	3.8	1.9	13.5	14.2	9.6	10.8	14.2	14.9
200% or More	13.2	12.6	3.8	2.1	14.1	13.6	10.9	9.6	14.4	14.1
HEALTH INSURANCE²
Private	12.9	12.2	3.6	2.1	13.7	13.2	10.8	10.7	14.1	13.6
Medicaid/CHIP	14.4	14.7	4.4	3.1	17.0	17.1	10.2	9.6	18.7	18.9
Other³	16.2	15.4	5.4	1.9	16.4	15.7	9.2	6.8	16.7	16.0
No Coverage	9.0	9.9	4.2	1.3	9.2	10.4	8.2	8.8	9.5	10.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.89A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5,220	5,460	392	196	4,829	5,264	1,313	1,108	3,516	4,156
GEOGRAPHIC REGION
Northeast	978	734	21	33	957	701	227	130	730	571
Midwest	971	1,182	93	30	878	1,152	291	303	588	849
South	2,005	2,097	138	57	1,867	2,040	494	402	1,373	1,638
West	1,267	1,446	140	75	1,127	1,371	301	274	826	1,097
COUNTY TYPE
Large Metro	3,109	2,635	198	77	2,911	2,557	736	594	2,175	1,963
Small Metro	1,567	2,059	152	106	1,415	1,953	392	374	1,023	1,579
Nonmetro	545	766	41	12	503	754	185	140	318	613
Urbanized	266	250	23	3	243	247	127	67	116	180
Less Urbanized	237	496	16	9	221	487	48	72	173	415
Completely Rural	42	20	3	0	39	19	10	1	28	18
POVERTY LEVEL¹
Less Than 100%	930	1,089	79	64	851	1,025	319	292	532	732
100-199%	949	959	91	13	858	946	261	277	597	669
200% or More	3,313	3,403	222	119	3,091	3,285	705	530	2,387	2,755
HEALTH INSURANCE²
Private	2,916	3,016	200	93	2,716	2,923	843	648	1,873	2,275
Medicaid/CHIP	1,317	1,281	170	101	1,146	1,179	238	248	909	931
Other³	672	949	22	2	650	947	59	57	592	890
No Coverage	748	866	12	9	736	857	213	209	523	648
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.89B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.9	2.0	1.6	0.8	1.9	2.1	3.9	3.3	1.6	1.9
GEOGRAPHIC REGION
Northeast	2.0	1.5	0.5	0.8	2.2	1.6	3.9	2.3	1.9	1.5
Midwest	1.7	2.1	1.8	0.6	1.7	2.2	4.1	4.3	1.3	1.9
South	1.9	2.0	1.4	0.6	2.0	2.1	3.9	3.2	1.7	2.0
West	1.9	2.2	2.3	1.2	1.9	2.3	3.7	3.4	1.6	2.1
COUNTY TYPE
Large Metro	2.0	1.7	1.5	0.5	2.1	1.9	3.9	3.4	1.8	1.6
Small Metro	1.9	2.4	2.0	1.4	1.9	2.5	3.7	3.4	1.6	2.4
Nonmetro	1.4	1.9	1.1	0.4	1.5	2.0	4.3	2.9	1.1	1.8
Urbanized	1.7	1.5	1.5	0.2	1.7	1.6	6.3	3.0	0.9	1.4
Less Urbanized	1.3	2.5	0.9	0.6	1.4	2.7	2.5	3.2	1.2	2.6
Completely Rural	1.0	0.4	0.7	0.2	1.0	0.4	2.7	0.4	0.8	0.4
POVERTY LEVEL¹
Less Than 100%	2.5	2.6	1.6	1.4	2.6	2.7	4.0	3.6	2.2	2.5
100-199%	1.8	1.9	1.7	0.3	1.8	2.1	3.4	3.6	1.5	1.7
200% or More	1.8	1.8	1.5	0.7	1.8	2.0	4.2	3.1	1.6	1.8
HEALTH INSURANCE²
Private	1.6	1.7	1.4	0.6	1.6	1.8	4.1	3.3	1.3	1.6
Medicaid/CHIP	2.9	2.6	1.8	1.2	3.2	2.9	3.3	3.2	3.2	2.9
Other³	1.0	1.2	1.8	0.1	0.9	1.3	2.3	2.3	0.9	1.2
No Coverage	2.8	3.0	1.0	0.6	2.8	3.2	4.4	4.0	2.5	3.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.90A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,781	1,891	112	25	1,669	1,866	337	357	1,332	1,509
GEOGRAPHIC REGION
Northeast	315	261	6	9	308	252	67	33	241	219
Midwest	357	339	27	*	329	339	85	66	245	273
South	608	755	36	2	571	753	97	145	474	608
West	502	537	43	14	460	522	88	113	372	409
COUNTY TYPE
Large Metro	1,056	827	54	21	1,002	806	195	176	807	630
Small Metro	521	837	53	4	468	833	98	127	370	706
Nonmetro	204	227	5	0	199	227	44	53	154	174
Urbanized	85	67	5	0	81	67	30	28	50	39
Less Urbanized	99	160	1	*	98	160	14	25	84	135
Completely Rural	20	*	*	*	20	*	*	*	20	*
POVERTY LEVEL¹
Less Than 100%	325	517	13	2	312	515	66	94	246	421
100-199%	249	309	27	1	221	308	60	116	162	191
200% or More	1,200	1,065	72	21	1,128	1,044	203	147	924	897
HEALTH INSURANCE²
Private	920	932	71	17	849	915	227	182	622	732
Medicaid/CHIP	444	467	42	8	402	459	59	100	343	359
Other³	238	338	4	*	233	338	11	9	222	329
No Coverage	289	342	1	*	288	342	58	78	230	264
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.90B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.6	0.7	0.5	0.1	0.7	0.7	1.0	1.1	0.6	0.7
GEOGRAPHIC REGION
Northeast	0.7	0.5	0.2	0.2	0.7	0.6	1.2	0.6	0.6	0.6
Midwest	0.6	0.6	0.5	*	0.6	0.6	1.2	0.9	0.5	0.6
South	0.6	0.7	0.4	0.0	0.6	0.8	0.8	1.1	0.6	0.7
West	0.8	0.8	0.7	0.2	0.8	0.9	1.1	1.4	0.7	0.8
COUNTY TYPE
Large Metro	0.7	0.5	0.4	0.1	0.7	0.6	1.0	1.0	0.7	0.5
Small Metro	0.6	1.0	0.7	0.1	0.6	1.1	0.9	1.2	0.6	1.1
Nonmetro	0.5	0.5	0.2	0.0	0.6	0.6	1.0	1.1	0.5	0.5
Urbanized	0.5	0.4	0.3	0.0	0.6	0.4	1.5	1.3	0.4	0.3
Less Urbanized	0.6	0.8	0.1	*	0.6	0.9	0.7	1.1	0.6	0.8
Completely Rural	0.5	*	*	*	0.5	*	*	*	0.6	*
POVERTY LEVEL¹
Less Than 100%	0.9	1.2	0.2	0.0	1.0	1.4	0.8	1.2	1.0	1.4
100-199%	0.5	0.6	0.5	0.0	0.5	0.7	0.8	1.5	0.4	0.5
200% or More	0.7	0.6	0.5	0.1	0.7	0.6	1.2	0.8	0.6	0.6
HEALTH INSURANCE²
Private	0.5	0.5	0.5	0.1	0.5	0.6	1.1	0.9	0.4	0.5
Medicaid/CHIP	1.0	1.0	0.4	0.1	1.1	1.1	0.8	1.3	1.2	1.1
Other³	0.3	0.4	0.3	*	0.3	0.5	0.4	0.4	0.3	0.5
No Coverage	1.1	1.2	0.1	*	1.1	1.3	1.2	1.5	1.1	1.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.91A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	15,636	15,364	545	429	15,091	14,935	1,051	1,066	14,040	13,869
GEOGRAPHIC REGION
Northeast	2,434	2,586	83	75	2,351	2,511	157	122	2,194	2,389
Midwest	3,226	3,304	109	87	3,117	3,217	247	233	2,870	2,983
South	6,254	5,810	233	185	6,021	5,625	366	489	5,655	5,136
West	3,720	3,664	119	82	3,602	3,582	281	222	3,320	3,360
COUNTY TYPE
Large Metro	8,651	7,670	284	182	8,368	7,488	616	477	7,751	7,011
Small Metro	4,691	5,085	165	175	4,526	4,909	303	428	4,222	4,481
Nonmetro	2,294	2,610	96	72	2,198	2,538	131	161	2,067	2,378
Urbanized	930	1,055	30	25	900	1,030	60	93	840	937
Less Urbanized	1,109	1,294	49	47	1,060	1,247	55	65	1,005	1,182
Completely Rural	255	261	17	*	238	261	16	3	222	258
POVERTY LEVEL¹
Less Than 100%	1,860	2,315	155	90	1,705	2,225	242	247	1,463	1,978
100-199%	2,715	2,554	105	63	2,610	2,492	216	253	2,394	2,239
200% or More	11,022	10,474	284	276	10,738	10,198	554	545	10,183	9,653
HEALTH INSURANCE²
Private	10,202	9,457	297	270	9,904	9,187	658	702	9,247	8,484
Medicaid/CHIP	2,720	3,212	225	150	2,495	3,061	244	239	2,251	2,822
Other³	6,373	6,104	39	8	6,334	6,097	93	58	6,241	6,039
No Coverage	719	895	19	18	700	877	117	114	583	763
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.91B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	5.7	5.5	2.2	1.7	6.0	5.9	3.1	3.2	6.5	6.3
GEOGRAPHIC REGION
Northeast	5.1	5.4	2.1	1.9	5.4	5.7	2.7	2.2	5.8	6.3
Midwest	5.6	5.8	2.1	1.7	6.0	6.2	3.4	3.3	6.4	6.6
South	6.0	5.5	2.4	1.9	6.3	5.9	2.9	3.8	6.9	6.2
West	5.7	5.5	2.0	1.4	6.0	6.0	3.5	2.8	6.4	6.5
COUNTY TYPE
Large Metro	5.6	5.1	2.1	1.3	6.0	5.5	3.3	2.7	6.4	5.9
Small Metro	5.6	6.0	2.1	2.3	6.0	6.4	2.9	3.9	6.5	6.8
Nonmetro	6.0	6.3	2.7	2.2	6.4	6.7	3.0	3.4	6.9	7.1
Urbanized	5.9	6.4	1.9	1.9	6.3	6.8	3.0	4.2	6.8	7.2
Less Urbanized	6.2	6.6	3.0	2.9	6.6	6.9	2.8	2.9	7.1	7.4
Completely Rural	5.9	5.1	4.3	*	6.0	5.4	4.2	0.9	6.2	5.8
POVERTY LEVEL¹
Less Than 100%	5.0	5.5	3.1	2.0	5.3	6.0	3.1	3.0	6.0	6.8
100-199%	5.1	5.1	2.0	1.4	5.5	5.4	2.8	3.3	6.0	5.9
200% or More	6.0	5.7	2.0	1.7	6.3	6.1	3.3	3.2	6.7	6.4
HEALTH INSURANCE²
Private	5.7	5.4	2.1	1.8	6.0	5.8	3.2	3.6	6.4	6.1
Medicaid/CHIP	6.0	6.6	2.4	1.8	7.0	7.6	3.4	3.1	7.9	8.7
Other³	9.1	8.0	3.1	0.5	9.2	8.2	3.7	2.4	9.4	8.4
No Coverage	2.7	3.1	1.7	1.2	2.7	3.2	2.4	2.2	2.8	3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.92A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1,098	1,240	82	35	1,016	1,205	175	251	841	954
GEOGRAPHIC REGION
Northeast	202	180	11	12	191	168	15	7	176	160
Midwest	191	281	25	6	167	275	32	26	135	249
South	374	541	33	16	341	526	75	140	266	385
West	330	238	13	1	317	237	53	77	264	160
COUNTY TYPE
Large Metro	673	586	43	21	630	565	104	104	526	461
Small Metro	338	509	32	11	307	498	53	111	254	387
Nonmetro	87	145	8	3	79	142	18	35	62	107
Urbanized	44	64	4	*	40	64	12	23	28	41
Less Urbanized	36	81	4	3	32	78	5	12	27	66
Completely Rural	7	*	*	*	7	*	0	*	7	*
POVERTY LEVEL¹
Less Than 100%	201	229	20	5	182	224	28	56	154	168
100-199%	193	228	18	1	174	227	42	94	132	133
200% or More	692	781	44	29	648	752	93	99	555	653
HEALTH INSURANCE²
Private	630	756	45	23	586	733	123	142	463	591
Medicaid/CHIP	235	268	32	6	203	262	33	64	170	198
Other³	224	297	3	*	220	296	22	8	198	288
No Coverage	108	155	5	6	103	149	17	44	86	105
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.92B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.4	0.4	0.3	0.1	0.4	0.5	0.5	0.7	0.4	0.4
GEOGRAPHIC REGION
Northeast	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	0.5	0.4
Midwest	0.3	0.5	0.5	0.1	0.3	0.5	0.4	0.4	0.3	0.6
South	0.4	0.5	0.3	0.2	0.4	0.5	0.6	1.1	0.3	0.5
West	0.5	0.4	0.2	0.0	0.5	0.4	0.7	1.0	0.5	0.3
COUNTY TYPE
Large Metro	0.4	0.4	0.3	0.1	0.4	0.4	0.6	0.6	0.4	0.4
Small Metro	0.4	0.6	0.4	0.1	0.4	0.6	0.5	1.0	0.4	0.6
Nonmetro	0.2	0.4	0.2	0.1	0.2	0.4	0.4	0.7	0.2	0.3
Urbanized	0.3	0.4	0.3	*	0.3	0.4	0.6	1.1	0.2	0.3
Less Urbanized	0.2	0.4	0.2	0.2	0.2	0.4	0.3	0.5	0.2	0.4
Completely Rural	0.2	*	*	*	0.2	*	0.0	*	0.2	*
POVERTY LEVEL¹
Less Than 100%	0.5	0.5	0.4	0.1	0.6	0.6	0.4	0.7	0.6	0.6
100-199%	0.4	0.5	0.3	0.0	0.4	0.5	0.5	1.2	0.3	0.3
200% or More	0.4	0.4	0.3	0.2	0.4	0.4	0.6	0.6	0.4	0.4
HEALTH INSURANCE²
Private	0.4	0.4	0.3	0.2	0.4	0.5	0.6	0.7	0.3	0.4
Medicaid/CHIP	0.5	0.6	0.3	0.1	0.6	0.7	0.5	0.8	0.6	0.6
Other³	0.3	0.4	0.3	*	0.3	0.4	0.9	0.3	0.3	0.4
No Coverage	0.4	0.5	0.4	0.4	0.4	0.6	0.4	0.8	0.4	0.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.93A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	304	481	29	1	275	480	44	78	231	402
GEOGRAPHIC REGION
Northeast	74	86	2	*	72	86	4	4	69	82
Midwest	48	93	11	1	38	92	6	8	32	84
South	92	251	15	*	76	251	22	52	54	199
West	90	51	1	*	89	51	12	14	77	37
COUNTY TYPE
Large Metro	205	189	11	*	194	189	32	21	163	167
Small Metro	84	248	18	1	66	247	12	51	54	195
Nonmetro	15	44	*	*	15	44	1	5	14	39
Urbanized	10	21	*	*	10	21	1	5	10	16
Less Urbanized	5	23	*	*	5	23	*	*	5	23
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	55	136	2	*	53	136	1	31	53	105
100-199%	48	101	6	*	43	101	12	43	31	58
200% or More	199	244	21	1	178	242	31	4	148	238
HEALTH INSURANCE²
Private	159	256	22	1	138	255	31	38	107	217
Medicaid/CHIP	68	102	7	*	61	102	11	11	51	92
Other³	93	166	*	*	93	166	8	5	86	161
No Coverage	23	110	*	*	23	110	*	29	23	81
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.93B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2
GEOGRAPHIC REGION
Northeast	0.2	0.2	0.0	*	0.2	0.2	0.1	0.1	0.2	0.2
Midwest	0.1	0.2	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.2
South	0.1	0.2	0.2	*	0.1	0.3	0.2	0.4	0.1	0.2
West	0.1	0.1	0.0	*	0.1	0.1	0.1	0.2	0.1	0.1
COUNTY TYPE
Large Metro	0.1	0.1	0.1	*	0.1	0.1	0.2	0.1	0.1	0.1
Small Metro	0.1	0.3	0.2	0.0	0.1	0.3	0.1	0.5	0.1	0.3
Nonmetro	0.0	0.1	*	*	0.0	0.1	0.0	0.1	0.0	0.1
Urbanized	0.1	0.1	*	*	0.1	0.1	0.0	0.2	0.1	0.1
Less Urbanized	0.0	0.1	*	*	0.0	0.1	*	*	0.0	0.1
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.1	0.3	0.0	*	0.2	0.4	0.0	0.4	0.2	0.4
100-199%	0.1	0.2	0.1	*	0.1	0.2	0.2	0.6	0.1	0.2
200% or More	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2
HEALTH INSURANCE²
Private	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.2	0.1	0.2
Medicaid/CHIP	0.2	0.2	0.1	*	0.2	0.3	0.2	0.1	0.2	0.3
Other³	0.1	0.2	*	*	0.1	0.2	0.3	0.2	0.1	0.2
No Coverage	0.1	0.4	*	*	0.1	0.4	*	0.6	0.1	0.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.94A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	29,408	27,026	749	418	28,659	26,607	2,983	2,861	25,676	23,747
GEOGRAPHIC REGION
Northeast	5,326	4,860	81	71	5,244	4,789	502	418	4,743	4,371
Midwest	6,182	5,577	168	84	6,014	5,492	716	615	5,298	4,877
South	11,368	10,566	292	139	11,076	10,427	1,042	1,127	10,033	9,300
West	6,532	6,022	207	124	6,325	5,899	723	700	5,602	5,198
COUNTY TYPE
Large Metro	16,415	14,685	404	195	16,011	14,490	1,699	1,430	14,312	13,060
Small Metro	8,906	8,886	249	166	8,657	8,720	894	1,013	7,763	7,707
Nonmetro	4,086	3,455	96	58	3,991	3,397	389	417	3,602	2,980
Urbanized	1,666	1,322	45	19	1,620	1,303	224	240	1,397	1,063
Less Urbanized	1,949	1,656	40	34	1,909	1,622	132	169	1,777	1,453
Completely Rural	472	477	11	*	462	473	34	8	428	464
POVERTY LEVEL¹
Less Than 100%	3,619	4,096	176	131	3,443	3,965	665	733	2,778	3,232
100-199%	5,535	4,905	171	50	5,364	4,854	607	734	4,757	4,120
200% or More	20,199	18,011	402	236	19,797	17,775	1,656	1,380	18,142	16,395
HEALTH INSURANCE²
Private	19,000	16,418	360	218	18,640	16,200	1,911	1,735	16,729	14,464
Medicaid/CHIP	5,306	5,567	324	184	4,982	5,383	637	661	4,345	4,722
Other³	9,345	9,066	52	16	9,293	9,050	224	122	9,069	8,927
No Coverage	2,109	2,218	36	17	2,073	2,200	343	452	1,730	1,748
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.94B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	10.7	9.8	3.0	1.7	11.4	10.6	8.8	8.5	11.9	10.9
GEOGRAPHIC REGION
Northeast	11.2	10.2	2.1	1.8	12.0	10.9	8.7	7.4	12.5	11.5
Midwest	10.8	9.7	3.2	1.6	11.6	10.5	10.0	8.7	11.8	10.8
South	10.9	10.0	3.0	1.4	11.7	10.9	8.2	8.9	12.2	11.2
West	10.0	9.1	3.4	2.0	10.6	9.8	8.9	8.7	10.9	10.0
COUNTY TYPE
Large Metro	10.7	9.7	3.0	1.4	11.4	10.6	9.0	8.1	11.8	11.0
Small Metro	10.7	10.5	3.2	2.2	11.4	11.3	8.4	9.2	11.9	11.7
Nonmetro	10.7	8.4	2.7	1.8	11.6	8.9	9.0	8.7	12.0	8.9
Urbanized	10.5	8.0	2.9	1.5	11.3	8.6	11.0	10.9	11.3	8.2
Less Urbanized	10.9	8.4	2.4	2.1	11.8	9.0	6.8	7.6	12.5	9.2
Completely Rural	10.9	9.4	2.6	*	11.7	9.8	8.9	2.3	12.0	10.4
POVERTY LEVEL¹
Less Than 100%	9.7	9.8	3.5	2.9	10.7	10.6	8.4	9.0	11.4	11.1
100-199%	10.5	9.7	3.2	1.1	11.3	10.6	7.8	9.5	11.9	10.8
200% or More	11.0	9.8	2.8	1.5	11.7	10.6	9.8	8.0	11.9	10.9
HEALTH INSURANCE²
Private	10.6	9.4	2.5	1.5	11.3	10.2	9.4	8.9	11.5	10.4
Medicaid/CHIP	11.7	11.4	3.4	2.2	13.9	13.3	8.8	8.5	15.2	14.5
Other³	13.3	11.9	4.3	1.0	13.5	12.1	8.8	5.0	13.6	12.4
No Coverage	7.8	7.8	3.1	1.2	8.0	8.2	7.1	8.6	8.2	8.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.95A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	4,841	4,779	381	157	4,460	4,622	1,266	1,097	3,194	3,526
GEOGRAPHIC REGION
Northeast	912	639	24	33	888	606	212	130	676	476
Midwest	918	1,058	90	17	828	1,041	285	292	543	749
South	1,866	1,772	127	51	1,739	1,721	484	397	1,255	1,324
West	1,144	1,310	139	56	1,005	1,254	284	278	720	976
COUNTY TYPE
Large Metro	2,902	2,376	197	72	2,705	2,304	711	590	1,994	1,714
Small Metro	1,417	1,804	145	72	1,271	1,731	377	366	894	1,365
Nonmetro	522	599	39	12	484	587	178	140	306	447
Urbanized	258	246	20	3	238	243	121	67	117	176
Less Urbanized	226	343	16	9	210	334	46	72	164	262
Completely Rural	38	10	3	0	35	10	10	1	25	8
POVERTY LEVEL¹
Less Than 100%	827	1,054	77	58	750	996	305	290	445	706
100-199%	898	806	96	11	803	795	256	277	546	518
200% or More	3,091	2,911	209	88	2,882	2,822	678	521	2,204	2,302
HEALTH INSURANCE²
Private	2,724	2,621	189	71	2,535	2,551	811	638	1,723	1,912
Medicaid/CHIP	1,170	1,123	170	78	1,000	1,045	224	248	776	798
Other³	620	820	24	2	596	818	60	55	536	763
No Coverage	697	803	12	9	685	794	213	209	472	585
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.95B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.8	1.7	1.5	0.6	1.8	1.8	3.8	3.3	1.5	1.6
GEOGRAPHIC REGION
Northeast	1.9	1.3	0.6	0.8	2.0	1.4	3.7	2.3	1.8	1.3
Midwest	1.6	1.8	1.7	0.3	1.6	2.0	4.0	4.1	1.2	1.7
South	1.8	1.7	1.3	0.5	1.8	1.8	3.8	3.1	1.5	1.6
West	1.7	2.0	2.3	0.9	1.7	2.1	3.5	3.5	1.4	1.9
COUNTY TYPE
Large Metro	1.9	1.6	1.5	0.5	1.9	1.7	3.8	3.3	1.6	1.4
Small Metro	1.7	2.1	1.9	0.9	1.7	2.2	3.6	3.3	1.4	2.1
Nonmetro	1.4	1.5	1.1	0.4	1.4	1.5	4.1	2.9	1.0	1.3
Urbanized	1.6	1.5	1.3	0.2	1.7	1.6	6.0	3.0	0.9	1.4
Less Urbanized	1.3	1.7	0.9	0.6	1.3	1.8	2.4	3.2	1.2	1.7
Completely Rural	0.9	0.2	0.7	0.2	0.9	0.2	2.7	0.4	0.7	0.2
POVERTY LEVEL¹
Less Than 100%	2.2	2.5	1.5	1.3	2.3	2.7	3.9	3.6	1.8	2.4
100-199%	1.7	1.6	1.8	0.2	1.7	1.7	3.3	3.6	1.4	1.4
200% or More	1.7	1.6	1.4	0.6	1.7	1.7	4.0	3.0	1.4	1.5
HEALTH INSURANCE²
Private	1.5	1.5	1.3	0.5	1.5	1.6	4.0	3.3	1.2	1.4
Medicaid/CHIP	2.6	2.3	1.8	0.9	2.8	2.6	3.1	3.2	2.7	2.5
Other³	0.9	1.1	2.0	0.1	0.9	1.1	2.4	2.3	0.8	1.1
No Coverage	2.6	2.8	1.0	0.6	2.6	2.9	4.4	4.0	2.2	2.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.96A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	10,065	9,490	567	396	9,499	9,094	1,776	1,376	7,723	7,717
GEOGRAPHIC REGION
Northeast	1,398	1,655	57	65	1,342	1,590	239	206	1,102	1,384
Midwest	2,191	1,749	126	84	2,065	1,665	408	321	1,656	1,344
South	3,757	3,401	232	126	3,526	3,275	660	505	2,866	2,770
West	2,718	2,685	152	121	2,567	2,564	468	344	2,098	2,219
COUNTY TYPE
Large Metro	5,418	4,804	286	190	5,133	4,614	981	690	4,151	3,924
Small Metro	3,472	3,257	215	148	3,257	3,109	588	423	2,669	2,686
Nonmetro	1,174	1,428	66	58	1,109	1,370	206	263	902	1,107
Urbanized	541	584	28	24	514	560	121	120	393	440
Less Urbanized	500	810	24	33	476	777	64	132	412	645
Completely Rural	133	34	14	1	119	33	22	11	97	22
POVERTY LEVEL¹
Less Than 100%	2,056	2,527	129	141	1,927	2,386	434	346	1,493	2,041
100-199%	2,278	1,830	144	55	2,134	1,776	427	340	1,708	1,436
200% or More	5,701	5,093	294	201	5,407	4,893	885	652	4,523	4,241
HEALTH INSURANCE²
Private	5,120	4,607	288	170	4,831	4,437	988	756	3,844	3,681
Medicaid/CHIP	2,619	2,856	240	173	2,379	2,683	404	353	1,976	2,330
Other³	1,862	1,995	43	20	1,819	1,974	114	108	1,706	1,866
No Coverage	1,643	1,559	10	*	1,633	1,501	339	238	1,294	1,263
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.96B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.7	3.4	2.3	1.6	3.8	3.6	5.3	4.1	3.6	3.5
GEOGRAPHIC REGION
Northeast	2.9	3.5	1.4	1.7	3.1	3.6	4.2	3.6	2.9	3.6
Midwest	3.8	3.0	2.4	1.6	4.0	3.2	5.7	4.5	3.7	3.0
South	3.6	3.2	2.4	1.3	3.7	3.4	5.2	4.0	3.5	3.3
West	4.1	4.1	2.5	2.0	4.3	4.3	5.8	4.3	4.1	4.3
COUNTY TYPE
Large Metro	3.5	3.2	2.1	1.3	3.7	3.4	5.2	3.9	3.4	3.3
Small Metro	4.2	3.8	2.8	1.9	4.3	4.0	5.5	3.8	4.1	4.1
Nonmetro	3.1	3.5	1.8	1.8	3.2	3.6	4.8	5.5	3.0	3.3
Urbanized	3.4	3.5	1.8	1.8	3.6	3.7	6.0	5.4	3.2	3.4
Less Urbanized	2.8	4.1	1.5	2.0	2.9	4.3	3.3	6.0	2.9	4.1
Completely Rural	3.1	0.7	3.4	0.6	3.0	0.7	5.8	3.1	2.7	0.5
POVERTY LEVEL¹
Less Than 100%	5.5	6.0	2.5	3.1	6.0	6.4	5.5	4.2	6.1	7.0
100-199%	4.3	3.6	2.7	1.2	4.5	3.9	5.5	4.4	4.3	3.8
200% or More	3.1	2.8	2.0	1.3	3.2	2.9	5.2	3.8	3.0	2.8
HEALTH INSURANCE²
Private	2.8	2.6	2.0	1.1	2.9	2.8	4.8	3.9	2.6	2.6
Medicaid/CHIP	5.8	5.9	2.6	2.1	6.7	6.7	5.6	4.5	6.9	7.2
Other³	2.7	2.6	3.5	1.2	2.6	2.6	4.5	4.5	2.6	2.6
No Coverage	6.1	5.5	0.8	*	6.3	5.6	7.0	4.5	6.1	5.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.97A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3,101	2,885	165	96	2,936	2,789	439	296	2,497	2,493
GEOGRAPHIC REGION
Northeast	451	537	13	19	438	519	69	55	369	464
Midwest	742	480	44	27	698	453	101	69	598	384
South	1,085	960	63	36	1,022	924	154	115	867	809
West	823	906	44	14	778	893	115	57	663	836
COUNTY TYPE
Large Metro	1,680	1,438	79	51	1,601	1,388	235	144	1,366	1,244
Small Metro	1,055	1,127	65	34	990	1,093	136	86	853	1,007
Nonmetro	366	319	21	11	345	308	68	66	278	242
Urbanized	134	123	7	*	126	118	38	*	88	105
Less Urbanized	185	196	8	6	177	191	24	53	153	138
Completely Rural	47	*	5	*	42	*	5	*	37	*
POVERTY LEVEL¹
Less Than 100%	653	969	32	16	620	953	98	107	522	847
100-199%	701	585	41	12	659	573	112	64	548	509
200% or More	1,735	1,312	91	68	1,644	1,244	217	106	1,427	1,138
HEALTH INSURANCE²
Private	1,394	1,012	95	50	1,299	962	233	136	1,066	826
Medicaid/CHIP	962	1,128	62	38	900	1,090	127	118	773	971
Other³	577	593	7	7	571	587	12	16	559	570
No Coverage	576	554	2	2	574	552	84	45	490	507
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.97B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.1	1.0	0.7	0.4	1.2	1.1	1.3	0.9	1.2	1.1
GEOGRAPHIC REGION
Northeast	0.9	1.1	0.3	0.5	1.0	1.2	1.2	1.0	1.0	1.2
Midwest	1.3	0.8	0.8	0.5	1.3	0.9	1.4	1.0	1.3	0.9
South	1.0	0.9	0.7	0.4	1.1	1.0	1.2	0.9	1.1	1.0
West	1.3	1.4	0.7	0.2	1.3	1.5	1.4	0.7	1.3	1.6
COUNTY TYPE
Large Metro	1.1	1.0	0.6	0.4	1.1	1.0	1.3	0.8	1.1	1.0
Small Metro	1.3	1.3	0.8	0.4	1.3	1.4	1.3	0.8	1.3	1.5
Nonmetro	1.0	0.8	0.6	0.3	1.0	0.8	1.6	1.4	0.9	0.7
Urbanized	0.8	0.7	0.5	*	0.9	0.8	1.9	*	0.7	0.8
Less Urbanized	1.0	1.0	0.5	0.3	1.1	1.1	1.3	2.4	1.1	0.9
Completely Rural	1.1	*	1.3	*	1.1	*	1.4	*	1.0	*
POVERTY LEVEL¹
Less Than 100%	1.7	2.3	0.6	0.4	1.9	2.6	1.2	1.3	2.1	2.9
100-199%	1.3	1.2	0.8	0.3	1.4	1.2	1.4	0.8	1.4	1.3
200% or More	0.9	0.7	0.6	0.4	1.0	0.7	1.3	0.6	0.9	0.8
HEALTH INSURANCE²
Private	0.8	0.6	0.7	0.3	0.8	0.6	1.1	0.7	0.7	0.6
Medicaid/CHIP	2.1	2.3	0.7	0.5	2.5	2.7	1.8	1.5	2.7	3.0
Other³	0.8	0.8	0.5	0.4	0.8	0.8	0.5	0.7	0.8	0.8
No Coverage	2.1	1.9	0.2	0.1	2.2	2.0	1.7	0.9	2.3	2.3
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.98A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	10,136	10,306	499	346	9,638	9,960	3,205	2,567	6,433	7,393
GEOGRAPHIC REGION
Northeast	1,612	1,934	56	45	1,556	1,890	606	427	950	1,463
Midwest	2,137	2,039	100	72	2,037	1,968	740	584	1,297	1,384
South	3,437	3,615	211	116	3,226	3,499	1,005	852	2,220	2,647
West	2,950	2,717	130	114	2,819	2,603	854	704	1,965	1,899
COUNTY TYPE
Large Metro	6,011	5,794	292	196	5,719	5,598	1,941	1,447	3,778	4,151
Small Metro	2,965	3,516	157	111	2,808	3,405	947	884	1,862	2,522
Nonmetro	1,160	996	50	39	1,110	957	318	237	793	720
Urbanized	612	431	31	18	580	413	182	99	398	314
Less Urbanized	458	535	15	21	443	514	113	125	330	388
Completely Rural	91	31	4	0	87	30	22	*	65	18
POVERTY LEVEL¹
Less Than 100%	2,037	2,197	78	47	1,959	2,149	729	558	1,229	1,592
100-199%	2,054	1,979	100	34	1,954	1,945	598	575	1,356	1,370
200% or More	5,952	6,082	321	265	5,631	5,817	1,784	1,386	3,847	4,431
HEALTH INSURANCE²
Private	5,821	5,645	320	216	5,502	5,429	2,315	1,837	3,187	3,592
Medicaid/CHIP	2,482	2,523	166	134	2,317	2,389	490	322	1,826	2,066
Other³	968	1,148	29	7	940	1,142	185	119	755	1,022
No Coverage	1,620	1,806	14	13	1,606	1,793	325	361	1,281	1,432
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.98B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.7	3.7	2.0	1.4	3.9	4.0	9.5	7.7	3.0	3.4
GEOGRAPHIC REGION
Northeast	3.4	4.1	1.4	1.1	3.6	4.3	10.5	7.5	2.5	3.8
Midwest	3.7	3.6	1.9	1.4	3.9	3.8	10.3	8.2	2.9	3.1
South	3.3	3.4	2.2	1.2	3.4	3.6	7.9	6.7	2.7	3.2
West	4.5	4.1	2.2	1.9	4.7	4.3	10.6	8.8	3.8	3.7
COUNTY TYPE
Large Metro	3.9	3.8	2.2	1.4	4.1	4.1	10.3	8.2	3.1	3.5
Small Metro	3.6	4.2	2.0	1.4	3.7	4.4	8.9	8.0	2.9	3.8
Nonmetro	3.0	2.4	1.4	1.2	3.2	2.5	7.3	5.0	2.6	2.2
Urbanized	3.8	2.6	2.0	1.3	4.0	2.7	9.0	4.5	3.2	2.4
Less Urbanized	2.6	2.7	0.9	1.3	2.7	2.8	5.8	5.7	2.3	2.4
Completely Rural	2.1	0.6	0.9	0.2	2.2	0.6	5.9	*	1.8	0.4
POVERTY LEVEL¹
Less Than 100%	5.4	5.2	1.5	1.0	6.1	5.8	9.2	6.9	5.0	5.5
100-199%	3.9	3.9	1.9	0.7	4.1	4.2	7.7	7.5	3.4	3.6
200% or More	3.2	3.3	2.2	1.7	3.3	3.5	10.5	8.0	2.5	2.9
HEALTH INSURANCE²
Private	3.2	3.2	2.2	1.4	3.3	3.4	11.3	9.4	2.2	2.6
Medicaid/CHIP	5.5	5.2	1.8	1.6	6.5	5.9	6.8	4.1	6.4	6.4
Other³	1.4	1.5	2.3	0.4	1.4	1.5	7.3	4.9	1.1	1.4
No Coverage	6.0	6.3	1.2	0.9	6.2	6.6	6.7	6.9	6.1	6.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.99A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	4,264	4,483	160	87	4,103	4,396	1,127	682	2,976	3,714
GEOGRAPHIC REGION
Northeast	639	855	18	18	622	837	200	110	421	728
Midwest	853	841	30	12	822	829	268	144	555	684
South	1,471	1,574	72	38	1,398	1,536	376	275	1,022	1,261
West	1,301	1,213	40	19	1,261	1,194	283	153	978	1,041
COUNTY TYPE
Large Metro	2,717	2,508	96	44	2,620	2,464	695	409	1,925	2,056
Small Metro	1,110	1,569	49	36	1,061	1,533	329	229	732	1,303
Nonmetro	437	406	15	7	422	399	103	44	319	355
Urbanized	247	152	12	5	234	147	59	9	175	138
Less Urbanized	161	241	2	2	159	239	39	33	119	206
Completely Rural	29	13	1	*	29	13	5	*	24	11
POVERTY LEVEL¹
Less Than 100%	1,000	1,148	25	4	975	1,144	299	139	676	1,005
100-199%	829	819	22	1	807	818	214	162	593	656
200% or More	2,401	2,510	114	82	2,287	2,428	581	375	1,706	2,052
HEALTH INSURANCE²
Private	2,257	2,196	108	66	2,150	2,130	794	455	1,356	1,675
Medicaid/CHIP	1,059	1,221	49	17	1,010	1,204	156	86	854	1,118
Other³	377	496	9	2	368	494	82	46	286	448
No Coverage	808	906	0	2	808	904	133	128	674	775
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.99B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	1.5	1.6	0.6	0.3	1.6	1.7	3.3	2.0	1.4	1.7
GEOGRAPHIC REGION
Northeast	1.3	1.8	0.5	0.4	1.4	1.9	3.5	1.9	1.1	1.9
Midwest	1.5	1.5	0.6	0.2	1.6	1.6	3.7	2.0	1.2	1.5
South	1.4	1.5	0.7	0.4	1.5	1.6	3.0	2.2	1.2	1.5
West	2.0	1.8	0.7	0.3	2.1	2.0	3.5	1.9	1.9	2.0
COUNTY TYPE
Large Metro	1.8	1.7	0.7	0.3	1.9	1.8	3.7	2.3	1.6	1.7
Small Metro	1.3	1.9	0.6	0.5	1.4	2.0	3.1	2.1	1.1	2.0
Nonmetro	1.1	1.0	0.4	0.2	1.2	1.0	2.4	0.9	1.1	1.1
Urbanized	1.6	0.9	0.8	0.4	1.6	1.0	2.9	0.4	1.4	1.1
Less Urbanized	0.9	1.2	0.1	0.1	1.0	1.3	2.0	1.5	0.8	1.3
Completely Rural	0.7	0.3	0.2	*	0.7	0.3	1.3	*	0.7	0.2
POVERTY LEVEL¹
Less Than 100%	2.7	2.7	0.5	0.1	3.0	3.1	3.8	1.7	2.8	3.4
100-199%	1.6	1.6	0.4	0.0	1.7	1.8	2.8	2.1	1.5	1.7
200% or More	1.3	1.4	0.8	0.5	1.4	1.4	3.4	2.2	1.1	1.4
HEALTH INSURANCE²
Private	1.3	1.3	0.8	0.4	1.3	1.3	3.9	2.3	0.9	1.2
Medicaid/CHIP	2.3	2.5	0.5	0.2	2.8	3.0	2.2	1.1	3.0	3.4
Other³	0.5	0.7	0.7	0.1	0.5	0.7	3.2	1.9	0.4	0.6
No Coverage	3.0	3.2	0.0	0.1	3.1	3.3	2.8	2.4	3.2	3.6
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.100A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	23,588	23,962	1,862	1,507	21,727	22,455	5,791	5,169	15,936	17,286
GEOGRAPHIC REGION
Northeast	3,722	4,224	222	232	3,500	3,992	991	826	2,509	3,165
Midwest	4,830	4,752	415	346	4,415	4,407	1,257	1,155	3,157	3,252
South	8,207	8,510	724	505	7,483	8,005	1,913	1,840	5,570	6,165
West	6,830	6,476	501	424	6,329	6,052	1,630	1,347	4,699	4,705
COUNTY TYPE
Large Metro	13,560	13,153	975	765	12,585	12,388	3,374	2,893	9,211	9,495
Small Metro	7,430	7,822	661	506	6,769	7,317	1,782	1,613	4,987	5,704
Nonmetro	2,599	2,987	226	236	2,373	2,751	635	664	1,738	2,087
Urbanized	1,325	1,356	106	105	1,218	1,250	352	370	867	880
Less Urbanized	1,026	1,525	88	111	938	1,413	222	264	716	1,149
Completely Rural	248	107	32	20	216	87	61	29	156	58
POVERTY LEVEL¹
Less Than 100%	4,417	4,884	430	352	3,987	4,532	1,379	1,242	2,608	3,290
100-199%	4,945	4,508	382	198	4,563	4,310	1,199	1,199	3,364	3,111
200% or More	14,049	14,477	1,050	957	12,999	13,520	3,036	2,635	9,964	10,886
HEALTH INSURANCE²
Private	13,516	13,400	1,007	818	12,509	12,583	3,764	3,454	8,745	9,129
Medicaid/CHIP	5,583	5,847	767	566	4,816	5,282	1,076	814	3,740	4,467
Other³	3,259	3,901	106	107	3,153	3,794	374	290	2,779	3,504
No Coverage	3,373	3,597	61	117	3,312	3,480	790	780	2,521	2,701
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.100B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	8.6	8.7	7.5	6.0	8.7	8.9	17.2	15.4	7.4	7.9
GEOGRAPHIC REGION
Northeast	7.8	8.9	5.6	5.9	8.0	9.1	17.2	14.6	6.6	8.3
Midwest	8.4	8.3	7.9	6.6	8.5	8.5	17.5	16.3	7.0	7.2
South	7.8	8.0	7.5	5.2	7.9	8.3	15.1	14.5	6.8	7.4
West	10.4	9.8	8.3	7.0	10.6	10.1	20.1	16.8	9.1	9.0
COUNTY TYPE
Large Metro	8.8	8.7	7.2	5.4	9.0	9.1	18.0	16.3	7.6	8.0
Small Metro	8.9	9.2	8.6	6.6	8.9	9.5	16.8	14.7	7.7	8.6
Nonmetro	6.8	7.2	6.3	7.4	6.9	7.2	14.6	13.9	5.8	6.3
Urbanized	8.3	8.2	6.9	7.9	8.5	8.2	17.4	16.8	7.0	6.8
Less Urbanized	5.8	7.7	5.3	6.9	5.8	7.8	11.5	11.9	5.0	7.2
Completely Rural	5.7	2.1	7.8	7.4	5.5	1.8	16.2	8.2	4.4	1.3
POVERTY LEVEL¹
Less Than 100%	11.8	11.7	8.4	7.7	12.3	12.1	17.5	15.3	10.7	11.3
100-199%	9.3	8.9	7.2	4.4	9.6	9.4	15.5	15.6	8.4	8.1
200% or More	7.6	7.9	7.2	6.0	7.7	8.0	17.9	15.2	6.5	7.2
HEALTH INSURANCE²
Private	7.5	7.7	7.1	5.5	7.6	7.9	18.4	17.6	6.0	6.6
Medicaid/CHIP	12.4	12.0	8.2	6.8	13.5	13.1	14.8	10.4	13.1	13.7
Other³	4.6	5.1	8.7	6.4	4.6	5.1	14.7	11.9	4.2	4.8
No Coverage	12.5	12.6	5.3	8.0	12.8	12.9	16.4	14.8	12.0	12.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.101A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	9,333	9,305	598	305	8,735	9,000	2,059	1,600	6,676	7,400
GEOGRAPHIC REGION
Northeast	1,387	1,762	66	51	1,320	1,711	347	242	973	1,468
Midwest	1,974	1,738	129	83	1,845	1,656	453	347	1,392	1,308
South	3,078	3,232	237	111	2,841	3,121	656	600	2,185	2,522
West	2,893	2,573	166	60	2,728	2,513	602	411	2,126	2,102
COUNTY TYPE
Large Metro	5,558	5,083	312	163	5,246	4,920	1,224	917	4,022	4,003
Small Metro	2,828	3,237	228	105	2,600	3,132	612	512	1,987	2,619
Nonmetro	947	986	58	37	889	948	223	171	666	777
Urbanized	454	356	27	18	428	338	122	66	306	272
Less Urbanized	398	610	20	15	377	595	84	101	293	494
Completely Rural	96	21	11	*	85	15	17	4	68	11
POVERTY LEVEL¹
Less Than 100%	1,850	2,199	117	53	1,733	2,146	509	428	1,224	1,718
100-199%	1,830	1,814	159	26	1,670	1,787	414	386	1,256	1,401
200% or More	5,594	5,247	322	225	5,272	5,021	1,075	740	4,196	4,281
HEALTH INSURANCE²
Private	4,971	4,615	326	199	4,645	4,416	1,315	1,004	3,330	3,412
Medicaid/CHIP	2,367	2,642	248	102	2,119	2,540	411	278	1,708	2,262
Other³	1,274	1,458	30	11	1,244	1,447	140	84	1,105	1,363
No Coverage	1,518	1,599	15	8	1,503	1,592	271	306	1,232	1,285
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.101B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2019 and 2020
Geographic/Socioeconomic Characteristic	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
TOTAL	3.4	3.4	2.4	1.2	3.5	3.6	6.1	4.8	3.1	3.4
GEOGRAPHIC REGION
Northeast	2.9	3.7	1.7	1.3	3.0	3.9	6.0	4.3	2.6	3.9
Midwest	3.4	3.0	2.4	1.6	3.5	3.2	6.3	4.9	3.1	2.9
South	2.9	3.1	2.4	1.1	3.0	3.3	5.2	4.7	2.7	3.0
West	4.4	3.9	2.8	1.0	4.6	4.2	7.4	5.1	4.1	4.0
COUNTY TYPE
Large Metro	3.6	3.4	2.3	1.2	3.7	3.6	6.5	5.2	3.3	3.4
Small Metro	3.4	3.8	3.0	1.4	3.4	4.1	5.8	4.7	3.1	4.0
Nonmetro	2.5	2.4	1.6	1.2	2.6	2.5	5.1	3.6	2.2	2.3
Urbanized	2.9	2.2	1.7	1.3	3.0	2.2	6.0	3.0	2.5	2.1
Less Urbanized	2.2	3.1	1.2	0.9	2.3	3.3	4.4	4.6	2.1	3.1
Completely Rural	2.2	0.4	2.7	*	2.2	0.3	4.5	1.2	1.9	0.2
POVERTY LEVEL¹
Less Than 100%	4.9	5.2	2.3	1.2	5.4	5.8	6.4	5.3	5.0	5.9
100-199%	3.5	3.6	3.0	0.6	3.5	3.9	5.4	5.0	3.2	3.7
200% or More	3.0	2.8	2.2	1.4	3.1	3.0	6.3	4.3	2.8	2.8
HEALTH INSURANCE²
Private	2.8	2.7	2.3	1.3	2.8	2.8	6.4	5.1	2.3	2.4
Medicaid/CHIP	5.2	5.4	2.6	1.2	5.9	6.3	5.7	3.6	6.0	7.0
Other³	1.8	1.9	2.5	0.6	1.8	1.9	5.5	3.5	1.7	1.9
No Coverage	5.6	5.6	1.3	0.5	5.8	5.9	5.6	5.8	5.9	5.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. NOTE: Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.102A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2019 and 2020
Drug or Method of Administration	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
HALLUCINOGENS	44,087	43,949	615	563	43,472	43,386	5,597	5,269	37,876	38,117
PCP	5,516	6,141	41	7	5,475	6,134	249	167	5,226	5,967
LSD	27,528	28,123	392	317	27,137	27,806	3,368	3,284	23,769	24,521
Peyote	5,670	5,040	49	24	5,621	5,016	208	111	5,413	4,905
Mescaline	7,571	6,913	21	3	7,550	6,911	176	98	7,373	6,813
Psilocybin/Mushrooms	25,254	26,111	285	204	24,968	25,908	2,990	2,936	21,979	22,971
Ecstasy	20,097	20,478	225	183	19,872	20,295	3,500	2,946	16,372	17,348
Ketamine	3,833	3,955	32	38	3,801	3,917	539	600	3,262	3,317
DMT, AMT, or 5-MeO-DIPT/Foxy	3,345	3,192	51	42	3,294	3,150	697	552	2,597	2,598
Salvia divinorum	5,188	5,106	52	28	5,136	5,079	699	423	4,437	4,655
INHALANTS	25,090	26,749	2,202	2,327	22,889	24,422	3,099	2,929	19,790	21,493
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush	7,122	8,168	126	155	6,995	8,013	541	549	6,454	7,464
Correction Fluid, Degreaser, or Cleaning Fluid	1,298	1,685	163	217	1,135	1,467	184	63	950	1,405
Gasoline or Lighter Fluid	2,814	3,132	436	472	2,378	2,660	321	334	2,057	2,326
Glue, Shoe Polish, or Toluene	2,723	3,489	525	692	2,198	2,797	297	330	1,901	2,467
Halothane, Ether, or Other Anesthetics	609	1,230	29	12	581	1,218	54	81	527	1,137
Lacquer Thinner or Other Paint Solvents	1,452	1,557	130	185	1,322	1,372	170	125	1,152	1,247
Lighter Gases	806	733	149	135	656	598	99	68	557	529
Nitrous Oxide or Whippits	12,640	12,891	139	125	12,500	12,766	1,138	1,031	11,363	11,735
Felt-Tip Pens or Felt-Tip/Magic Markers	6,595	7,640	1,599	1,875	4,996	5,765	1,412	1,336	3,584	4,428
Spray Paints	1,800	1,864	407	439	1,394	1,425	268	282	1,126	1,143
Computer Cleaner/Air Duster	2,885	2,685	188	116	2,697	2,569	551	285	2,146	2,283
Other Aerosol Sprays	1,368	1,372	131	112	1,237	1,260	193	134	1,044	1,126
NEEDLE USE¹	4,592	5,417	19	2	4,572	5,415	280	187	4,292	5,228
Heroin Needle Use¹	2,710	2,896	5	*	2,705	2,896	172	133	2,533	2,763
Cocaine Needle Use¹	2,380	2,698	2	*	2,378	2,698	89	21	2,289	2,677
Methamphetamine Needle Use¹	2,141	2,724	*	*	2,141	2,724	142	75	1,999	2,649
HEROIN	5,696	6,252	21	*	5,675	6,251	389	226	5,287	6,024
Smoke Heroin¹	2,567	3,028	13	*	2,554	3,027	193	154	2,361	2,873
Sniff or Snort Heroin¹	3,746	4,378	4	*	3,741	4,378	285	170	3,457	4,208
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210614

Table 1.102B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2019 and 2020
Drug or Method of Administration	Aged 12+ (2019)	Aged 12+ (2020)	Aged 12-17 (2019)	Aged 12-17 (2020)	Aged 18+ (2019)	Aged 18+ (2020)	Aged 18-25 (2019)	Aged 18-25 (2020)	Aged 26+ (2019)	Aged 26+ (2020)
HALLUCINOGENS	16.0	15.9	2.5	2.3	17.4	17.2	16.6	15.7	17.5	17.5
PCP	2.0	2.2	0.2	0.0	2.2	2.4	0.7	0.5	2.4	2.7
LSD	10.0	10.2	1.6	1.3	10.8	11.0	10.0	9.8	11.0	11.2
Peyote	2.1	1.8	0.2	0.1	2.2	2.0	0.6	0.3	2.5	2.2
Mescaline	2.8	2.5	0.1	0.0	3.0	2.7	0.5	0.3	3.4	3.1
Psilocybin/Mushrooms	9.2	9.4	1.1	0.8	10.0	10.3	8.9	8.8	10.1	10.5
Ecstasy	7.3	7.4	0.9	0.7	7.9	8.1	10.4	8.8	7.6	7.9
Ketamine	1.4	1.4	0.1	0.2	1.5	1.6	1.6	1.8	1.5	1.5
DMT, AMT, or 5-MeO-DIPT/Foxy	1.2	1.2	0.2	0.2	1.3	1.3	2.1	1.6	1.2	1.2
Salvia divinorum	1.9	1.8	0.2	0.1	2.1	2.0	2.1	1.3	2.0	2.1
INHALANTS	9.1	9.7	8.8	9.3	9.1	9.7	9.2	8.7	9.1	9.8
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush	2.6	2.9	0.5	0.6	2.8	3.2	1.6	1.6	3.0	3.4
Correction Fluid, Degreaser, or Cleaning Fluid	0.5	0.6	0.7	0.9	0.5	0.6	0.5	0.2	0.4	0.6
Gasoline or Lighter Fluid	1.0	1.1	1.7	1.9	1.0	1.1	1.0	1.0	0.9	1.1
Glue, Shoe Polish, or Toluene	1.0	1.3	2.1	2.8	0.9	1.1	0.9	1.0	0.9	1.1
Halothane, Ether, or Other Anesthetics	0.2	0.4	0.1	0.0	0.2	0.5	0.2	0.2	0.2	0.5
Lacquer Thinner or Other Paint Solvents	0.5	0.6	0.5	0.7	0.5	0.5	0.5	0.4	0.5	0.6
Lighter Gases	0.3	0.3	0.6	0.5	0.3	0.2	0.3	0.2	0.3	0.2
Nitrous Oxide or Whippits	4.6	4.7	0.6	0.5	5.0	5.1	3.4	3.1	5.2	5.4
Felt-Tip Pens or Felt-Tip/Magic Markers	2.4	2.8	6.4	7.5	2.0	2.3	4.2	4.0	1.7	2.0
Spray Paints	0.7	0.7	1.6	1.8	0.6	0.6	0.8	0.8	0.5	0.5
Computer Cleaner/Air Duster	1.0	1.0	0.8	0.5	1.1	1.0	1.6	0.9	1.0	1.0
Other Aerosol Sprays	0.5	0.5	0.5	0.4	0.5	0.5	0.6	0.4	0.5	0.5
NEEDLE USE¹	1.7	2.0	0.1	0.0	1.8	2.1	0.8	0.6	2.0	2.4
Heroin Needle Use¹	1.0	1.0	0.0	*	1.1	1.1	0.5	0.4	1.2	1.3
Cocaine Needle Use¹	0.9	1.0	0.0	*	1.0	1.1	0.3	0.1	1.1	1.2
Methamphetamine Needle Use¹	0.8	1.0	*	*	0.9	1.1	0.4	0.2	0.9	1.2
HEROIN	2.1	2.3	0.1	*	2.3	2.5	1.2	0.7	2.4	2.8
Smoke Heroin¹	0.9	1.1	0.1	*	1.0	1.2	0.6	0.5	1.1	1.3
Sniff or Snort Heroin¹	1.4	1.6	0.0	*	1.5	1.7	0.8	0.5	1.6	1.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ These estimates may be inconsistent with estimates presented in other detailed tables because NSDUH data are not edited for consistency across discrete sections of the interview, except with regard to skip logic. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.103A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	82,559	75,198	9,724	9,254	9,724	9,254
Hydrocodone Products	43,571	37,657	5,068	4,729	5,068	4,729
Zohydro^®ER	338	401	35	30	*	*
Oxycodone Products	24,372	21,756	3,185	3,153	3,185	3,153
OxyContin^®	8,799	7,136	1,207	1,317	1,207	1,317
Tramadol Products	17,183	16,718	1,340	1,513	1,340	1,513
Codeine Products	24,106	19,998	2,380	2,447	2,380	2,447
Morphine Products	5,838	5,541	455	492	455	492
Fentanyl Products	2,530	2,403	269	356	269	356
Buprenorphine Products	2,469	2,605	686	690	686	690
Oxymorphone Products	856	925	234	159	234	*
Demerol^®	918	394	51	31	51	*
Hydromorphone Products	1,614	1,314	179	219	179	219
Methadone	1,064	1,422	240	229	240	*
Any Other Prescription Pain Reliever¹	22,829	20,878	930	1,117	930	1,117
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.103B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	30.0	27.2	3.5	3.3	11.8	12.3
Hydrocodone Products	15.8	13.6	1.8	1.7	11.6	12.6
Zohydro^®ER	0.1	0.1	0.0	0.0	*	*
Oxycodone Products	8.9	7.9	1.2	1.1	13.1	14.5
OxyContin^®	3.2	2.6	0.4	0.5	13.7	18.5
Tramadol Products	6.2	6.0	0.5	0.5	7.8	9.0
Codeine Products	8.8	7.2	0.9	0.9	9.9	12.2
Morphine Products	2.1	2.0	0.2	0.2	7.8	8.9
Fentanyl Products	0.9	0.9	0.1	0.1	10.6	14.8
Buprenorphine Products	0.9	0.9	0.2	0.2	27.8	26.5
Oxymorphone Products	0.3	0.3	0.1	0.1	27.3	*
Demerol^®	0.3	0.1	0.0	0.0	5.6	*
Hydromorphone Products	0.6	0.5	0.1	0.1	11.1	16.6
Methadone	0.4	0.5	0.1	0.1	22.5	*
Any Other Prescription Pain Reliever¹	8.3	7.5	0.3	0.4	4.1	5.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.104A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	3,980	3,079	567	396	567	396
Hydrocodone Products	767	676	160	107	160	107
Zohydro^®ER	28	18	7	*	*	*
Oxycodone Products	703	552	164	94	164	94
OxyContin^®	288	274	69	68	69	*
Tramadol Products	335	190	52	35	52	*
Codeine Products	1,386	1,148	215	128	215	128
Morphine Products	318	181	40	20	40	*
Fentanyl Products	68	33	5	*	*	*
Buprenorphine Products	72	50	10	8	*	*
Oxymorphone Products	47	34	5	13	*	*
Demerol^®	34	7	4	*	*	*
Hydromorphone Products	12	31	6	5	*	*
Methadone	42	12	16	*	*	*
Any Other Prescription Pain Reliever¹	1,912	1,313	124	149	124	149
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.104B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	16.0	12.3	2.3	1.6	14.2	12.9
Hydrocodone Products	3.1	2.7	0.6	0.4	20.9	15.8
Zohydro^®ER	0.1	0.1	0.0	*	*	*
Oxycodone Products	2.8	2.2	0.7	0.4	23.3	17.1
OxyContin^®	1.2	1.1	0.3	0.3	23.8	*
Tramadol Products	1.3	0.8	0.2	0.1	15.6	*
Codeine Products	5.6	4.6	0.9	0.5	15.5	11.2
Morphine Products	1.3	0.7	0.2	0.1	12.5	*
Fentanyl Products	0.3	0.1	0.0	*	*	*
Buprenorphine Products	0.3	0.2	0.0	0.0	*	*
Oxymorphone Products	0.2	0.1	0.0	0.1	*	*
Demerol^®	0.1	0.0	0.0	*	*	*
Hydromorphone Products	0.0	0.1	0.0	0.0	*	*
Methadone	0.2	0.0	0.1	*	*	*
Any Other Prescription Pain Reliever¹	7.7	5.3	0.5	0.6	6.5	11.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.105A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	78,579	72,118	9,158	8,858	9,158	8,858
Hydrocodone Products	42,804	36,981	4,908	4,623	4,908	4,623
Zohydro^®ER	310	382	28	30	*	*
Oxycodone Products	23,669	21,204	3,020	3,059	3,020	3,059
OxyContin^®	8,510	6,862	1,138	1,250	1,138	1,250
Tramadol Products	16,848	16,528	1,287	1,478	1,287	1,478
Codeine Products	22,720	18,850	2,165	2,319	2,165	2,319
Morphine Products	5,520	5,360	415	472	415	472
Fentanyl Products	2,462	2,370	264	356	264	356
Buprenorphine Products	2,397	2,555	676	682	676	682
Oxymorphone Products	808	891	228	146	228	*
Demerol^®	884	386	48	31	48	*
Hydromorphone Products	1,602	1,283	173	213	173	*
Methadone	1,022	1,410	223	229	223	*
Any Other Prescription Pain Reliever¹	20,916	19,565	807	968	807	968
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.105B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	31.4	28.6	3.7	3.5	11.7	12.3
Hydrocodone Products	17.1	14.7	2.0	1.8	11.5	12.5
Zohydro^®ER	0.1	0.2	0.0	0.0	*	*
Oxycodone Products	9.5	8.4	1.2	1.2	12.8	14.4
OxyContin^®	3.4	2.7	0.5	0.5	13.4	18.2
Tramadol Products	6.7	6.6	0.5	0.6	7.6	8.9
Codeine Products	9.1	7.5	0.9	0.9	9.5	12.3
Morphine Products	2.2	2.1	0.2	0.2	7.5	8.8
Fentanyl Products	1.0	0.9	0.1	0.1	10.7	15.0
Buprenorphine Products	1.0	1.0	0.3	0.3	28.2	26.7
Oxymorphone Products	0.3	0.4	0.1	0.1	28.3	*
Demerol^®	0.4	0.2	0.0	0.0	5.4	*
Hydromorphone Products	0.6	0.5	0.1	0.1	10.8	*
Methadone	0.4	0.6	0.1	0.1	21.8	*
Any Other Prescription Pain Reliever¹	8.4	7.8	0.3	0.4	3.9	4.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.106A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	8,357	6,858	1,754	1,361	1,754	1,361
Hydrocodone Products	3,607	3,069	855	703	855	703
Zohydro^®ER	45	29	3	*	*	*
Oxycodone Products	2,497	2,059	615	622	615	622
OxyContin^®	922	683	266	180	266	180
Tramadol Products	1,220	1,180	228	242	228	242
Codeine Products	2,600	2,086	434	291	434	291
Morphine Products	726	426	96	48	96	*
Fentanyl Products	252	285	49	34	49	*
Buprenorphine Products	286	257	124	49	124	*
Oxymorphone Products	141	142	55	33	*	*
Demerol^®	50	14	11	3	*	*
Hydromorphone Products	96	48	30	3	*	*
Methadone	79	138	29	10	*	*
Any Other Prescription Pain Reliever¹	2,794	2,081	207	133	207	133
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.106B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	24.8	20.5	5.2	4.1	21.0	19.8
Hydrocodone Products	10.7	9.2	2.5	2.1	23.7	22.9
Zohydro^®ER	0.1	0.1	0.0	*	*	*
Oxycodone Products	7.4	6.1	1.8	1.9	24.6	30.2
OxyContin^®	2.7	2.0	0.8	0.5	28.8	26.3
Tramadol Products	3.6	3.5	0.7	0.7	18.7	20.5
Codeine Products	7.7	6.2	1.3	0.9	16.7	13.9
Morphine Products	2.2	1.3	0.3	0.1	13.2	*
Fentanyl Products	0.7	0.9	0.1	0.1	19.5	*
Buprenorphine Products	0.8	0.8	0.4	0.1	43.2	*
Oxymorphone Products	0.4	0.4	0.2	0.1	*	*
Demerol^®	0.1	0.0	0.0	0.0	*	*
Hydromorphone Products	0.3	0.1	0.1	0.0	*	*
Methadone	0.2	0.4	0.1	0.0	*	*
Any Other Prescription Pain Reliever¹	8.3	6.2	0.6	0.4	7.4	6.4
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.107A – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	70,222	65,261	7,404	7,498	7,404	7,498
Hydrocodone Products	39,197	33,912	4,053	3,920	4,053	3,920
Zohydro^®ER	265	353	25	30	*	*
Oxycodone Products	21,172	19,146	2,405	2,437	2,405	2,437
OxyContin^®	7,588	6,179	872	1,070	872	1,070
Tramadol Products	15,627	15,349	1,059	1,236	1,059	1,236
Codeine Products	20,121	16,763	1,731	2,028	1,731	2,028
Morphine Products	4,794	4,934	319	424	319	424
Fentanyl Products	2,210	2,084	215	322	215	322
Buprenorphine Products	2,110	2,298	552	633	552	633
Oxymorphone Products	667	749	173	113	*	*
Demerol^®	834	372	37	28	37	*
Hydromorphone Products	1,506	1,236	143	210	143	*
Methadone	944	1,272	194	219	194	*
Any Other Prescription Pain Reliever¹	18,122	17,484	600	835	600	835
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.107B – Any Use and Misuse of Prescription Pain Reliever Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Pain Reliever Subtypes in Past Year: Among Past Year Any Users of Prescription Pain Reliever Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Pain Reliever Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Pain Reliever Subtypes (2020)
ANY PRESCRIPTION PAIN RELIEVER	32.4	29.9	3.4	3.4	10.5	11.5
Hydrocodone Products	18.1	15.5	1.9	1.8	10.3	11.6
Zohydro^®ER	0.1	0.2	0.0	0.0	*	*
Oxycodone Products	9.8	8.8	1.1	1.1	11.4	12.7
OxyContin^®	3.5	2.8	0.4	0.5	11.5	17.3
Tramadol Products	7.2	7.0	0.5	0.6	6.8	8.0
Codeine Products	9.3	7.7	0.8	0.9	8.6	12.1
Morphine Products	2.2	2.3	0.1	0.2	6.7	8.6
Fentanyl Products	1.0	1.0	0.1	0.1	9.7	15.4
Buprenorphine Products	1.0	1.1	0.3	0.3	26.2	27.5
Oxymorphone Products	0.3	0.3	0.1	0.1	*	*
Demerol^®	0.4	0.2	0.0	0.0	4.4	*
Hydromorphone Products	0.7	0.6	0.1	0.1	9.5	*
Methadone	0.4	0.6	0.1	0.1	20.5	*
Any Other Prescription Pain Reliever¹	8.4	8.0	0.3	0.4	3.3	4.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of pain relievers containing other active ingredients. Reports of misuse of “any other prescription pain reliever” that correspond only to the specific pain reliever categories shown in the table are excluded from estimates for Any Other Prescription Pain Reliever and are included instead in the relevant pain reliever category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.108A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	18,290	18,332	4,929	5,092	4,929	5,092
Amphetamine or Methylphenidate Products	14,294	13,863	4,711	4,699	4,711	4,699
Amphetamine Products	12,647	11,853	4,486	4,435	4,486	4,435
Methylphenidate Products	3,383	3,812	704	661	704	661
Anorectic (Weight-Loss) Stimulants	2,220	2,790	207	231	207	231
Provigil^®	536	536	87	119	*	*
Any Other Prescription Stimulant¹	2,594	2,763	31	97	31	97
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.108B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	6.6	6.6	1.8	1.8	26.9	27.8
Amphetamine or Methylphenidate Products	5.2	5.0	1.7	1.7	33.0	33.9
Amphetamine Products	4.6	4.3	1.6	1.6	35.5	37.4
Methylphenidate Products	1.2	1.4	0.3	0.2	20.8	17.3
Anorectic (Weight-Loss) Stimulants	0.8	1.0	0.1	0.1	9.3	8.3
Provigil^®	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Stimulant¹	0.9	1.0	0.0	0.0	1.2	3.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.109A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	1,837	1,593	430	288	430	288
Amphetamine or Methylphenidate Products	1,643	1,409	407	253	407	253
Amphetamine Products	1,301	964	373	235	373	235
Methylphenidate Products	590	625	80	61	80	61
Anorectic (Weight-Loss) Stimulants	72	32	15	5	*	*
Provigil^®	9	12	2	*	*	*
Any Other Prescription Stimulant¹	360	272	17	22	17	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.109B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	7.4	6.4	1.7	1.2	23.4	18.1
Amphetamine or Methylphenidate Products	6.6	5.6	1.6	1.0	24.8	18.0
Amphetamine Products	5.2	3.9	1.5	0.9	28.6	24.3
Methylphenidate Products	2.4	2.5	0.3	0.2	13.6	9.8
Anorectic (Weight-Loss) Stimulants	0.3	0.1	0.1	0.0	*	*
Provigil^®	0.0	0.0	0.0	*	*	*
Any Other Prescription Stimulant¹	1.4	1.1	0.1	0.1	4.7	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.110A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	16,453	16,739	4,499	4,804	4,499	4,804
Amphetamine or Methylphenidate Products	12,650	12,454	4,304	4,446	4,304	4,446
Amphetamine Products	11,346	10,890	4,114	4,200	4,114	4,200
Methylphenidate Products	2,792	3,187	623	600	623	600
Anorectic (Weight-Loss) Stimulants	2,148	2,758	193	226	193	226
Provigil^®	527	524	85	119	*	*
Any Other Prescription Stimulant¹	2,235	2,491	14	76	14	76
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.110B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	6.6	6.6	1.8	1.9	27.3	28.7
Amphetamine or Methylphenidate Products	5.1	4.9	1.7	1.8	34.0	35.7
Amphetamine Products	4.5	4.3	1.6	1.7	36.3	38.6
Methylphenidate Products	1.1	1.3	0.2	0.2	22.3	18.8
Anorectic (Weight-Loss) Stimulants	0.9	1.1	0.1	0.1	9.0	8.2
Provigil^®	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Stimulant¹	0.9	1.0	0.0	0.0	0.6	3.0
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.111A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	4,320	3,773	1,951	1,616	1,951	1,616
Amphetamine or Methylphenidate Products	3,998	3,536	1,926	1,603	1,926	1,603
Amphetamine Products	3,615	3,168	1,845	1,529	1,845	1,529
Methylphenidate Products	1,011	887	300	216	300	216
Anorectic (Weight-Loss) Stimulants	189	192	27	19	*	*
Provigil^®	47	21	10	6	*	*
Any Other Prescription Stimulant¹	361	247	14	15	14	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.111B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	12.8	11.3	5.8	4.8	45.2	42.8
Amphetamine or Methylphenidate Products	11.9	10.6	5.7	4.8	48.2	45.3
Amphetamine Products	10.7	9.5	5.5	4.6	51.0	48.3
Methylphenidate Products	3.0	2.6	0.9	0.6	29.7	24.4
Anorectic (Weight-Loss) Stimulants	0.6	0.6	0.1	0.1	*	*
Provigil^®	0.1	0.1	0.0	0.0	*	*
Any Other Prescription Stimulant¹	1.1	0.7	0.0	0.0	4.0	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.112A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	12,133	12,966	2,548	3,188	2,548	3,188
Amphetamine or Methylphenidate Products	8,652	8,918	2,378	2,843	2,378	2,843
Amphetamine Products	7,732	7,721	2,269	2,671	2,269	2,671
Methylphenidate Products	1,781	2,300	323	383	323	383
Anorectic (Weight-Loss) Stimulants	1,959	2,566	165	207	165	207
Provigil^®	480	503	76	113	*	*
Any Other Prescription Stimulant¹	1,874	2,244	*	60	*	60
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.112B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Stimulant Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Stimulant Subtypes (2020)
ANY PRESCRIPTION STIMULANT	5.6	5.9	1.2	1.5	21.0	24.6
Amphetamine or Methylphenidate Products	4.0	4.1	1.1	1.3	27.5	31.9
Amphetamine Products	3.6	3.5	1.0	1.2	29.3	34.6
Methylphenidate Products	0.8	1.1	0.1	0.2	18.1	16.7
Anorectic (Weight-Loss) Stimulants	0.9	1.2	0.1	0.1	8.4	8.1
Provigil^®	0.2	0.2	0.0	0.1	*	*
Any Other Prescription Stimulant¹	0.9	1.0	*	0.0	*	2.7
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of stimulants containing other active ingredients. Reports of misuse of “any other prescription stimulant” that correspond only to the specific stimulant categories shown in the table are excluded from estimates for Any Other Prescription Stimulant and are included instead in the relevant stimulant category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.113A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	35,601	35,018	5,220	5,460	5,220	5,460
Benzodiazepine Tranquilizers	28,316	26,095	4,819	4,739	4,819	4,739
Alprazolam Products	16,748	14,507	3,668	3,419	3,668	3,419
Lorazepam Products	7,787	7,189	795	723	795	723
Clonazepam Products	5,998	6,357	1,029	1,234	1,029	1,234
Diazepam Products	5,672	5,706	758	971	758	971
Muscle Relaxants	6,049	8,127	552	845	552	845
Cyclobenzaprine	4,955	7,289	361	738	361	738
Soma^®	1,182	1,215	223	206	223	*
Any Other Prescription Tranquilizer¹	5,738	5,428	97	228	97	228
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.113B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	12.9	12.6	1.9	2.0	14.7	15.6
Benzodiazepine Tranquilizers	10.3	9.4	1.8	1.7	17.0	18.2
Alprazolam Products	6.1	5.2	1.3	1.2	21.9	23.6
Lorazepam Products	2.8	2.6	0.3	0.3	10.2	10.1
Clonazepam Products	2.2	2.3	0.4	0.4	17.2	19.4
Diazepam Products	2.1	2.1	0.3	0.4	13.4	17.0
Muscle Relaxants	2.2	2.9	0.2	0.3	9.1	10.4
Cyclobenzaprine	1.8	2.6	0.1	0.3	7.3	10.1
Soma^®	0.4	0.4	0.1	0.1	18.8	*
Any Other Prescription Tranquilizer¹	2.1	2.0	0.0	0.1	1.7	4.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.114A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	1,010	588	392	196	392	196
Benzodiazepine Tranquilizers	700	398	371	152	371	*
Alprazolam Products	613	308	359	151	359	*
Lorazepam Products	84	48	9	9	*	*
Clonazepam Products	83	41	33	2	*	*
Diazepam Products	80	44	16	7	*	*
Muscle Relaxants	45	27	15	7	*	*
Cyclobenzaprine	32	27	4	7	*	*
Soma^®	11	*	10	*	*	*
Any Other Prescription Tranquilizer¹	367	184	16	23	16	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.114B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	4.1	2.4	1.6	0.8	38.8	33.3
Benzodiazepine Tranquilizers	2.8	1.6	1.5	0.6	52.9	*
Alprazolam Products	2.5	1.2	1.4	0.6	58.6	*
Lorazepam Products	0.3	0.2	0.0	0.0	*	*
Clonazepam Products	0.3	0.2	0.1	0.0	*	*
Diazepam Products	0.3	0.2	0.1	0.0	*	*
Muscle Relaxants	0.2	0.1	0.1	0.0	*	*
Cyclobenzaprine	0.1	0.1	0.0	0.0	*	*
Soma^®	0.0	*	0.0	*	*	*
Any Other Prescription Tranquilizer¹	1.5	0.7	0.1	0.1	4.3	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.115A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	34,591	34,430	4,829	5,264	4,829	5,264
Benzodiazepine Tranquilizers	27,615	25,697	4,448	4,587	4,448	4,587
Alprazolam Products	16,134	14,199	3,308	3,269	3,308	3,269
Lorazepam Products	7,703	7,140	786	714	786	714
Clonazepam Products	5,916	6,316	996	1,232	996	1,232
Diazepam Products	5,592	5,662	742	965	742	965
Muscle Relaxants	6,005	8,099	537	838	537	838
Cyclobenzaprine	4,923	7,262	358	731	358	731
Soma^®	1,170	1,214	213	206	213	*
Any Other Prescription Tranquilizer¹	5,371	5,244	81	205	81	205
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.115B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	13.8	13.7	1.9	2.1	14.0	15.3
Benzodiazepine Tranquilizers	11.0	10.2	1.8	1.8	16.1	17.9
Alprazolam Products	6.4	5.6	1.3	1.3	20.5	23.0
Lorazepam Products	3.1	2.8	0.3	0.3	10.2	10.0
Clonazepam Products	2.4	2.5	0.4	0.5	16.8	19.5
Diazepam Products	2.2	2.2	0.3	0.4	13.3	17.0
Muscle Relaxants	2.4	3.2	0.2	0.3	8.9	10.3
Cyclobenzaprine	2.0	2.9	0.1	0.3	7.3	10.1
Soma^®	0.5	0.5	0.1	0.1	18.2	*
Any Other Prescription Tranquilizer¹	2.1	2.1	0.0	0.1	1.5	3.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.116A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	3,419	3,338	1,313	1,108	1,313	1,108
Benzodiazepine Tranquilizers	2,922	2,822	1,260	1,087	1,260	1,087
Alprazolam Products	2,229	1,992	1,091	932	1,091	932
Lorazepam Products	630	701	132	169	132	169
Clonazepam Products	599	641	214	216	214	*
Diazepam Products	451	561	138	117	138	*
Muscle Relaxants	314	396	59	64	59	*
Cyclobenzaprine	258	351	35	41	35	*
Soma^®	70	73	33	42	*	*
Any Other Prescription Tranquilizer¹	515	466	33	3	33	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.116B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	10.1	10.0	3.9	3.3	38.4	33.2
Benzodiazepine Tranquilizers	8.7	8.4	3.7	3.2	43.1	38.5
Alprazolam Products	6.6	5.9	3.2	2.8	49.0	46.8
Lorazepam Products	1.9	2.1	0.4	0.5	21.0	24.1
Clonazepam Products	1.8	1.9	0.6	0.6	35.7	*
Diazepam Products	1.3	1.7	0.4	0.4	30.6	*
Muscle Relaxants	0.9	1.2	0.2	0.2	18.9	*
Cyclobenzaprine	0.8	1.0	0.1	0.1	13.5	*
Soma^®	0.2	0.2	0.1	0.1	*	*
Any Other Prescription Tranquilizer¹	1.5	1.4	0.1	0.0	6.4	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.117A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	31,172	31,092	3,516	4,156	3,516	4,156
Benzodiazepine Tranquilizers	24,693	22,875	3,188	3,500	3,188	3,500
Alprazolam Products	13,906	12,207	2,217	2,336	2,217	2,336
Lorazepam Products	7,074	6,439	654	545	654	545
Clonazepam Products	5,317	5,675	782	1,016	782	1,016
Diazepam Products	5,141	5,101	604	847	604	847
Muscle Relaxants	5,690	7,703	477	774	477	774
Cyclobenzaprine	4,665	6,911	323	690	323	690
Soma^®	1,100	1,141	179	164	179	*
Any Other Prescription Tranquilizer¹	4,856	4,778	48	202	48	202
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.117B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Tranquilizer Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Tranquilizer Subtypes (2020)
ANY PRESCRIPTION TRANQUILIZER	14.4	14.2	1.6	1.9	11.3	13.4
Benzodiazepine Tranquilizers	11.4	10.5	1.5	1.6	12.9	15.3
Alprazolam Products	6.4	5.6	1.0	1.1	15.9	19.1
Lorazepam Products	3.3	2.9	0.3	0.2	9.2	8.5
Clonazepam Products	2.5	2.6	0.4	0.5	14.7	17.9
Diazepam Products	2.4	2.3	0.3	0.4	11.7	16.6
Muscle Relaxants	2.6	3.5	0.2	0.4	8.4	10.0
Cyclobenzaprine	2.2	3.2	0.1	0.3	6.9	10.0
Soma^®	0.5	0.5	0.1	0.1	16.3	*
Any Other Prescription Tranquilizer¹	2.2	2.2	0.0	0.1	1.0	4.2
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of tranquilizers containing other active ingredients. Reports of misuse of “any other prescription tranquilizer” that correspond only to the specific tranquilizer categories shown in the table are excluded from estimates for Any Other Prescription Tranquilizer and are included instead in the relevant tranquilizer category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.118A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	15,636	15,364	1,098	1,240	1,098	1,240
Zolpidem Products	8,816	8,050	774	807	774	807
Eszopiclone Products	932	991	21	54	21	54
Zaleplon Products	414	252	25	*	*	*
Benzodiazepine Sedatives	1,729	1,675	68	101	68	101
Flurazepam	140	113	*	16	*	*
Temazepam Products	1,038	898	42	83	42	*
Triazolam Products	580	689	26	27	26	*
Barbiturates	510	597	44	50	*	*
Any Other Prescription Sedative¹	5,441	5,946	237	291	237	291
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.118B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	5.7	5.5	0.4	0.4	7.0	8.1
Zolpidem Products	3.2	2.9	0.3	0.3	8.8	10.0
Eszopiclone Products	0.3	0.4	0.0	0.0	2.2	5.4
Zaleplon Products	0.2	0.1	0.0	*	*	*
Benzodiazepine Sedatives	0.6	0.6	0.0	0.0	3.9	6.0
Flurazepam	0.1	0.0	*	0.0	*	*
Temazepam Products	0.4	0.3	0.0	0.0	4.1	*
Triazolam Products	0.2	0.2	0.0	0.0	4.4	*
Barbiturates	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Sedative¹	2.0	2.1	0.1	0.1	4.3	4.9
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.119A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	545	429	82	35	82	35
Zolpidem Products	143	66	38	4	*	*
Eszopiclone Products	17	4	4	1	*	*
Zaleplon Products	30	6	7	*	*	*
Benzodiazepine Sedatives	69	25	11	5	*	*
Flurazepam	10	9	3	5	*	*
Temazepam Products	23	*	2	*	*	*
Triazolam Products	39	16	6	*	*	*
Barbiturates	47	15	11	*	*	*
Any Other Prescription Sedative¹	358	324	24	20	24	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.119B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	2.2	1.7	0.3	0.1	15.1	8.1
Zolpidem Products	0.6	0.3	0.2	0.0	*	*
Eszopiclone Products	0.1	0.0	0.0	0.0	*	*
Zaleplon Products	0.1	0.0	0.0	*	*	*
Benzodiazepine Sedatives	0.3	0.1	0.0	0.0	*	*
Flurazepam	0.0	0.0	0.0	0.0	*	*
Temazepam Products	0.1	*	0.0	*	*	*
Triazolam Products	0.2	0.1	0.0	*	*	*
Barbiturates	0.2	0.1	0.0	*	*	*
Any Other Prescription Sedative¹	1.4	1.3	0.1	0.1	6.8	*
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.120A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	15,091	14,935	1,016	1,205	1,016	1,205
Zolpidem Products	8,673	7,984	736	803	736	803
Eszopiclone Products	915	987	17	52	17	52
Zaleplon Products	384	246	19	*	*	*
Benzodiazepine Sedatives	1,660	1,650	57	96	57	96
Flurazepam	130	104	*	*	*	*
Temazepam Products	1,015	898	41	83	41	*
Triazolam Products	541	673	19	27	19	*
Barbiturates	463	582	33	50	*	*
Any Other Prescription Sedative¹	5,083	5,622	212	271	212	271
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.120B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	6.0	5.9	0.4	0.5	6.7	8.1
Zolpidem Products	3.5	3.2	0.3	0.3	8.5	10.1
Eszopiclone Products	0.4	0.4	0.0	0.0	1.8	5.3
Zaleplon Products	0.2	0.1	0.0	*	*	*
Benzodiazepine Sedatives	0.7	0.7	0.0	0.0	3.4	5.8
Flurazepam	0.1	0.0	*	*	*	*
Temazepam Products	0.4	0.4	0.0	0.0	4.0	*
Triazolam Products	0.2	0.3	0.0	0.0	3.6	*
Barbiturates	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Sedative¹	2.0	2.2	0.1	0.1	4.2	4.8
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.121A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	1,051	1,066	175	251	175	251
Zolpidem Products	436	428	120	189	120	*
Eszopiclone Products	35	70	4	5	*	*
Zaleplon Products	10	13	2	*	*	*
Benzodiazepine Sedatives	113	146	28	16	*	*
Flurazepam	12	16	3	*	*	*
Temazepam Products	38	22	20	9	*	*
Triazolam Products	75	108	12	7	*	*
Barbiturates	29	57	4	5	*	*
Any Other Prescription Sedative¹	572	500	26	40	26	40
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.121B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	3.1	3.2	0.5	0.7	16.6	23.5
Zolpidem Products	1.3	1.3	0.4	0.6	27.5	*
Eszopiclone Products	0.1	0.2	0.0	0.0	*	*
Zaleplon Products	0.0	0.0	0.0	*	*	*
Benzodiazepine Sedatives	0.3	0.4	0.1	0.0	*	*
Flurazepam	0.0	0.0	0.0	*	*	*
Temazepam Products	0.1	0.1	0.1	0.0	*	*
Triazolam Products	0.2	0.3	0.0	0.0	*	*
Barbiturates	0.1	0.2	0.0	0.0	*	*
Any Other Prescription Sedative¹	1.7	1.5	0.1	0.1	4.6	8.1
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.122A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	14,040	13,869	841	954	841	954
Zolpidem Products	8,236	7,556	616	613	616	613
Eszopiclone Products	880	917	12	47	12	*
Zaleplon Products	374	233	16	*	*	*
Benzodiazepine Sedatives	1,547	1,503	29	80	29	80
Flurazepam	118	88	*	12	*	*
Temazepam Products	977	875	21	74	21	*
Triazolam Products	466	565	*	20	*	*
Barbiturates	434	525	29	45	*	*
Any Other Prescription Sedative¹	4,510	5,122	186	230	186	230
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.122B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Sedative Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Sedative Subtypes (2020)
ANY PRESCRIPTION SEDATIVE	6.5	6.3	0.4	0.4	6.0	6.9
Zolpidem Products	3.8	3.5	0.3	0.3	7.5	8.1
Eszopiclone Products	0.4	0.4	0.0	0.0	1.4	*
Zaleplon Products	0.2	0.1	0.0	*	*	*
Benzodiazepine Sedatives	0.7	0.7	0.0	0.0	1.9	5.3
Flurazepam	0.1	0.0	*	0.0	*	*
Temazepam Products	0.5	0.4	0.0	0.0	2.2	*
Triazolam Products	0.2	0.3	*	0.0	*	*
Barbiturates	0.2	0.2	0.0	0.0	*	*
Any Other Prescription Sedative¹	2.1	2.3	0.1	0.1	4.1	4.5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes use or misuse of sedatives containing other active ingredients. Reports of misuse of “any other prescription sedative” that correspond only to the specific sedative categories shown in the table are excluded from estimates for Any Other Prescription Sedative and are included instead in the relevant sedative category. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.123A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	29,408	27,026	4,841	4,779	4,841	4,779
Benzodiazepine Tranquilizers	28,316	26,095	4,819	4,739	4,819	4,739
Alprazolam Products	16,748	14,507	3,668	3,419	3,668	3,419
Lorazepam Products	7,787	7,189	795	723	795	723
Clonazepam Products	5,998	6,357	1,029	1,234	1,029	1,234
Diazepam Products	5,672	5,706	758	971	758	971
Benzodiazepine Sedatives	1,729	1,675	68	101	68	101
Flurazepam	140	113	*	16	*	*
Temazepam Products	1,038	898	42	83	42	*
Triazolam Products	580	689	26	27	26	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	58	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.123B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	10.7	9.8	1.8	1.7	16.5	17.7
Benzodiazepine Tranquilizers	10.3	9.4	1.8	1.7	17.0	18.2
Alprazolam Products	6.1	5.2	1.3	1.2	21.9	23.6
Lorazepam Products	2.8	2.6	0.3	0.3	10.2	10.1
Clonazepam Products	2.2	2.3	0.4	0.4	17.2	19.4
Diazepam Products	2.1	2.1	0.3	0.4	13.4	17.0
Benzodiazepine Sedatives	0.6	0.6	0.0	0.0	3.9	6.0
Flurazepam	0.1	0.0	*	0.0	*	*
Temazepam Products	0.4	0.3	0.0	0.0	4.1	*
Triazolam Products	0.2	0.2	0.0	0.0	4.4	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	0.0	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.124A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	749	418	381	157	381	*
Benzodiazepine Tranquilizers	700	398	371	152	371	*
Alprazolam Products	613	308	359	151	359	*
Lorazepam Products	84	48	9	9	*	*
Clonazepam Products	83	41	33	2	*	*
Diazepam Products	80	44	16	7	*	*
Benzodiazepine Sedatives	69	25	11	5	*	*
Flurazepam	10	9	3	5	*	*
Temazepam Products	23	*	2	*	*	*
Triazolam Products	39	16	6	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	*	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.124B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	3.0	1.7	1.5	0.6	50.9	*
Benzodiazepine Tranquilizers	2.8	1.6	1.5	0.6	52.9	*
Alprazolam Products	2.5	1.2	1.4	0.6	58.6	*
Lorazepam Products	0.3	0.2	0.0	0.0	*	*
Clonazepam Products	0.3	0.2	0.1	0.0	*	*
Diazepam Products	0.3	0.2	0.1	0.0	*	*
Benzodiazepine Sedatives	0.3	0.1	0.0	0.0	*	*
Flurazepam	0.0	0.0	0.0	0.0	*	*
Temazepam Products	0.1	*	0.0	*	*	*
Triazolam Products	0.2	0.1	0.0	*	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	*	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.125A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	28,659	26,607	4,460	4,622	4,460	4,622
Benzodiazepine Tranquilizers	27,615	25,697	4,448	4,587	4,448	4,587
Alprazolam Products	16,134	14,199	3,308	3,269	3,308	3,269
Lorazepam Products	7,703	7,140	786	714	786	714
Clonazepam Products	5,916	6,316	996	1,232	996	1,232
Diazepam Products	5,592	5,662	742	965	742	965
Benzodiazepine Sedatives	1,660	1,650	57	96	57	96
Flurazepam	130	104	*	*	*	*
Temazepam Products	1,015	898	41	83	41	*
Triazolam Products	541	673	19	27	19	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	58	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.125B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	11.4	10.6	1.8	1.8	15.6	17.4
Benzodiazepine Tranquilizers	11.0	10.2	1.8	1.8	16.1	17.9
Alprazolam Products	6.4	5.6	1.3	1.3	20.5	23.0
Lorazepam Products	3.1	2.8	0.3	0.3	10.2	10.0
Clonazepam Products	2.4	2.5	0.4	0.5	16.8	19.5
Diazepam Products	2.2	2.2	0.3	0.4	13.3	17.0
Benzodiazepine Sedatives	0.7	0.7	0.0	0.0	3.4	5.8
Flurazepam	0.1	0.0	*	*	*	*
Temazepam Products	0.4	0.4	0.0	0.0	4.0	*
Triazolam Products	0.2	0.3	0.0	0.0	3.6	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	0.0	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.126A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	2,983	2,861	1,266	1,097	1,266	1,097
Benzodiazepine Tranquilizers	2,922	2,822	1,260	1,087	1,260	1,087
Alprazolam Products	2,229	1,992	1,091	932	1,091	932
Lorazepam Products	630	701	132	169	132	169
Clonazepam Products	599	641	214	216	214	*
Diazepam Products	451	561	138	117	138	*
Benzodiazepine Sedatives	113	146	28	16	*	*
Flurazepam	12	16	3	*	*	*
Temazepam Products	38	22	20	9	*	*
Triazolam Products	75	108	12	7	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	4	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.126B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	8.8	8.5	3.8	3.3	42.4	38.3
Benzodiazepine Tranquilizers	8.7	8.4	3.7	3.2	43.1	38.5
Alprazolam Products	6.6	5.9	3.2	2.8	49.0	46.8
Lorazepam Products	1.9	2.1	0.4	0.5	21.0	24.1
Clonazepam Products	1.8	1.9	0.6	0.6	35.7	*
Diazepam Products	1.3	1.7	0.4	0.4	30.6	*
Benzodiazepine Sedatives	0.3	0.4	0.1	0.0	*	*
Flurazepam	0.0	0.0	0.0	*	*	*
Temazepam Products	0.1	0.1	0.1	0.0	*	*
Triazolam Products	0.2	0.3	0.0	0.0	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	0.0	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.127A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	25,676	23,747	3,194	3,526	3,194	3,526
Benzodiazepine Tranquilizers	24,693	22,875	3,188	3,500	3,188	3,500
Alprazolam Products	13,906	12,207	2,217	2,336	2,217	2,336
Lorazepam Products	7,074	6,439	654	545	654	545
Clonazepam Products	5,317	5,675	782	1,016	782	1,016
Diazepam Products	5,141	5,101	604	847	604	847
Benzodiazepine Sedatives	1,547	1,503	29	80	29	80
Flurazepam	118	88	*	12	*	*
Temazepam Products	977	875	21	74	21	*
Triazolam Products	466	565	*	20	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	54	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.

210616

Table 1.127B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2019 and 2020
Benzodiazepine Subtype	Any Use in Past Year (2019)	Any Use in Past Year (2020)	Misuse in Past Year among Total Population (2019)	Misuse in Past Year among Total Population (2020)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2019)	Misuse in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2020)
ANY PRESCRIPTION BENZODIAZEPINE	11.9	10.9	1.5	1.6	12.4	14.8
Benzodiazepine Tranquilizers	11.4	10.5	1.5	1.6	12.9	15.3
Alprazolam Products	6.4	5.6	1.0	1.1	15.9	19.1
Lorazepam Products	3.3	2.9	0.3	0.2	9.2	8.5
Clonazepam Products	2.5	2.6	0.4	0.5	14.7	17.9
Diazepam Products	2.4	2.3	0.3	0.4	11.7	16.6
Benzodiazepine Sedatives	0.7	0.7	0.0	0.0	1.9	5.3
Flurazepam	0.1	0.0	*	0.0	*	*
Temazepam Products	0.5	0.4	0.0	0.0	2.2	*
Triazolam Products	0.2	0.3	*	0.0	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives¹	da	da	*	0.0	da	da
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues. NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details. ¹ Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2019 and Quarters 1 and 4, 2020.